data_2mcz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mcz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.533 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 10.2 m120 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.444 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.533 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.767 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 8.5 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE1' HD22 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.554 ' CA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.767 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.757 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.632 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.632 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.464 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.582 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.689 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.757 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' NE2' ' A' ' 81' ' ' GLN . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.704 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.704 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.658 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.6 t-20 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.658 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.483 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HA ' HG21 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.57 HD12 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 80' ' ' ILE . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.624 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 65.7 tp60 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.624 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.61 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' SER . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.57 ' HE2' HD12 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' HG21 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.592 ' HB ' HG22 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 82' ' ' PHE . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.578 HG13 HD12 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.721 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.756 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 18' ' ' ASP . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 17' ' ' THR . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 28' ' ' LEU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HG2' ' HG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.528 ' HG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.594 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HH ' HD13 ' A' ' 43' ' ' ILE . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.754 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.754 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.406 HD13 ' HH ' ' A' ' 30' ' ' TYR . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.82 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.557 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 44' ' ' ILE . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.641 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.7 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.504 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.517 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.518 ' CD1' ' HZ1' ' A' ' 87' ' ' LYS . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.565 HG13 ' CG2' ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.641 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.563 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.626 HG12 ' CE1' ' A' ' 82' ' ' PHE . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.416 HG21 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.439 ' NE1' ' O ' ' A' ' 64' ' ' ARG . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t30 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 58' ' ' CYS . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 29' ' ' ASN . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.769 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.293 36.8 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.578 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.769 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.574 ' HH ' HD13 ' A' ' 43' ' ' ILE . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.407 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' HH ' ' A' ' 30' ' ' TYR . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.583 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.444 ' HA ' ' CG2' ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.548 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.502 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.706 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.433 ' O ' ' HE2' ' A' ' 73' ' ' MET . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.498 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.528 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.635 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.503 HG12 HD11 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.738 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.578 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.44 ' N ' HG22 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.578 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.451 HD12 HG23 ' A' ' 43' ' ' ILE . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.684 ' O ' HG21 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.583 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' HG21 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.417 ' HG ' ' C ' ' A' ' 48' ' ' ASN . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.675 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.678 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.565 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.651 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 84' ' ' SER . 3.2 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.412 HE21 ' CB ' ' A' ' 101' ' ' SER . 58.9 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' N ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.543 ' N ' HG23 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.558 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.554 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.548 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.791 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.661 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.569 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.901 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.901 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 12' ' ' ARG . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.817 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.33 44.5 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.661 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.661 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.817 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HG3' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.723 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.512 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.433 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.723 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.608 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.608 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.566 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' SER . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 80' ' ' ILE . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 HD13 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.522 HE21 ' CB ' ' A' ' 101' ' ' SER . 57.1 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 92' ' ' LYS . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.471 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.577 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.522 ' CB ' HE21 ' A' ' 85' ' ' GLN . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.658 HG12 ' CE1' ' A' ' 82' ' ' PHE . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.435 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.843 ' N ' HE21 ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 57' ' ' ARG . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.6 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.671 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.617 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.465 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 t-20 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.674 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.648 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.674 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.477 ' HE2' ' O ' ' A' ' 89' ' ' SER . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.589 ' HE3' HD12 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.569 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.676 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.676 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.526 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.555 HG22 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.648 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.874 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.65 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.65 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.649 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.516 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.795 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.953 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.673 ' O ' HG22 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.953 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.714 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' HG21 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.874 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.567 HG21 ' O ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.714 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.71 ' SG ' HG23 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.604 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.601 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.836 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 80' ' ' ILE . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.432 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.836 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.507 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.526 ' H ' HG21 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' SG ' ' A' ' 63' ' ' CYS . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.537 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 46.3 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.545 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.449 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.663 ' HA ' HE22 ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.752 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.785 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.785 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.744 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.621 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG3' HG22 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.914 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 80' ' ' ILE . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 HD12 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.447 ' N ' HG22 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.723 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 18.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 HG23 ' CH2' ' A' ' 113' ' ' TRP . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.914 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.578 ' H ' HG23 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.404 ' HB ' HG22 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.494 ' OG ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.6 HG12 ' CZ ' ' A' ' 82' ' ' PHE . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.588 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.541 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.588 HG12 ' HG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.471 ' CH2' HG23 ' A' ' 86' ' ' ILE . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.75 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.466 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.509 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.509 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.478 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 43' ' ' ILE . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.544 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HG3' HE21 ' A' ' 81' ' ' GLN . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.749 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.749 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.711 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.449 HD22 ' HE1' ' A' ' 73' ' ' MET . 64.5 t30 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.57 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.491 HE21 ' HG3' ' A' ' 60' ' ' ARG . 65.3 tp60 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.6 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.535 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.667 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.735 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.735 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.89 ' O ' HD13 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.684 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.925 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 21' ' ' GLU . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.509 ' N ' HD11 ' A' ' 24' ' ' ILE . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.541 HD22 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 ' C ' HG13 ' A' ' 44' ' ' ILE . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 26' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m120 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.925 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.536 HG21 ' O ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.775 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.486 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG3' ' NE2' ' A' ' 81' ' ' GLN . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.714 ' CG ' HG22 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.76 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.714 HG22 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.753 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 57.0 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.753 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.602 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 97' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.602 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.681 HG12 ' CE1' ' A' ' 82' ' ' PHE . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 86' ' ' ILE . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 98' ' ' GLY . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.749 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.554 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.732 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.749 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.474 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HG3' HE21 ' A' ' 81' ' ' GLN . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.557 HE21 ' HG3' ' A' ' 60' ' ' ARG . 66.0 tp60 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.429 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.555 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.72 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.683 ' HG ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.567 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.658 HG12 ' CE1' ' A' ' 82' ' ' PHE . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' H ' HG23 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 61' ' ' LYS . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.683 ' CD ' ' HG ' ' A' ' 99' ' ' SER . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.916 ' O ' HD11 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 3' ' ' ASN . 10.1 m120 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 5.4 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.562 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.658 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.522 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.75 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.686 HG12 ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.75 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 43' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.566 ' CG ' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.496 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.503 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.503 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.414 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.676 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.545 HD12 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' SER . 70.2 tp60 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.566 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.654 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.607 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.704 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.523 ' CD1' HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.592 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.596 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.725 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.71 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.785 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 23.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.554 HD11 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.676 HG23 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.688 ' HA ' HE22 ' A' ' 15' ' ' GLN . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.785 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.631 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.596 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.545 ' HB3' ' C ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 m120 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 44' ' ' ILE . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.427 HH22 ' CB ' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.793 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.793 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.564 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.595 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.617 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 86' ' ' ILE . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD12 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.467 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.813 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.508 ' HA ' HD12 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.504 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.591 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.605 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.551 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.639 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HD2' HG22 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 2.8 t-20 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.511 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.642 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.7 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.546 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.583 ' N ' HE22 ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' OH ' HD12 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.783 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.521 ' C ' HG22 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.678 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.76 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 36' ' ' TYR . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.783 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.556 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.7 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 44' ' ' ILE . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.648 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.76 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.601 ' HD3' ' NE2' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.498 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.463 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.638 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.472 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.438 HG12 HG23 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 33.4 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.683 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.9 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.468 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.687 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' CD ' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.687 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.518 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG12 ' CD1' ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.583 ' CD ' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.658 ' O ' HD11 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.468 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 10' ' ' PHE . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.628 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.719 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.58 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.753 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.643 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.456 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.567 HG23 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.643 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.753 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.745 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.745 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.525 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.54 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.435 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 90' ' ' CYS . 99.3 m-20 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.648 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.52 ' HA ' HG23 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.442 ' N ' HG21 ' A' ' 91' ' ' THR . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.538 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.42 ' CB ' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.635 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.635 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.57 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.615 ' H ' ' HB3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.814 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.644 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.493 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 1.3 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 18' ' ' ASP . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 17' ' ' THR . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.814 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.43 ' HH ' ' HG3' ' A' ' 5' ' ' PRO . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.558 HD12 HG21 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ILE . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' HG2' ' HH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.558 ' CD ' HG21 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.651 HD22 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.651 ' HG3' HD22 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.456 HD12 ' HE2' ' A' ' 87' ' ' LYS . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG23 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.798 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 51.7 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.798 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.516 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.923 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.489 ' N ' HD21 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.641 HG12 ' CE1' ' A' ' 82' ' ' PHE . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.597 ' HB3' HD11 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 106' ' ' ILE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.923 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.56 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.442 ' O ' HG11 ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.602 HD22 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.71 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.701 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.544 HE22 ' CA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 13' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.592 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.53 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.701 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' CG ' ' N ' ' A' ' 42' ' ' SER . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.6 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 m120 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.6 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.56 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.687 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.455 ' HA ' HG21 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.609 HD12 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.784 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.923 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.436 ' N ' HG21 ' A' ' 91' ' ' THR . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' HG21 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.485 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.672 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.672 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.58 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.451 HD13 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 35' ' ' GLY . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.513 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.492 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 105' ' ' ILE . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.58 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.557 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.546 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.761 HD22 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.761 ' CD2' HD22 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.77 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.77 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD2' HD13 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.593 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.608 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.617 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.544 ' H ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 80' ' ' ILE . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.527 ' N ' HG23 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.498 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 9.0 mm100 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.42 ' O ' HD23 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.649 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.512 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.521 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HG13 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.409 ' HG ' HG12 ' A' ' 112' ' ' ILE . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 63' ' ' CYS . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.409 HG12 ' HG ' ' A' ' 107' ' ' SER . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.472 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.573 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.575 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HD2' HD13 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.256 24.8 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.725 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 HD11 ' CZ3' ' A' ' 51' ' ' TRP . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.685 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.697 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.433 HG22 ' NH1' ' A' ' 57' ' ' ARG . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.549 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.583 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.698 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.489 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.822 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.454 ' HA ' HG21 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.736 ' HG3' ' CG2' ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.736 ' CG2' ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.74 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 44.1 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.74 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.419 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.52 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HB ' HG22 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 82' ' ' PHE . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 61' ' ' LYS . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 105' ' ' ILE . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.419 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 97' ' ' ILE . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.71 ' CD ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' GLU . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' GLU . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.71 ' HB3' ' CD ' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.583 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.531 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' HA3' HG22 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.477 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.477 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.46 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.487 ' HD2' HE21 ' A' ' 81' ' ' GLN . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.492 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' SER . 18.4 tm0? -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.619 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG23 ' CH2' ' A' ' 113' ' ' TRP . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.628 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.692 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 HH21 ' A' ' 122' ' ' ARG . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.682 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.682 ' N ' ' HG3' ' A' ' 92' ' ' LYS . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.492 ' H ' HG21 ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.538 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.559 HD13 HG13 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CH2' HG23 ' A' ' 86' ' ' ILE . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.538 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.492 HG21 ' H ' ' A' ' 98' ' ' GLY . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.703 HH21 HG23 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.533 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 10.2 m120 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.454 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.512 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.444 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.533 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.767 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 8.5 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CE1' HD22 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.554 ' CA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.767 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.757 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.632 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.632 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.683 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.464 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.582 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.689 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.757 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' NE2' ' A' ' 81' ' ' GLN . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.704 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.704 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.658 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.6 t-20 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.658 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.483 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HA ' HG21 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.57 HD12 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 80' ' ' ILE . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.624 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 65.7 tp60 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.624 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.61 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 101' ' ' SER . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.57 ' HE2' HD12 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' HG21 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.721 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.592 ' HB ' HG22 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 82' ' ' PHE . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.578 HG13 HD12 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.721 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.502 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.475 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 HG23 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.756 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 18' ' ' ASP . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 17' ' ' THR . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 28' ' ' LEU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HG2' ' HG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.528 ' HG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.594 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HH ' HD13 ' A' ' 43' ' ' ILE . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.754 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.754 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 HD13 ' HH ' ' A' ' 30' ' ' TYR . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.82 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.557 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 44' ' ' ILE . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.641 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.7 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.504 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.517 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.518 ' CD1' ' HZ1' ' A' ' 87' ' ' LYS . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.565 HG13 ' CG2' ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.641 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.563 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.521 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.626 HG12 ' CE1' ' A' ' 82' ' ' PHE . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 HG21 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.439 ' NE1' ' O ' ' A' ' 64' ' ' ARG . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t30 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 58' ' ' CYS . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 29' ' ' ASN . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.769 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.293 36.8 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.578 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.769 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.574 ' HH ' HD13 ' A' ' 43' ' ' ILE . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.407 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' HH ' ' A' ' 30' ' ' TYR . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.53 HD13 HG21 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.583 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.551 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.444 ' HA ' ' CG2' ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.706 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.548 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.502 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.706 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.433 ' O ' ' HE2' ' A' ' 73' ' ' MET . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' H ' HG23 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.498 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.738 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.528 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.635 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD11 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.503 HG12 HD11 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.738 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.481 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.578 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.44 ' N ' HG22 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.578 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.791 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.451 HD12 HG23 ' A' ' 43' ' ' ILE . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.684 ' O ' HG21 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.583 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' HG21 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.417 ' HG ' ' C ' ' A' ' 48' ' ' ASN . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.675 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.675 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.678 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.565 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.651 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 84' ' ' SER . 3.2 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.412 HE21 ' CB ' ' A' ' 101' ' ' SER . 58.9 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.543 HG23 ' N ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.543 ' N ' HG23 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.558 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.554 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.548 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.791 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.686 HG11 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.661 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.569 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.901 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.901 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 12' ' ' ARG . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.817 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.33 44.5 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.661 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.661 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.817 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.467 ' HG3' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' CD ' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.723 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.512 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.9 m120 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.433 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.723 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.558 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.608 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.608 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' SER . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 80' ' ' ILE . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 HD13 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.522 HE21 ' CB ' ' A' ' 101' ' ' SER . 57.1 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' N ' ' HG3' ' A' ' 92' ' ' LYS . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.471 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.577 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.522 ' CB ' HE21 ' A' ' 85' ' ' GLN . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.658 HG12 ' CE1' ' A' ' 82' ' ' PHE . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.535 HG12 HD11 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.435 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.843 ' N ' HE21 ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.768 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 57' ' ' ARG . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.465 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.6 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.671 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.617 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA3' HG22 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.586 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.785 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.465 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 t-20 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.674 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.674 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.477 ' HE2' ' O ' ' A' ' 89' ' ' SER . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.589 HD12 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.589 ' HE3' HD12 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.569 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.569 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.676 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.676 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.526 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.555 HG22 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.57 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.648 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.874 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.65 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.65 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.649 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.764 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.516 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.795 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.953 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.673 ' O ' HG22 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.953 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.714 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' O ' HG21 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.874 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.567 HG21 ' O ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.714 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.502 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.71 ' SG ' HG23 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.604 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.601 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.836 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 80' ' ' ILE . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.432 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.836 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.507 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.526 ' H ' HG21 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.71 HG23 ' SG ' ' A' ' 63' ' ' CYS . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.537 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 46.3 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.509 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.545 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.449 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.663 ' HA ' HE22 ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.752 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.785 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.785 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.744 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.621 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.576 ' HG3' HG22 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.914 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.576 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 80' ' ' ILE . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 HD12 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.447 ' N ' HG22 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.723 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 18.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 HG23 ' CH2' ' A' ' 113' ' ' TRP . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' HD3' ' OG ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.914 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.578 HG23 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.578 ' H ' HG23 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.404 ' HB ' HG22 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.494 ' OG ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.6 HG12 ' CZ ' ' A' ' 82' ' ' PHE . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.588 ' HG ' HG12 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.541 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.588 HG12 ' HG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.471 ' CH2' HG23 ' A' ' 86' ' ' ILE . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.75 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.466 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.509 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.509 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.478 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 43' ' ' ILE . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.544 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HG3' HE21 ' A' ' 81' ' ' GLN . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.749 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.749 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.434 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.711 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.449 HD22 ' HE1' ' A' ' 73' ' ' MET . 64.5 t30 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.528 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.57 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.711 HG22 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.491 HE21 ' HG3' ' A' ' 60' ' ' ARG . 65.3 tp60 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.6 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.535 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.667 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.735 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.613 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.564 HD13 HG13 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.564 HG13 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.613 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.735 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.89 ' O ' HD13 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.684 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.925 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 21' ' ' GLU . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.509 ' N ' HD11 ' A' ' 24' ' ' ILE . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.541 HD22 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.534 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.499 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 ' C ' HG13 ' A' ' 44' ' ' ILE . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 26' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m120 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.925 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.536 HG21 ' O ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.775 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.486 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG3' ' NE2' ' A' ' 81' ' ' GLN . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.714 ' CG ' HG22 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.76 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.714 HG22 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.753 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 57.0 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.753 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.602 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 97' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.602 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.681 HG12 ' CE1' ' A' ' 82' ' ' PHE . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.551 HG12 HD11 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 86' ' ' ILE . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.48 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.514 HD13 ' HA3' ' A' ' 98' ' ' GLY . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.749 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.603 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.603 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.554 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.732 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.749 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.474 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HG ' ' C ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HG3' HE21 ' A' ' 81' ' ' GLN . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.557 HE21 ' HG3' ' A' ' 60' ' ' ARG . 66.0 tp60 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.694 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.429 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.555 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.72 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.683 ' HG ' ' CD ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.567 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' CG1' ' A' ' 86' ' ' ILE . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.658 HG12 ' CE1' ' A' ' 82' ' ' PHE . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' H ' HG23 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 61' ' ' LYS . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.683 ' CD ' ' HG ' ' A' ' 99' ' ' SER . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.916 ' O ' HD11 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.448 HD21 ' HA ' ' A' ' 3' ' ' ASN . 10.1 m120 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.541 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 5.4 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.562 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.658 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.522 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.75 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.686 HG12 ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.75 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 43' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.566 ' CG ' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.496 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.503 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.503 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.414 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.676 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.545 HD12 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 84' ' ' SER . 70.2 tp60 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.566 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.654 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.607 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.704 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.523 ' CD1' HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.592 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.596 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.725 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.424 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.71 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.785 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 23.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.554 HD11 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.676 ' CD1' HG23 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.676 HG23 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.688 ' HA ' HE22 ' A' ' 15' ' ' GLN . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.785 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.631 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.596 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.545 ' HB3' ' C ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 m120 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 44' ' ' ILE . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.427 HH22 ' CB ' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.793 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.793 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.564 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.595 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.617 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 86' ' ' ILE . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD12 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.467 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.813 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.508 ' HA ' HD12 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.504 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.504 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.591 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.605 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.551 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.639 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HD2' HG22 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 2.8 t-20 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.511 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.642 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.7 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.426 ' CG2' ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.546 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' N ' HE22 ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' OH ' HD12 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.783 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.521 ' C ' HG22 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.678 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.76 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 36' ' ' TYR . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.783 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.556 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.7 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 44' ' ' ILE . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.648 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.76 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' HD3' ' NE2' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.463 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.689 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.638 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.472 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.438 HG12 HG23 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.683 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 33.4 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.9 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.468 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.687 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' CD ' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.687 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.518 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG12 ' CD1' ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.583 ' CD ' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.658 ' O ' HD11 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.468 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 10' ' ' PHE . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.628 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.719 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.58 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.753 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.643 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.456 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.828 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 m120 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.567 HG23 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.643 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.753 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.484 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.745 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.745 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.525 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.54 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.435 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 90' ' ' CYS . 99.3 m-20 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.474 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.648 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.52 ' HA ' HG23 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.648 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.641 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.442 ' N ' HG21 ' A' ' 91' ' ' THR . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.641 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.538 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.57 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.42 ' CB ' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.635 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.635 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.57 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.615 ' H ' ' HB3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.814 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.644 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.493 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 1.3 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 18' ' ' ASP . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' N ' HG23 ' A' ' 17' ' ' THR . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.814 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.497 ' CD1' HD12 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.43 ' HH ' ' HG3' ' A' ' 5' ' ' PRO . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' HA3' HG23 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.718 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.558 HD12 HG21 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ILE . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG2' ' OG1' ' A' ' 110' ' ' THR . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' HG2' ' HH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.558 ' CD ' HG21 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.651 HD22 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.651 ' HG3' HD22 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 HD12 ' HE2' ' A' ' 87' ' ' LYS . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 HG23 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.798 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 51.7 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.798 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.516 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.923 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.557 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.489 ' N ' HD21 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.641 HG12 ' CE1' ' A' ' 82' ' ' PHE . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.597 ' HB3' HD11 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD12 ' A' ' 106' ' ' ILE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.923 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.56 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.442 ' O ' HG11 ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.602 HD22 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.71 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.701 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.544 HE22 ' CA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' A' ' 13' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.545 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.592 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.53 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.701 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' CG ' ' N ' ' A' ' 42' ' ' SER . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.6 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 m120 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.6 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.56 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.687 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.923 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.687 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.455 ' HA ' HG21 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.609 HD12 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.784 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.923 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.436 ' N ' HG21 ' A' ' 91' ' ' THR . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' H ' HG21 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.774 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.485 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.672 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.672 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.58 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.451 HD13 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 35' ' ' GLY . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.513 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.492 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 105' ' ' ILE . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.58 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.557 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.56 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.546 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.761 HD22 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.761 ' CD2' HD22 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.77 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.77 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.54 ' CD2' HD13 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' HG22 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.582 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.593 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.608 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.655 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.617 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.544 ' H ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 80' ' ' ILE . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.527 ' N ' HG23 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.498 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 9.0 mm100 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.42 ' O ' HD23 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.649 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.512 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HG23 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA3' HD11 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.521 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.52 HD13 HG13 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.409 ' HG ' HG12 ' A' ' 112' ' ' ILE . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 63' ' ' CYS . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.409 HG12 ' HG ' ' A' ' 107' ' ' SER . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.472 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.573 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HD2' HD13 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.256 24.8 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.725 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 HD11 ' CZ3' ' A' ' 51' ' ' TRP . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.685 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.697 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.433 HG22 ' NH1' ' A' ' 57' ' ' ARG . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.549 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.583 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.698 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.489 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.822 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.822 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.454 ' HA ' HG21 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.736 ' HG3' ' CG2' ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.736 ' CG2' ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HA ' HG21 ' A' ' 86' ' ' ILE . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.74 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 44.1 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.74 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.419 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.52 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HB ' HG22 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' O ' ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 82' ' ' PHE . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 61' ' ' LYS . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 105' ' ' ILE . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.419 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.578 HG22 ' HB ' ' A' ' 97' ' ' ILE . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.71 ' CD ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' GLU . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' GLU . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.71 ' HB3' ' CD ' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.531 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' HA3' HG22 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.477 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.477 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.487 ' HD2' HE21 ' A' ' 81' ' ' GLN . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.492 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' SER . 18.4 tm0? -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.619 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.512 HG23 ' CH2' ' A' ' 113' ' ' TRP . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.628 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.692 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 HH21 ' A' ' 122' ' ' ARG . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.682 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.682 ' N ' ' HG3' ' A' ' 92' ' ' LYS . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.492 ' H ' HG21 ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.538 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.559 HD13 HG13 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.414 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.559 HG13 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CH2' HG23 ' A' ' 86' ' ' ILE . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.538 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.492 HG21 ' H ' ' A' ' 98' ' ' GLY . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.703 HH21 HG23 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 94.2 m-20 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 8.4 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' NH1' ' A' ' 12' ' ' ARG . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.706 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.765 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.706 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.725 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.725 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.671 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 40.3 t30 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.502 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.831 HD11 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' HZ2' ' A' ' 113' ' ' TRP . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.64 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 10.4 tp-100 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.64 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.663 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.598 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 96' ' ' LEU . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.747 HD13 HG12 ' A' ' 111' ' ' VAL . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' HD12 ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.747 HG12 HD13 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.541 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.529 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.771 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 19' ' ' GLU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.623 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.777 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HD2' HH11 ' A' ' 39' ' ' ARG . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.777 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.835 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.697 HG22 HD12 ' A' ' 46' ' ' LEU . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' PHE . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.66 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 61' ' ' LYS 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 14.6 p-10 -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.707 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.422 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.621 ' H ' ' HB2' ' A' ' 84' ' ' SER . 9.5 tp-100 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.66 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.621 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.527 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 95' ' ' ARG . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.554 ' HA ' HD23 ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.922 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.438 HG22 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 22' ' ' PHE 0.293 46.1 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HZ ' ' HB3' ' A' ' 15' ' ' GLN . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.676 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' HA ' HG23 ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 73' ' ' MET . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.709 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.582 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 76' ' ' VAL . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' SER . 9.3 tp-100 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.777 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.709 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.43 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 96' ' ' LEU . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.777 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.869 HD13 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.869 HG12 HD13 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 105' ' ' ILE . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.732 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.532 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.504 ' H ' HE21 ' A' ' 15' ' ' GLN . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.749 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.809 ' H ' HG23 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ASN . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.809 HG23 ' H ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.682 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.692 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.692 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' HA ' ' A' ' 81' ' ' GLN . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.596 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' SER . 25.5 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.852 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.635 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.671 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.721 HG12 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' HD12 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.852 HG21 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.695 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.88 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.88 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.33 69.6 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.695 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 42' ' ' SER . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HG3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.735 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.77 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.0 m-20 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.735 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.623 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.608 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.524 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.518 ' HG2' ' OG ' ' A' ' 101' ' ' SER . 7.0 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.786 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 91' ' ' THR . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.814 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.679 ' HA ' HD23 ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.755 HD13 HG12 ' A' ' 111' ' ' VAL . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.755 HG12 HD13 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.814 HG21 ' HB ' ' A' ' 97' ' ' ILE . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.604 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLN . . . . . 0.705 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 9.9 mp0 . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.774 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.496 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.722 HE22 ' HA ' ' A' ' 28' ' ' LEU . 9.2 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 45' ' ' CYS . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.687 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.722 ' HA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.595 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.595 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 t30 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.614 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.68 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.595 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.66 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.501 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.769 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.769 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.588 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.702 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.617 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.702 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.541 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.541 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.576 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.66 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.821 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.657 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.696 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 3.8 mt-30 -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.696 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.951 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.951 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.739 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 41' ' ' PHE . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HE2' ' HD2' ' A' ' 39' ' ' ARG . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.739 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.429 ' NH2' HD13 ' A' ' 112' ' ' ILE . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.619 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.666 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' N ' HG21 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.85 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 93' ' ' GLY . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 91' ' ' THR . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 106' ' ' ILE . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.429 HD13 ' NH2' ' A' ' 64' ' ' ARG . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.565 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 65.2 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.528 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.451 HD23 ' OE1' ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.806 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.806 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.562 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.635 ' HG3' HG23 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.935 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.744 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.751 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 4.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.751 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG22 HG23 ' A' ' 76' ' ' VAL . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.935 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.632 ' H ' HG22 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.725 HD13 HG12 ' A' ' 111' ' ' VAL . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' HG23 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.725 HG12 HD13 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 ' OG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.749 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.697 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.502 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 54' ' ' ALA . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 48' ' ' ASN . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.756 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.465 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.752 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.549 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.752 HG23 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.91 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 62' ' ' SER . 9.8 tp-100 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 11.4 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.91 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.626 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.719 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLN . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 1.6 mp0 . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.913 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 10' ' ' PHE . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 8' ' ' LEU . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' HG23 ' A' ' 52' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.913 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.782 HG23 ' H ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.784 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.656 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.721 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.77 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.456 HD11 ' HE2' ' A' ' 87' ' ' LYS . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 7.3 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.824 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' CD ' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.638 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.596 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.518 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.793 HD13 HG12 ' A' ' 111' ' ' VAL . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.793 HG12 HD13 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' A' ' 97' ' ' ILE . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 119' ' ' ILE . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 3.0 mp0 . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.553 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 ' H ' HE21 ' A' ' 15' ' ' GLN . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.562 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.489 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' H ' HH21 ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 HH21 ' H ' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.544 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.98 ' HG3' HG23 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HG13 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.98 HG23 ' HG3' ' A' ' 69' ' ' PRO . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 76' ' ' VAL . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.575 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.727 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.585 ' OG ' ' HA ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.585 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.736 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 106' ' ' ILE . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.886 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.92 HE22 ' HA ' ' A' ' 28' ' ' LEU . 4.8 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 49' ' ' SER . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.692 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.92 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.446 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.586 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.77 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.785 HD12 HG21 ' A' ' 52' ' ' THR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 52' ' ' THR . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 24' ' ' ILE . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.77 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.785 HG21 HD12 ' A' ' 44' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.436 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.678 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.742 HD11 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 84' ' ' SER . 11.2 tp-100 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.704 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.742 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.796 HG12 HD13 ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.599 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.548 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.743 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.699 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.531 ' HB2' ' CD2' ' A' ' 28' ' ' LEU . 25.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.578 HD12 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HG21 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.541 HD21 ' CE2' ' A' ' 22' ' ' PHE . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.684 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.626 ' H ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 52' ' ' THR . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.725 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.797 HG22 HD12 ' A' ' 46' ' ' LEU . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.496 HH22 ' HB2' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.811 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.811 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.549 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.602 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.609 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.847 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 9.7 tp-100 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.847 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 122' ' ' ARG . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.543 ' H ' HG22 ' A' ' 91' ' ' THR . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.789 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.621 HD13 ' HA ' ' A' ' 100' ' ' SER . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.57 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.621 ' HA ' HD13 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.712 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.608 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.632 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.632 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 34.1 t30 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 26' ' ' THR . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.706 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.811 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.536 ' C ' HG21 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.751 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.811 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' TYR . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 52' ' ' THR . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 46' ' ' LEU . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.672 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.751 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.712 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 68' ' ' ASP . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.595 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.659 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.769 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 5.6 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.769 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 7.1 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.697 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.695 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.762 HD13 HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.602 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.518 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 4' ' ' ALA . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 57' ' ' ARG . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.643 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.446 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.773 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 HG21 ' A' ' 52' ' ' THR . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.787 HD12 HG22 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 50' ' ' VAL . 91.5 m-20 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.787 HG22 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.708 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.773 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.776 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 8.3 m120 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HE2' ' HB3' ' A' ' 102' ' ' ALA . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.615 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB3' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.832 HD13 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.637 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.637 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.785 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.807 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.612 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.4 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.804 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.807 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.766 HD12 HG22 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.766 HG22 HD12 ' A' ' 46' ' ' LEU . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HB3' HG13 ' A' ' 111' ' ' VAL . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HG2' ' OH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' HG23 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.725 HD21 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.725 ' HG3' HD21 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.546 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.816 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 8.5 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.816 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.527 ' OH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 91' ' ' THR . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.922 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.507 ' N ' HD22 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 111' ' ' VAL . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.674 ' HB3' HD12 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 82' ' ' PHE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.922 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HG2' HD11 ' A' ' 16' ' ' LEU . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.734 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 5.5 mt-30 -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 5' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.734 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.592 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.649 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 44' ' ' ILE . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.649 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.803 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.952 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.641 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 63' ' ' CYS . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.52 HD12 ' CZ3' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.952 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.773 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.694 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.459 HD12 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.665 HD13 HG12 ' A' ' 111' ' ' VAL . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.632 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.588 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.705 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.484 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.596 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.78 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.705 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.686 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.606 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 46' ' ' LEU . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.591 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.637 ' HA ' HG23 ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.53 ' N ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.452 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 53.5 mm-40 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.65 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 91' ' ' THR . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.59 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.775 HD13 HG12 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG12 HD13 ' A' ' 106' ' ' ILE . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.495 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.59 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.738 HG21 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.609 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.541 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.479 HE22 ' HA ' ' A' ' 28' ' ' LEU 0.256 29.4 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 26' ' ' THR . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.741 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.599 HG21 ' HB3' ' A' ' 22' ' ' PHE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.551 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.727 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.727 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.71 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.828 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.565 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 1.1 ' HG3' HG23 ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.1 HG23 ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.829 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 6.4 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.829 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.667 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.618 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.621 HD13 HG12 ' A' ' 111' ' ' VAL . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 106' ' ' ILE . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.618 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.433 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.667 HD12 ' HA3' ' A' ' 98' ' ' GLY . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.564 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.893 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 28' ' ' LEU . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.64 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.504 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.442 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.701 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.663 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 76' ' ' VAL . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' SER . 0.8 OUTLIER -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.637 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' HD12 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.663 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.55 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 93' ' ' GLY . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.694 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 91' ' ' THR . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.758 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.758 HG12 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.545 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 97' ' ' ILE . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.733 HH21 HG21 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 94.2 m-20 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 8.4 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' NH1' ' A' ' 12' ' ' ARG . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.706 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.765 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.706 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.725 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.725 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.671 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 40.3 t30 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.502 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.831 HD11 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' HZ2' ' A' ' 113' ' ' TRP . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.64 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 10.4 tp-100 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.64 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.663 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.598 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 96' ' ' LEU . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.747 HD13 HG12 ' A' ' 111' ' ' VAL . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' HD12 ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.747 HG12 HD13 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.541 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.529 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.771 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 19' ' ' GLU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.623 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.777 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HD2' HH11 ' A' ' 39' ' ' ARG . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.777 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.835 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.697 HG22 HD12 ' A' ' 46' ' ' LEU . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' PHE . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.66 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 61' ' ' LYS 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 14.6 p-10 -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.707 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.422 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.621 ' H ' ' HB2' ' A' ' 84' ' ' SER . 9.5 tp-100 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.66 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.621 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.527 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 95' ' ' ARG . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.554 ' HA ' HD23 ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.922 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.438 HG22 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.44 ' HB3' ' HZ ' ' A' ' 22' ' ' PHE 0.293 46.1 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HZ ' ' HB3' ' A' ' 15' ' ' GLN . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.549 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.676 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' HA ' HG23 ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 73' ' ' MET . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.709 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.582 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 76' ' ' VAL . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' SER . 9.3 tp-100 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.777 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.709 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.43 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 96' ' ' LEU . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.777 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.869 HD13 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.869 HG12 HD13 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 105' ' ' ILE . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.732 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.504 ' H ' HE21 ' A' ' 15' ' ' GLN . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.749 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.809 ' H ' HG23 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ASN . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.809 HG23 ' H ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.682 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.692 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.692 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' HA ' ' A' ' 81' ' ' GLN . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.596 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' SER . 25.5 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.852 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.635 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.671 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.721 HG12 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' HD12 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.852 HG21 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.695 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.88 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.88 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.33 69.6 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.695 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 42' ' ' SER . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HG3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.735 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.77 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.0 m-20 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.735 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.623 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.608 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.524 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.518 ' HG2' ' OG ' ' A' ' 101' ' ' SER . 7.0 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.786 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 91' ' ' THR . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.814 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.679 ' HA ' HD23 ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.755 HD13 HG12 ' A' ' 111' ' ' VAL . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.755 HG12 HD13 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.814 HG21 ' HB ' ' A' ' 97' ' ' ILE . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.604 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.705 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 9.9 mp0 . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.774 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.496 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.722 HE22 ' HA ' ' A' ' 28' ' ' LEU . 9.2 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 45' ' ' CYS . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.687 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.722 ' HA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.595 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.4 t30 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.614 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.68 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.595 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.501 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.769 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.769 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.588 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.702 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.617 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.702 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.541 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.541 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.576 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.66 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.821 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.657 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.696 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 3.8 mt-30 -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.696 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.951 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.951 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.739 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 41' ' ' PHE . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HE2' ' HD2' ' A' ' 39' ' ' ARG . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.739 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' NH2' HD13 ' A' ' 112' ' ' ILE . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.619 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.666 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' N ' HG21 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.85 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 93' ' ' GLY . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 91' ' ' THR . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 106' ' ' ILE . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.429 HD13 ' NH2' ' A' ' 64' ' ' ARG . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.565 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 65.2 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.528 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.451 HD23 ' OE1' ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.806 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.806 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.562 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.635 ' HG3' HG23 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.935 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.744 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.751 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 4.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.751 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG22 HG23 ' A' ' 76' ' ' VAL . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.935 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.632 ' H ' HG22 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.725 HD13 HG12 ' A' ' 111' ' ' VAL . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' HG23 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.725 HG12 HD13 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 ' OG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.749 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.697 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 54' ' ' ALA . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 48' ' ' ASN . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.756 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.465 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.752 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.549 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.752 HG23 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.91 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' A' ' 62' ' ' SER . 9.8 tp-100 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 11.4 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.91 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.626 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.719 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 1.6 mp0 . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.913 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 10' ' ' PHE . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 8' ' ' LEU . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' HG23 ' A' ' 52' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.913 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.782 HG23 ' H ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.784 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.656 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.721 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.77 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.456 HD11 ' HE2' ' A' ' 87' ' ' LYS . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 7.3 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' CD ' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.638 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.596 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.793 HD13 HG12 ' A' ' 111' ' ' VAL . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.793 HG12 HD13 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' A' ' 97' ' ' ILE . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 119' ' ' ILE . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 3.0 mp0 . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.553 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.52 ' H ' HE21 ' A' ' 15' ' ' GLN . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.655 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.562 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.589 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.489 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' H ' HH21 ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 HH21 ' H ' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.544 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.98 ' HG3' HG23 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HG13 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.98 HG23 ' HG3' ' A' ' 69' ' ' PRO . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 76' ' ' VAL . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.575 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.727 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.585 ' OG ' ' HA ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.585 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.736 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 106' ' ' ILE . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.886 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.92 HE22 ' HA ' ' A' ' 28' ' ' LEU . 4.8 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 49' ' ' SER . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.692 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.92 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.446 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.586 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.77 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.785 HD12 HG21 ' A' ' 52' ' ' THR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 52' ' ' THR . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 24' ' ' ILE . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.77 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.785 HG21 HD12 ' A' ' 44' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.436 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.678 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.742 HD11 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 84' ' ' SER . 11.2 tp-100 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.704 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.742 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.796 HG12 HD13 ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.599 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.548 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.743 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.699 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.531 ' HB2' ' CD2' ' A' ' 28' ' ' LEU . 25.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.578 HD12 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HG21 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.541 HD21 ' CE2' ' A' ' 22' ' ' PHE . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.684 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.626 ' H ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 52' ' ' THR . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.725 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.797 HG22 HD12 ' A' ' 46' ' ' LEU . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.496 HH22 ' HB2' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.811 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.811 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.602 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.609 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.847 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 9.7 tp-100 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.847 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 122' ' ' ARG . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.543 ' H ' HG22 ' A' ' 91' ' ' THR . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.789 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.621 HD13 ' HA ' ' A' ' 100' ' ' SER . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.57 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.621 ' HA ' HD13 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.712 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.608 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.632 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.632 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 34.1 t30 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 26' ' ' THR . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.706 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.811 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' C ' HG21 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.751 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.811 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' TYR . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 52' ' ' THR . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 46' ' ' LEU . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.672 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.751 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.712 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 68' ' ' ASP . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.595 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.659 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.769 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 5.6 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.769 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 7.1 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.697 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.695 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.762 HD13 HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.602 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.518 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 4' ' ' ALA . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 57' ' ' ARG . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.643 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.446 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.773 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 HG21 ' A' ' 52' ' ' THR . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.787 HD12 HG22 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 50' ' ' VAL . 91.5 m-20 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.787 HG22 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.708 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.773 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.776 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 8.3 m120 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HE2' ' HB3' ' A' ' 102' ' ' ALA . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.615 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB3' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.832 HD13 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.637 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.637 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.785 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.807 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.612 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.4 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.804 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.807 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.766 HD12 HG22 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.766 HG22 HD12 ' A' ' 46' ' ' LEU . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HB3' HG13 ' A' ' 111' ' ' VAL . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HG2' ' OH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' HG23 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.725 HD21 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.725 ' HG3' HD21 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.546 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.816 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 8.5 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.816 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.527 ' OH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 91' ' ' THR . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.922 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.507 ' N ' HD22 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 111' ' ' VAL . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.674 ' HB3' HD12 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 82' ' ' PHE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.922 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HG2' HD11 ' A' ' 16' ' ' LEU . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.734 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 5.5 mt-30 -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 5' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.734 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.649 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 44' ' ' ILE . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.649 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.803 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.952 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.641 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 63' ' ' CYS . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.52 HD12 ' CZ3' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.952 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.773 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.694 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.459 HD12 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.665 HD13 HG12 ' A' ' 111' ' ' VAL . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.632 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.588 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.705 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.484 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.596 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.78 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.705 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.686 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.606 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 46' ' ' LEU . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.591 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.637 ' HA ' HG23 ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.53 ' N ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.452 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 53.5 mm-40 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.65 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 91' ' ' THR . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.59 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.775 HD13 HG12 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG12 HD13 ' A' ' 106' ' ' ILE . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.495 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.59 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.738 HG21 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.541 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.479 HE22 ' HA ' ' A' ' 28' ' ' LEU 0.256 29.4 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 26' ' ' THR . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.741 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.599 HG21 ' HB3' ' A' ' 22' ' ' PHE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.551 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.727 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.727 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.71 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.828 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.565 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 1.1 ' HG3' HG23 ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.1 HG23 ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.829 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 6.4 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.829 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.667 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.618 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.621 HD13 HG12 ' A' ' 111' ' ' VAL . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 106' ' ' ILE . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.618 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.433 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.667 HD12 ' HA3' ' A' ' 98' ' ' GLY . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.564 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.893 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 28' ' ' LEU . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.64 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.504 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.442 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.701 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.663 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 76' ' ' VAL . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' SER . 0.8 OUTLIER -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.637 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' HD12 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.663 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.55 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 93' ' ' GLY . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.694 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 91' ' ' THR . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.758 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.758 HG12 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.545 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 97' ' ' ILE . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.733 HH21 HG21 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 10.2 m120 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.788 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 8.5 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.587 ' CA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.788 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' NH1' ' A' ' 12' ' ' ARG . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.706 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.765 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.706 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.575 HH11 ' NE2' ' A' ' 81' ' ' GLN . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.725 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.725 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.671 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.6 t-20 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.502 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.831 HD11 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' HZ2' ' A' ' 113' ' ' TRP . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.64 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 65.7 tp60 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.64 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.663 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.598 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 96' ' ' LEU . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.747 HD13 HG12 ' A' ' 111' ' ' VAL . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' HD12 ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.747 HG12 HD13 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.541 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.529 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.771 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 19' ' ' GLU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.623 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.777 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HD2' HH11 ' A' ' 39' ' ' ARG . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.777 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.835 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.697 HG22 HD12 ' A' ' 46' ' ' LEU . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' PHE . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.66 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 61' ' ' LYS 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.707 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.422 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.621 ' H ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.66 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.621 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.527 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 95' ' ' ARG . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.554 ' HA ' HD23 ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.922 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.438 HG22 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t30 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.802 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.293 36.8 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HZ ' ' HB3' ' A' ' 15' ' ' GLN . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.802 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.676 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.498 ' HA ' HG23 ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 73' ' ' MET . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.709 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.582 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 76' ' ' VAL . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.777 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.709 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.43 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 96' ' ' LEU . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.777 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.869 HD13 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.869 HG12 HD13 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 105' ' ' ILE . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.732 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.532 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.504 ' H ' HE21 ' A' ' 15' ' ' GLN . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.749 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.809 ' H ' HG23 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ASN . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.809 HG23 ' H ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.682 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.692 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.692 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' HA ' ' A' ' 81' ' ' GLN . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.596 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' SER . 3.2 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.444 HE21 ' CB ' ' A' ' 101' ' ' SER . 58.9 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.852 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.635 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.671 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.721 HG12 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' HD12 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.468 HE21 ' H ' ' A' ' 117' ' ' THR . 21.4 tp60 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.468 ' H ' HE21 ' A' ' 115' ' ' GLN . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.852 HG21 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.695 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.88 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.88 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.837 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.33 44.5 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.695 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.837 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HG3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.735 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.77 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 50' ' ' VAL . 9.9 m120 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.735 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.623 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.608 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.524 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.56 HE21 ' CB ' ' A' ' 101' ' ' SER . 57.1 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.786 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 91' ' ' THR . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.814 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.679 ' HA ' HD23 ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.56 ' CB ' HE21 ' A' ' 85' ' ' GLN . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.755 HD13 HG12 ' A' ' 111' ' ' VAL . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.755 HG12 HD13 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.814 HG21 ' HB ' ' A' ' 97' ' ' ILE . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.604 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . 0.884 ' N ' HE21 ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.774 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.496 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.678 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.6 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 45' ' ' CYS . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.687 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.678 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.595 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.595 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 t-20 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.614 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.68 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.595 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.66 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.501 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.769 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.769 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.588 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.702 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.617 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.702 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.541 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.541 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.576 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.66 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.821 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.657 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.621 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.539 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.951 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.951 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.739 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 41' ' ' PHE . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HE2' ' HD2' ' A' ' 39' ' ' ARG . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.739 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.429 ' NH2' HD13 ' A' ' 112' ' ' ILE . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.619 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.666 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' N ' HG21 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.85 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 93' ' ' GLY . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 91' ' ' THR . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 106' ' ' ILE . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.429 HD13 ' NH2' ' A' ' 64' ' ' ARG . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.565 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.813 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 46.3 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.528 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.7 ' HA ' HE22 ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.813 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.806 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.806 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.562 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.54 ' CD ' HE21 ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.635 ' HG3' HG23 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.935 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.744 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.751 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 18.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.751 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG22 HG23 ' A' ' 76' ' ' VAL . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.935 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.632 ' H ' HG22 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.725 HD13 HG12 ' A' ' 111' ' ' VAL . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' HG23 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.725 HG12 HD13 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 ' OG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.749 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.697 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.502 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 54' ' ' ALA . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 48' ' ' ASN . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG3' HE21 ' A' ' 81' ' ' GLN . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.756 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.465 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.752 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.498 HD22 ' HA ' ' A' ' 90' ' ' CYS . 64.5 t30 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.549 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.752 HG23 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.91 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 60' ' ' ARG . 65.3 tp60 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.6 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.91 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.626 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.719 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.913 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 10' ' ' PHE . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 8' ' ' LEU . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' HG23 ' A' ' 52' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m120 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.913 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.782 HG23 ' H ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.784 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG3' ' NE2' ' A' ' 81' ' ' GLN . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.656 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.721 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.77 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.456 HD11 ' HE2' ' A' ' 87' ' ' LYS . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 57.0 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.824 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.518 ' CD ' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.638 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.596 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.518 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.793 HD13 HG12 ' A' ' 111' ' ' VAL . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.793 HG12 HD13 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' A' ' 97' ' ' ILE . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 119' ' ' ILE . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.553 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.761 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.562 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.745 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.761 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.489 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' H ' HH21 ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 HH21 ' H ' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.63 ' HG3' HE21 ' A' ' 81' ' ' GLN . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.544 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.98 ' HG3' HG23 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HG13 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.98 HG23 ' HG3' ' A' ' 69' ' ' PRO . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 76' ' ' VAL . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.63 HE21 ' HG3' ' A' ' 60' ' ' ARG . 66.0 tp60 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.575 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.727 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.585 ' OG ' ' HA ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.585 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.736 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 106' ' ' ILE . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.886 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 3' ' ' ASN . 10.1 m120 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 5.4 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 49' ' ' SER . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.692 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' HE22 ' A' ' 15' ' ' GLN . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.694 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.586 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.77 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.785 HD12 HG21 ' A' ' 52' ' ' THR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 52' ' ' THR . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 24' ' ' ILE . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.77 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.785 HG21 HD12 ' A' ' 44' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.436 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.678 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.742 HD11 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 84' ' ' SER . 70.2 tp60 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.704 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.742 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.557 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.796 HG12 HD13 ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.599 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.548 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.743 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.699 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.857 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 23.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.578 HD12 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HG21 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HA ' HE22 ' A' ' 15' ' ' GLN . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.857 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.684 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.626 ' H ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 52' ' ' THR . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 m120 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.725 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.797 HG22 HD12 ' A' ' 46' ' ' LEU . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.496 HH22 ' HB2' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.811 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.811 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.549 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.602 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.609 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.847 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.5 tp60 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.847 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 122' ' ' ARG . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.543 ' H ' HG22 ' A' ' 91' ' ' THR . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.789 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.621 HD13 ' HA ' ' A' ' 100' ' ' SER . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.57 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.621 ' HA ' HD13 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.712 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.608 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.632 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.632 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 2.8 t-20 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 26' ' ' THR . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.706 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.811 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.536 ' C ' HG21 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.751 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.811 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' TYR . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 52' ' ' THR . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 46' ' ' LEU . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.672 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.751 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.712 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 68' ' ' ASP . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.595 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.659 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.769 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 33.4 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.769 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.9 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.697 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.474 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.695 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.762 HD13 HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.602 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.518 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 4' ' ' ALA . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 57' ' ' ARG . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.643 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.446 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.773 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 HG21 ' A' ' 52' ' ' THR . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.787 HD12 HG22 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.6 m120 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.787 HG22 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.708 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.773 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.776 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 90' ' ' CYS . 99.3 m-20 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HE2' ' HB3' ' A' ' 102' ' ' ALA . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.645 ' HB3' HD22 ' A' ' 71' ' ' ASN . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB3' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.832 HD13 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.637 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.637 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.785 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.807 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.498 HE22 ' CB ' ' A' ' 28' ' ' LEU . 1.3 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.804 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.807 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.766 HD12 HG22 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.766 HG22 HD12 ' A' ' 46' ' ' LEU . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HB3' HG13 ' A' ' 111' ' ' VAL . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HG2' ' OH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' HG23 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.725 HD21 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.725 ' HG3' HD21 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.546 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.816 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 51.7 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.816 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.527 ' OH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 91' ' ' THR . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.922 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.507 ' N ' HD22 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 111' ' ' VAL . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.674 ' HB3' HD12 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 82' ' ' PHE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.922 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HG2' HD11 ' A' ' 16' ' ' LEU . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.734 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.585 HE22 ' CA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 5' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.734 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.592 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.649 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 44' ' ' ILE . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 m120 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.649 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.803 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.952 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.641 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 63' ' ' CYS . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.52 HD12 ' CZ3' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.952 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.773 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.694 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.459 HD12 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.665 HD13 HG12 ' A' ' 111' ' ' VAL . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.665 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.632 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.588 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.705 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.484 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.596 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.78 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.705 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.686 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.606 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 46' ' ' LEU . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.591 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.637 ' HA ' HG23 ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.53 ' N ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.452 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 9.0 mm100 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.65 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 91' ' ' THR . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.59 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.775 HD13 HG12 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG12 HD13 ' A' ' 106' ' ' ILE . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.495 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.59 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.445 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.738 HG21 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.609 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.541 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.256 24.8 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 26' ' ' THR . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.741 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.599 HG21 ' HB3' ' A' ' 22' ' ' PHE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' CB ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.697 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.551 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.727 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.727 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.71 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.828 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.565 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 1.1 ' HG3' HG23 ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.1 HG23 ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.829 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 44.1 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.829 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.667 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.618 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.621 HD13 HG12 ' A' ' 111' ' ' VAL . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 106' ' ' ILE . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.618 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.433 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.667 HD12 ' HA3' ' A' ' 98' ' ' GLY . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.564 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.893 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 28' ' ' LEU . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.64 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.504 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.442 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HD2' HE21 ' A' ' 81' ' ' GLN . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.701 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.663 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 76' ' ' VAL . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.571 HE21 ' HD2' ' A' ' 60' ' ' ARG . 18.4 tm0? -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.637 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' HD12 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.663 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.55 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 93' ' ' GLY . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.694 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 91' ' ' THR . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.758 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.758 HG12 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.545 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 97' ' ' ILE . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.733 HH21 HG21 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.213 -0.82 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' SER . 36.0 m -79.06 -24.13 43.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.724 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 10.2 m120 59.37 35.57 23.16 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 68.2 116.15 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.496 0 O-C-N 124.015 0.822 . . . . 0.0 111.079 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.5 Cg_exo -53.59 -46.11 36.15 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.971 1.78 . . . . 0.0 111.648 -171.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.1 pt-20 142.78 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.934 2.094 . . . . 0.0 109.156 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -82.31 123.5 29.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.763 0.792 . . . . 0.0 111.328 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 9' ' ' PRO . 28.3 tp -114.8 113.11 44.74 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.099 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 8' ' ' LEU . 9.7 Cg_exo -58.48 -29.0 87.3 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.015 1.81 . . . . 0.0 111.897 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 8.4 m-30 -63.02 -42.86 99.9 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.141 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.82 145.61 50.15 Favored 'General case' 0 C--O 1.201 -1.456 0 CA-C-N 113.222 -1.808 . . . . 0.0 113.342 -165.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -126.84 85.84 60.0 Favored Pre-proline 0 C--O 1.216 -0.696 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 173.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.58 144.15 93.91 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 122.089 1.859 . . . . 0.0 111.32 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 49.8 p -67.27 -33.92 76.33 Favored 'General case' 0 C--N 1.266 -3.033 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.936 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.788 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 8.5 mt-30 -96.15 -14.64 22.64 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.915 1.34 . . . . 0.0 111.828 -166.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.38 -9.14 59.23 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.343 -167.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -63.74 -44.14 94.4 Favored 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.97 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -123.06 1.92 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -114.36 -55.6 2.48 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.444 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.1 m-85 65.41 -35.92 0.21 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.785 1.634 . . . . 0.0 115.202 170.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 98.2 mt-10 -122.79 136.45 54.87 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 28' ' ' LEU . 44.8 m-85 -141.47 158.26 63.88 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 7.2 Cg_exo -71.02 157.44 57.92 Favored 'Trans proline' 0 C--O 1.247 0.959 1 C-N-CA 125.539 4.159 . . . . 0.0 112.495 174.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 45' ' ' CYS . 96.7 mt -64.61 136.52 26.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.965 0.888 . . . . 0.0 111.405 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.46 18.72 51.73 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.945 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -105.59 127.79 53.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 109.63 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -99.41 132.52 44.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.596 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.587 ' CA ' HE22 ' A' ' 15' ' ' GLN . 10.9 mp -111.51 144.04 41.38 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.961 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.788 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 59.8 t30 -90.88 104.42 17.01 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.141 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -107.27 133.64 51.53 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.221 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB2' ' NH1' ' A' ' 12' ' ' ARG . 98.5 mt-10 -123.47 138.52 54.56 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 124.592 1.183 . . . . 0.0 110.15 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.2 m -86.66 130.39 34.5 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -62.56 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 116.639 2.088 . . . . 0.0 116.639 -169.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 96.4 Cg_endo -79.36 53.23 4.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.405 1.403 . . . . 0.0 113.844 -172.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.07 9.54 65.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.706 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 83.5 m-85 -82.72 137.29 34.47 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.571 -1.651 . . . . 0.0 111.515 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.765 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 78.2 p -64.19 -33.91 76.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -56.84 152.9 22.1 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HE ' ' HD2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -83.49 105.18 4.93 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.513 . . . . 0.0 108.913 177.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HD2' ' HE ' ' A' ' 39' ' ' ARG . 23.8 Cg_exo -62.07 144.11 95.66 Favored 'Trans proline' 0 CA--C 1.487 -1.832 0 C-N-CA 121.796 1.664 . . . . 0.0 111.024 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -150.57 158.25 43.93 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 68.5 m -70.29 145.8 51.02 Favored 'General case' 0 C--N 1.273 -2.725 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.447 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -100.43 130.94 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.33 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 52' ' ' THR . 3.0 mp -120.1 130.35 74.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -71.26 95.37 1.28 Allowed 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.688 175.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 52' ' ' THR . 94.1 mt -109.61 -30.28 7.98 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 57.5 mmtt -116.0 114.71 24.97 Favored 'General case' 0 CA--C 1.423 -3.908 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 56.3 34.45 24.08 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 124.811 1.32 . . . . 0.0 110.514 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 59.63 34.05 22.14 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.816 0.817 . . . . 0.0 110.57 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 45.6 t -126.72 159.34 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -81.36 152.9 27.28 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 123.94 0.896 . . . . 0.0 112.421 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 44' ' ' ILE . 82.7 p -61.7 -41.3 97.4 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 123.886 0.874 . . . . 0.0 112.764 -171.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.03 87.73 0.06 OUTLIER Glycine 0 C--N 1.313 -0.722 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.269 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -87.36 -2.34 58.55 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.069 0.461 . . . . 0.0 111.772 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.18 135.76 47.74 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 54.41 31.66 15.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.798 172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 26.5 mmm180 -65.31 -39.68 92.8 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.214 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.706 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 62.1 m -114.41 147.6 38.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 -172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.765 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 77.1 mtp85 -127.75 138.14 52.66 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 114.287 -2.965 . . . . 0.0 115.286 -166.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.575 HH11 ' NE2' ' A' ' 81' ' ' GLN . 64.1 ttp85 -70.51 134.69 47.94 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 112.436 164.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.725 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.2 tmtt? -96.74 144.49 26.69 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.939 0.896 . . . . 0.0 110.714 175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.725 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 67.9 m -67.25 141.17 57.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.683 0.754 . . . . 0.0 111.892 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 81' ' ' GLN . 97.1 m -95.98 176.13 6.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.885 1.274 . . . . 0.0 109.624 -175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -140.72 154.09 46.19 Favored 'General case' 0 C--O 1.186 -2.285 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.671 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 2.6 t-20 -131.98 21.58 0.08 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 18.9 Cg_exo -70.5 -11.24 29.54 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 116.198 1.576 . . . . 0.0 116.198 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -60.04 -29.93 90.38 Favored 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 121.246 1.481 . . . . 0.0 112.467 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 39.78 147.43 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.498 0 C-N-CA 127.343 2.257 . . . . 0.0 116.796 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HG3' ' C ' ' A' ' 73' ' ' MET . 91.0 Cg_endo -69.39 150.16 70.13 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.301 2.667 . . . . 0.0 110.996 172.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.32 -45.24 98.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -63.84 -40.08 95.75 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.594 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.51 2.5 22.82 Favored Glycine 0 CA--C 1.498 -1.024 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.502 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 61.3 ttp -107.15 109.09 20.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 87' ' ' LYS . 3.0 p -134.46 140.05 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.26 174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.9 m170 -115.58 140.06 49.51 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.303 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HA ' HG22 ' A' ' 86' ' ' ILE . 7.5 p -103.25 92.43 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 CA-C-O 121.626 0.727 . . . . 0.0 111.66 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.831 HD11 ' HE2' ' A' ' 87' ' ' LYS . 68.4 mt -62.84 -48.73 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.045 0.926 . . . . 0.0 112.791 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 85' ' ' GLN . 75.7 mmtt -112.04 -41.27 4.01 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.692 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 151.42 169.41 17.02 Favored Glycine 1 N--CA 1.385 -4.702 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -174.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' HZ2' ' A' ' 113' ' ' TRP . 49.5 mm -69.98 -25.72 28.52 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.253 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 169.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.64 ' HG3' ' H ' ' A' ' 82' ' ' PHE . 65.7 tp60 -72.15 -178.58 2.49 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.64 ' H ' ' HG3' ' A' ' 81' ' ' GLN . 29.3 t80 -62.94 130.05 43.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.71 0.767 . . . . 0.0 112.644 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.81 -5.04 85.5 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.798 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.637 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 60.6 m -87.85 166.18 14.75 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.4 0.619 . . . . 0.0 111.316 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 51.9 tt0 -144.93 149.53 35.42 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.476 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.2 pt -132.62 163.69 37.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 C-N-CA 123.675 0.79 . . . . 0.0 112.633 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -112.01 138.99 47.89 Favored 'General case' 0 CA--C 1.482 -1.652 0 CA-C-O 121.351 0.596 . . . . 0.0 111.447 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HD1' ' HB3' ' A' ' 69' ' ' PRO . 44.0 m-85 -112.15 93.58 4.52 Favored 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 113.674 -1.603 . . . . 0.0 107.824 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 m -109.55 118.41 36.52 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.518 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 35.4 m -80.53 -38.44 29.68 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.942 0.877 . . . . 0.0 109.759 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 53.5 m -152.45 159.7 43.34 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.244 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -64.49 -46.57 82.43 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 120.859 1.663 . . . . 0.0 113.52 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 91' ' ' THR . . . -106.36 78.37 0.25 Allowed Glycine 0 CA--C 1.496 -1.123 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.7 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.589 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.8 p90 -158.0 173.64 16.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.537 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 94.4 mtt-85 -122.64 140.71 52.53 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.478 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.3 tt -109.87 118.78 37.4 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.3 -1.76 . . . . 0.0 106.744 172.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.663 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -66.12 -44.26 91.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.826 -1.079 . . . . 0.0 113.506 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.598 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -91.11 -129.02 4.24 Favored Glycine 0 C--O 1.221 -0.691 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.518 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.455 ' CB ' ' HA ' ' A' ' 115' ' ' GLN . 32.5 t -85.86 92.02 8.52 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.65 0.738 . . . . 0.0 111.208 -175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 96' ' ' LEU . 19.8 m -61.31 -41.96 97.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 170.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.0 p -117.67 97.92 6.11 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -71.21 141.17 50.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.509 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.4 m -125.13 128.12 47.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 17.2 t -91.09 120.46 32.06 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.368 0.604 . . . . 0.0 111.845 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.67 161.31 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.157 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.747 HD13 HG12 ' A' ' 111' ' ' VAL . 36.2 mm -82.03 125.12 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.084 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.528 ' HB3' HD12 ' A' ' 112' ' ' ILE . 86.8 p -90.61 -13.79 33.7 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.679 0.752 . . . . 0.0 111.482 171.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.83 -73.07 0.46 Allowed Glycine 0 C--O 1.213 -1.185 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.04 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -95.86 -4.2 44.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.374 0.607 . . . . 0.0 111.465 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -154.66 168.75 25.76 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.249 0.547 . . . . 0.0 111.164 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.747 HG12 HD13 ' A' ' 106' ' ' ILE . 20.1 m -119.6 132.02 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.255 0 CA-C-O 121.339 0.59 . . . . 0.0 109.941 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -127.02 160.79 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.44 -177.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.541 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.7 m95 -89.73 148.86 23.02 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 27.1 p-10 -78.53 -0.08 28.16 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.613 0.72 . . . . 0.0 109.883 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 56.9 tt0 -61.75 120.76 11.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.184 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 117' ' ' THR . 75.6 mm-40 -66.62 -41.88 87.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.178 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.5 t 165.85 154.58 0.08 OUTLIER Pre-proline 0 C--O 1.25 1.113 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.45 137.98 73.24 Favored 'Trans proline' 0 C--N 1.359 1.099 0 CA-C-N 119.906 1.002 . . . . 0.0 112.231 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 88.8 mt -137.02 132.56 47.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.492 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -133.73 113.87 12.8 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 117.738 -1.585 . . . . 0.0 110.597 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 29.1 t70 -62.3 -48.27 80.6 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 117.21 -1.376 . . . . 0.0 113.825 -176.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -95.33 0.59 53.8 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.246 -1.782 . . . . 0.0 107.864 164.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 6.3 t-20 58.56 41.39 22.47 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.13 -1.395 . . . . 0.0 112.494 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.83 131.25 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.765 0.826 . . . . 0.0 112.845 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 29.4 Cg_endo -67.0 -63.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.102 1.201 . . . . 0.0 114.868 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.5 pt-20 160.92 173.92 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.7 1.2 . . . . 0.0 108.155 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -87.53 122.84 31.76 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.326 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 19.6 tp -117.66 105.8 47.3 Favored Pre-proline 0 C--O 1.223 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.132 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 38.7 Cg_endo -62.91 -25.99 74.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.499 2.133 . . . . 0.0 112.918 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.529 ' HB3' ' SG ' ' A' ' 58' ' ' CYS 0.266 19.6 m-30 -63.7 -42.94 97.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.347 1.07 . . . . 0.0 109.778 -178.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -110.68 153.58 25.05 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.996 -1.911 . . . . 0.0 114.747 -161.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -132.63 79.64 64.01 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.931 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 18.1 Cg_exo -62.28 145.97 95.94 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.667 1.578 . . . . 0.0 110.658 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 29' ' ' ASN . 2.2 t -89.63 2.25 54.96 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.128 -171.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.771 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -132.48 -16.41 2.7 Favored 'General case' 0 C--O 1.185 -2.296 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.62 -176.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -83.9 -5.5 59.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -172.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -61.26 -46.2 91.34 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.201 -174.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -116.69 6.26 13.29 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.771 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 70.2 mt-10 -132.01 71.69 1.48 Allowed 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.681 1.229 . . . . 0.0 108.622 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.6 m-85 -65.48 -37.26 86.3 Favored 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 113.4 -1.727 . . . . 0.0 112.63 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 73.5 mt-10 -109.45 126.93 54.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 19' ' ' GLU . 42.3 m-85 -136.8 156.8 75.83 Favored Pre-proline 0 C--O 1.219 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.963 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 91.8 Cg_endo -70.63 161.69 45.16 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.939 3.759 . . . . 0.0 113.25 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.8 mp -67.05 133.79 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 19.74 51.27 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.681 -174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 89.2 m -112.43 128.57 56.35 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-O 121.593 0.711 . . . . 0.0 109.118 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -102.96 130.72 50.14 Favored 'General case' 0 N--CA 1.411 -2.416 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HA ' ' OE1' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -102.96 133.81 47.45 Favored 'General case' 0 CA--C 1.456 -2.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.692 173.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.623 ' N ' HE22 ' A' ' 15' ' ' GLN . 58.9 t30 -74.6 106.35 6.14 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.2 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -105.63 137.56 43.27 Favored 'General case' 0 CA--C 1.49 -1.33 0 C-N-CA 127.474 2.309 . . . . 0.0 113.187 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 17.3 pt-20 -135.41 147.94 49.16 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.777 ' SG ' ' HD3' ' A' ' 40' ' ' PRO . 85.9 m -90.82 145.67 24.58 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -58.11 160.56 8.66 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -60.63 144.76 99.57 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.0 1.133 . . . . 0.0 112.432 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 87.62 10.8 69.6 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.786 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 81.7 m-85 -105.56 129.44 53.83 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.492 1.146 . . . . 0.0 112.366 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 15.5 m -61.42 -41.34 97.0 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -61.73 -41.17 99.57 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 -165.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HD2' HH11 ' A' ' 39' ' ' ARG . 0.0 OUTLIER 49.65 73.96 0.9 Allowed Pre-proline 0 C--N 1.299 -1.602 0 CA-C-O 121.342 0.592 . . . . 0.0 111.542 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.777 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 16.2 Cg_exo -64.63 144.2 83.59 Favored 'Trans proline' 0 CA--C 1.492 -1.612 0 C-N-CA 123.545 2.83 . . . . 0.0 111.123 -176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -79.74 -71.93 0.43 Allowed 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 117.735 -1.586 . . . . 0.0 108.219 171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 m -159.61 171.99 18.62 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.876 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.72 144.67 26.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -138.2 148.06 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.739 -170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.835 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 4.9 m -67.53 38.03 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 119.199 0.909 . . . . 0.0 112.095 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -63.48 -42.25 98.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -168.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -108.37 123.7 49.23 Favored 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.893 -177.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 98.8 m-20 56.84 33.85 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.514 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 12.5 m 54.81 22.04 3.95 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.215 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 21.6 t -104.45 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.159 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 97.4 m95 -147.2 159.37 43.72 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.115 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.697 HG22 HD12 ' A' ' 46' ' ' LEU . 77.3 p -66.3 -34.86 78.94 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.761 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.1 102.82 0.93 Allowed Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.502 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.678 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . . . -82.44 2.36 33.05 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.38 1.072 . . . . 0.0 112.025 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -70.58 139.23 51.4 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 58.21 29.25 17.7 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.101 1.361 . . . . 0.0 111.587 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 54' ' ' ALA 0.292 92.9 mtt-85 -65.73 -39.3 91.0 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 177.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' PHE . 68.0 m -120.13 146.11 46.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 84.7 mtp180 -122.32 112.62 18.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.581 -173.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.66 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.275 42.9 ttm180 -74.82 142.22 44.21 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 128.444 2.697 . . . . 0.0 110.842 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 61' ' ' LYS 0.379 55.4 mtpt -95.59 152.07 18.77 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 175.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.9 t -69.89 140.63 53.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 112.618 -2.083 . . . . 0.0 111.618 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 89.4 m -98.32 155.83 17.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.465 1.106 . . . . 0.0 110.702 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 33.3 ptt-85 -134.79 137.76 43.67 Favored 'General case' 0 C--O 1.198 -1.658 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -143.47 48.42 0.95 Allowed Pre-proline 0 C--N 1.305 -1.332 0 C-N-CA 118.637 -1.225 . . . . 0.0 112.729 174.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.707 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.1 Cg_endo -61.16 -17.1 50.4 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.516 2.144 . . . . 0.0 114.043 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.337 37.0 Cg_exo -51.52 -41.33 60.93 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.048 1.832 . . . . 0.0 110.89 173.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 56.88 153.36 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.839 -174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.422 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 75.7 Cg_endo -67.11 153.09 78.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 110.691 172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 79.7 t -61.83 -46.81 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.201 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.0 t-20 -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 111.203 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.422 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 112.05 6.07 24.64 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.295 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.7 mtt -92.08 95.66 9.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 117.088 0.444 . . . . 0.0 110.655 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -128.98 134.83 63.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 39.4 m-70 -117.69 131.71 56.59 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.689 HG23 HG13 ' A' ' 80' ' ' ILE . 3.8 p -107.48 104.04 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.881 -174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.77 -44.37 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' A' ' 84' ' ' SER . 75.7 mmtt -100.01 -6.2 26.87 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -171.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.4 14.36 68.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.969 -175.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG13 HG23 ' A' ' 76' ' ' VAL 0.306 96.6 mt 53.74 88.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 123.336 1.541 . . . . 0.0 115.006 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.621 ' H ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -154.06 175.46 13.39 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 111.735 -2.484 . . . . 0.0 104.785 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.66 ' HB3' ' CG ' ' A' ' 60' ' ' ARG . 26.5 t80 -58.57 130.77 48.38 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.987 0.812 . . . . 0.0 112.491 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.58 -3.06 68.03 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.621 ' HB2' ' H ' ' A' ' 81' ' ' GLN . 41.9 t -70.31 142.4 52.22 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.49 0.662 . . . . 0.0 111.818 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 56.9 tt0 -132.41 124.92 29.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.192 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -127.34 163.06 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.126 -176.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 5.5 mptt -106.46 142.22 36.48 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.155 0.502 . . . . 0.0 110.642 -172.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -121.16 70.24 0.92 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.121 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' MET . 22.1 p -79.96 160.32 25.97 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.244 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.527 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 81.4 m -124.65 -51.81 1.71 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.036 0.922 . . . . 0.0 111.518 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 92.3 m -144.25 162.89 35.22 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.16 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.46 -49.98 61.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 167.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 91' ' ' THR . . . -103.65 62.2 0.42 Allowed Glycine 0 CA--C 1.465 -3.056 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -149.29 168.45 23.3 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -174.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 95' ' ' ARG . 24.3 ptt85 -127.68 141.31 51.64 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 173.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -95.83 120.17 35.63 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 122.124 0.964 . . . . 0.0 109.621 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.8 mm -66.17 -44.38 91.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 113.53 -1.668 . . . . 0.0 112.779 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.538 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -96.75 -138.69 10.14 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.613 -175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -84.11 124.78 31.48 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.21 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.554 ' HA ' HD23 ' A' ' 96' ' ' LEU . 7.1 m -86.85 -8.22 57.5 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.875 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.3 t -142.11 143.24 32.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . . . -118.61 147.07 44.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 79.8 m -119.61 127.63 53.12 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.415 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 24.2 t -92.41 127.98 38.1 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.35 0.595 . . . . 0.0 112.431 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.55 162.85 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.902 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.922 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -94.21 119.64 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -88.65 -13.89 38.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.373 0.606 . . . . 0.0 110.887 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 127.07 -75.46 0.41 Allowed Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.198 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -66.8 -36.96 83.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.365 0.602 . . . . 0.0 111.123 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.7 t -151.14 178.61 9.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.413 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 106' ' ' ILE . 22.2 m -112.5 132.41 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.438 HG22 HH22 ' A' ' 64' ' ' ARG . 50.8 pt -125.77 159.45 33.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.778 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.439 ' HZ2' HG23 ' A' ' 80' ' ' ILE . 99.6 m95 -94.16 143.7 26.15 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -90.34 -0.53 57.68 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 9.4 pt20 -65.43 147.06 54.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.298 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.1 mt-10 -67.13 -41.91 85.35 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.776 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 164.08 158.03 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.156 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.18 142.39 86.54 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.142 1.228 . . . . 0.0 111.274 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.538 HD13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 mp -141.08 146.7 23.36 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.435 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 76.0 m -147.19 110.4 4.82 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.27 0.941 . . . . 0.0 109.279 168.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -64.09 -44.28 92.83 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-N 119.068 0.849 . . . . 0.0 110.401 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 . . . . . 0 C--O 1.26 1.615 0 C-N-CA 126.177 1.791 . . . . 0.0 112.782 -177.465 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 120.611 0.244 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.9 m -74.09 -21.45 59.9 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 t30 58.36 39.25 25.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.393 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 66.24 129.74 0.03 OUTLIER Pre-proline 0 C--O 1.222 -0.358 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.52 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 24.1 Cg_endo -59.19 -34.89 98.46 Favored 'Trans proline' 0 CA--C 1.488 -1.808 0 C-N-CA 121.989 1.793 . . . . 0.0 111.668 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 134.78 178.42 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.347 2.279 . . . . 0.0 107.854 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -79.74 119.72 23.04 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 171.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.1 tp -93.46 115.33 64.89 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.27 -23.22 66.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.117 1.878 . . . . 0.0 113.942 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.58 9.34 31.46 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.458 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -143.23 148.79 37.0 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.806 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.24 88.97 29.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 122.034 0.921 . . . . 0.0 110.465 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 Cg_exo -69.99 155.47 65.11 Favored 'Trans proline' 0 CA--C 1.487 -1.826 0 C-N-CA 124.438 3.425 . . . . 0.0 111.434 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.9 p -89.78 -0.88 57.82 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.104 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.802 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.293 36.8 mt-30 -122.2 -37.54 2.81 Favored 'General case' 0 C--O 1.191 -2.019 0 CA-C-O 122.486 1.136 . . . . 0.0 108.33 -169.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.13 -41.3 98.12 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -171.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 18' ' ' ASP . 10.2 t -61.41 -45.74 93.07 Favored 'General case' 0 C--N 1.272 -2.764 0 O-C-N 123.338 0.399 . . . . 0.0 111.974 -169.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 17' ' ' THR . 90.6 m-20 -98.86 -4.63 32.62 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.897 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 93.0 mt-10 -120.24 -59.45 1.78 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 117.847 -1.541 . . . . 0.0 111.644 -166.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 82.1 m-85 68.85 -33.32 0.24 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.179 1.391 . . . . 0.0 114.025 176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -99.58 120.81 40.27 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' HZ ' ' HB3' ' A' ' 15' ' ' GLN . 95.8 m-85 -138.87 150.56 65.87 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.188 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 22' ' ' PHE . 8.6 Cg_exo -71.48 156.0 58.86 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.991 3.794 . . . . 0.0 113.342 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 1.9 mp -69.08 132.58 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.77 23.48 33.06 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.649 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 130.24 56.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.296 0.569 . . . . 0.0 110.042 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -95.43 132.44 40.5 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.191 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.4 mp -111.47 146.09 37.86 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.802 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 58.5 t30 -89.65 106.34 18.4 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.123 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 12.0 m-85 -114.58 138.34 50.77 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 125.569 1.548 . . . . 0.0 114.663 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.29 147.75 49.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.267 176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 92.8 m -90.13 150.33 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . 86.7 mtt180 -50.97 155.85 1.91 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.84 142.76 94.6 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 CA-C-N 119.083 0.708 . . . . 0.0 111.08 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.549 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 82.1 -1.32 87.22 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 114.98 -1.009 . . . . 0.0 114.775 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 72.9 m-85 -82.91 140.04 33.06 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 70.3 m -82.64 -179.79 7.54 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.978 175.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.1 171.23 38.39 Favored Glycine 0 C--N 1.291 -1.947 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.28 83.58 10.87 Favored Pre-proline 0 C--N 1.313 -1.005 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.551 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -63.46 145.28 92.12 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 123.009 2.473 . . . . 0.0 111.431 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -128.49 -81.14 0.58 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 29.0 m -143.35 150.59 39.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.136 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 pt -109.41 133.57 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 52' ' ' THR . 1.9 mp -121.83 130.2 74.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 C-N-CA 123.714 0.805 . . . . 0.0 110.921 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 8.6 m -52.66 27.2 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 52' ' ' THR . 56.8 mt -64.18 -41.44 97.11 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.786 0.834 . . . . 0.0 112.98 -176.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 26.5 tptp -96.2 118.42 32.73 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.225 -169.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' VAL . 66.3 t30 55.21 35.29 24.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.662 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 5.5 m 48.83 21.8 0.48 Allowed 'General case' 0 C--N 1.358 0.937 0 CA-C-O 121.14 0.495 . . . . 0.0 111.235 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 85.8 t -104.88 -84.65 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.676 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.6 m95 -154.74 161.54 41.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.146 0.579 . . . . 0.0 110.191 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 44' ' ' ILE . 72.8 p -65.54 -34.15 77.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.962 0.505 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.588 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 153.22 68.74 0.01 OUTLIER Glycine 0 C--O 1.213 -1.19 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.178 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -70.84 -12.65 61.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.495 0.664 . . . . 0.0 109.973 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -67.44 135.32 52.95 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.137 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 56.97 28.9 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.359 -1.291 . . . . 0.0 110.997 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 30.2 mmm180 -66.09 -39.31 89.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.3 m -110.77 139.59 45.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -130.16 144.26 51.25 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 118.332 -1.347 . . . . 0.0 110.51 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 12.6 ptp85 -105.94 140.08 39.5 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.777 0.431 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 62' ' ' SER . 88.6 tttt -80.21 144.7 32.73 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 48.4 t -65.22 141.82 58.52 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.576 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.498 ' HA ' HG23 ' A' ' 111' ' ' VAL . 76.1 m -92.4 163.33 13.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 122.867 0.467 . . . . 0.0 111.248 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.47 150.11 41.81 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 57.5 t30 -139.77 66.69 34.52 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 60.4 Cg_endo -81.09 -14.66 10.76 Favored 'Trans proline' 0 CA--C 1.582 2.895 0 C-N-CA 121.711 1.607 . . . . 0.0 115.707 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -61.6 -26.9 80.96 Favored 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 121.559 1.593 . . . . 0.0 112.535 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.6 p30 48.45 151.48 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 73' ' ' MET . 15.7 Cg_exo -66.19 153.44 78.05 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.387 2.725 . . . . 0.0 111.611 175.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.74 -44.62 97.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -92.24 5.21 51.33 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.89 22.5 74.3 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.903 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.709 ' HB3' ' O ' ' A' ' 89' ' ' SER . 98.9 mmm -104.44 90.4 3.52 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.079 -170.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.0 p -136.37 139.65 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 61.9 m170 -116.51 145.98 42.93 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.582 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -115.57 106.19 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.957 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.7 mt -64.77 -45.28 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.86 8.0 18.55 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.582 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.01 18.94 62.05 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.621 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG12 HG21 ' A' ' 76' ' ' VAL . 43.9 mm 63.96 78.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 121.8 0.809 . . . . 0.0 111.968 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.541 ' O ' ' HB2' ' A' ' 84' ' ' SER . 65.3 tp60 -147.01 166.58 26.39 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.218 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 70.4 t80 -62.21 129.66 41.78 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.0 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.6 -5.79 77.18 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.563 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 21.6 m -75.18 152.18 38.44 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.125 0.57 . . . . 0.0 111.082 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.3 tt0 -128.44 135.79 49.97 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.07 161.45 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.777 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.4 mmtt -106.44 152.5 23.55 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -120.82 39.31 3.82 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.448 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.709 ' O ' ' HB3' ' A' ' 73' ' ' MET . 7.1 m -71.22 104.85 3.23 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 121.375 0.607 . . . . 0.0 111.235 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.43 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 36.6 m -69.69 -39.44 76.96 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -150.79 160.1 44.09 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.186 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -63.47 -46.71 84.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 91' ' ' THR . . . -117.91 77.99 0.29 Allowed Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.503 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 1.5 p90 -153.75 169.31 23.65 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -123.51 142.38 51.07 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 173.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.4 tt -107.58 117.16 33.37 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HB ' HG21 ' A' ' 119' ' ' ILE . 64.5 mt -66.44 -45.26 89.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -94.51 -127.35 4.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.282 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 101' ' ' SER . 12.9 m -86.13 120.95 28.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 118.635 -1.226 . . . . 0.0 109.897 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 96' ' ' LEU . 96.7 p -91.0 -1.48 57.82 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.636 1.174 . . . . 0.0 108.799 177.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.777 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 34.9 p -152.17 160.12 43.46 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.041 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -135.22 149.71 49.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 117.736 0.244 . . . . 0.0 110.597 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 m -119.99 130.77 54.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.4 t -85.7 127.34 34.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.123 0.487 . . . . 0.0 112.209 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.83 160.63 39.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.083 -179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.869 HD13 HG12 ' A' ' 111' ' ' VAL . 35.4 mm -79.32 126.97 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.841 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.1 p -88.82 -8.39 54.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 109.95 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 114.62 -69.02 0.25 Allowed Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.735 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.91 -41.5 97.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.941 0.876 . . . . 0.0 110.139 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -148.08 -172.28 4.02 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.869 HG12 HD13 ' A' ' 106' ' ' ILE . 6.6 m -111.62 131.4 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.401 0.62 . . . . 0.0 110.225 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 pt -127.31 162.61 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.417 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 98.2 m95 -94.82 146.9 23.88 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 105' ' ' ILE . 33.6 p-10 -88.6 3.72 49.51 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 66.0 tp60 -56.32 127.84 32.87 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.459 0.647 . . . . 0.0 110.388 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 117' ' ' THR . 16.6 pt-20 -66.31 -40.74 90.16 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.541 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t 167.29 143.16 0.05 OUTLIER Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.44 139.94 84.96 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.126 1.081 . . . . 0.0 110.918 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.732 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 90.1 mt -128.72 130.65 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.458 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 80.7 m -132.13 110.17 10.49 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 117.777 -1.569 . . . . 0.0 109.295 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 33.3 t70 -63.33 -43.95 96.31 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.564 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 . . . . . 0 C--O 1.274 2.348 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.204 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.4 m -78.95 -18.47 53.7 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.532 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 66.9 m-80 60.45 35.41 20.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 125.635 1.574 . . . . 0.0 112.103 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 71.47 135.35 0.05 OUTLIER Pre-proline 0 N--CA 1.441 -0.907 0 O-C-N 124.26 0.975 . . . . 0.0 111.385 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 33.9 Cg_endo -64.39 -55.17 0.62 Allowed 'Trans proline' 0 C--N 1.326 -0.651 0 C-N-CA 120.635 0.89 . . . . 0.0 110.179 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.4 pt-20 145.35 -168.07 0.0 OUTLIER 'General case' 0 C--O 1.243 0.731 0 C-N-CA 127.587 2.355 . . . . 0.0 106.914 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -101.05 126.51 47.74 Favored 'General case' 0 N--CA 1.413 -2.287 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.071 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.19 108.18 59.44 Favored Pre-proline 0 N--CA 1.424 -1.751 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.343 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.24 -25.84 72.12 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.869 1.713 . . . . 0.0 112.209 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 36' ' ' TYR 0.253 15.9 m-30 -63.33 -45.06 93.04 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.203 1.001 . . . . 0.0 110.017 -176.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.04 158.54 15.94 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.252 -1.795 . . . . 0.0 114.642 -165.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -121.62 73.41 31.96 Favored Pre-proline 0 N--CA 1.438 -1.043 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.0 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.87 151.44 68.42 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.807 1.672 . . . . 0.0 111.822 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.504 ' H ' HE21 ' A' ' 15' ' ' GLN . 2.0 p -99.6 -6.8 26.72 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.757 -167.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -123.53 -33.99 3.14 Favored 'General case' 0 C--O 1.201 -1.491 0 CA-C-O 122.041 0.925 . . . . 0.0 111.221 -171.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.77 -21.89 56.75 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.89 1.676 . . . . 0.0 114.14 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 18' ' ' ASP . 9.8 t -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.276 -2.627 0 O-C-N 123.794 0.684 . . . . 0.0 110.093 -171.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 17' ' ' THR . 1.5 p30 -119.33 7.23 11.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.585 0.707 . . . . 0.0 110.21 174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 96.1 mt-10 -130.56 64.32 1.55 Allowed 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 122.865 1.317 . . . . 0.0 108.38 -174.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.749 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.9 m-85 -65.03 -38.18 90.04 Favored 'General case' 0 C--N 1.253 -3.627 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.442 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.18 132.81 54.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -145.53 163.19 33.11 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.513 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -69.05 157.14 62.91 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.107 3.871 . . . . 0.0 113.564 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.9 mp -67.55 133.93 30.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.032 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 11.17 61.64 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.181 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.3 m -100.4 129.41 46.37 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 44' ' ' ILE . 25.2 m-85 -101.62 128.46 47.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.058 -173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.3 mp -96.58 140.79 30.68 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.898 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 56.4 t30 -92.05 104.18 16.6 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.277 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.08 136.42 50.13 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.487 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -118.7 133.14 56.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.0 m -84.59 128.5 34.63 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -55.32 163.2 1.82 Allowed Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 123.214 0.322 . . . . 0.0 111.204 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.78 -31.4 71.92 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.477 2.118 . . . . 0.0 108.788 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 106' ' ' ILE . . . -68.59 -2.57 28.93 Favored Glycine 0 CA--C 1.558 2.776 0 CA-C-N 113.931 -1.486 . . . . 0.0 114.342 175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.5 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 91.9 m-85 -121.26 133.39 55.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.3 m -62.43 -41.48 98.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.944 1.698 . . . . 0.0 113.519 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.14 51.75 Favored Glycine 0 CA--C 1.501 -0.791 0 CA-C-N 114.59 -1.186 . . . . 0.0 115.32 -167.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -68.54 121.89 82.56 Favored Pre-proline 0 CA--C 1.514 -0.434 0 O-C-N 125.055 1.091 . . . . 0.0 109.065 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.99 141.55 89.61 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 CA-C-N 119.391 0.818 . . . . 0.0 110.954 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.17 147.48 40.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 m -74.04 147.38 42.93 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 pt -103.49 127.45 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 123.752 0.657 . . . . 0.0 110.139 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.809 ' H ' HG23 ' A' ' 52' ' ' THR . 1.7 mp -124.25 130.07 73.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.988 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 18.6 m -60.85 43.65 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.7 mt -63.7 -42.02 98.04 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.632 1.173 . . . . 0.0 112.889 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tptm -109.66 121.84 46.12 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.456 -171.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 50' ' ' VAL . 63.4 t30 54.83 37.1 27.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.187 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 p 49.29 21.72 0.58 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.944 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 48' ' ' ASN . 61.2 t -100.0 -92.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.854 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -152.29 167.99 26.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.834 0.288 . . . . 0.0 110.985 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.809 HG23 ' H ' ' A' ' 44' ' ' ILE . 77.5 p -65.75 -32.42 73.96 Favored 'General case' 0 CA--C 1.554 1.098 0 O-C-N 123.298 0.373 . . . . 0.0 111.881 -176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.682 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 139.7 59.53 0.04 OUTLIER Glycine 0 C--O 1.214 -1.132 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.84 25.69 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -108.57 152.3 24.95 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.401 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 49.66 22.65 0.82 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 124.333 1.053 . . . . 0.0 111.031 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.1 mmm180 -66.03 -39.3 90.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.225 0.535 . . . . 0.0 111.117 -175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 60.4 m -115.37 146.72 41.3 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 103.104 -2.925 . . . . 0.0 103.104 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.23 151.81 51.63 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.789 -166.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 18.7 ptp180 -124.71 154.34 40.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.376 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.692 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -115.59 153.33 31.44 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.638 0.733 . . . . 0.0 112.048 -172.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.692 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 58.4 m -67.78 146.42 53.74 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.165 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' N ' ' HA ' ' A' ' 81' ' ' GLN . 10.2 m -93.47 -178.81 4.84 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.127 0.489 . . . . 0.0 112.145 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 64' ' ' ARG . 43.0 ptt85 -131.14 136.26 48.19 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.596 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 1.7 m120 -137.79 20.46 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.676 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 54.4 Cg_exo -55.33 -33.5 85.41 Favored 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 121.561 1.507 . . . . 0.0 114.044 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 2.1 Cg_endo -59.39 -29.4 90.07 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 121.547 1.498 . . . . 0.0 111.846 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.09 154.19 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.825 0 C-N-CA 124.85 1.26 . . . . 0.0 113.634 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.33 158.36 57.81 Favored 'Trans proline' 0 C--O 1.218 -0.493 0 C-N-CA 123.941 3.094 . . . . 0.0 111.969 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.76 -44.68 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.643 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -93.93 5.92 50.13 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.573 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.4 23.28 65.7 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 97.9 mmm -108.7 88.24 2.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.692 0.758 . . . . 0.0 111.256 -171.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 3.1 p -141.54 142.23 29.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.009 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 64.1 m170 -116.15 148.98 39.78 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.23 131.14 73.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.2 mt -94.17 -75.1 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.547 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -64.37 -42.09 96.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 133.25 11.28 1.79 Allowed Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.28 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 50.1 mm 83.62 79.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' SER . 3.2 pt20 -162.81 -173.14 3.36 Favored 'General case' 0 C--O 1.246 0.877 0 CA-C-O 121.527 0.679 . . . . 0.0 111.696 172.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 106' ' ' ILE . 40.7 t80 -64.29 131.95 48.8 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.311 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.33 23.75 58.16 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 118.769 -1.681 . . . . 0.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 57.6 m -127.19 152.48 47.32 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 0.0 109.929 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.444 HE21 ' CB ' ' A' ' 101' ' ' SER . 58.9 tt0 -127.07 139.08 53.26 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.206 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.88 162.81 33.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.293 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.671 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -108.98 151.96 25.62 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.725 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -126.92 48.99 2.11 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.54 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.7 t -70.76 141.44 51.45 Favored 'General case' 0 C--O 1.202 -1.438 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 60.6 m -89.17 -39.06 13.83 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.66 0.743 . . . . 0.0 112.05 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 93' ' ' GLY . 6.7 m -174.3 161.31 3.43 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.038 -165.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.21 -47.39 82.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.349 -1.34 . . . . 0.0 111.367 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 91' ' ' THR . . . -104.45 68.49 0.27 Allowed Glycine 0 CA--C 1.502 -0.754 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.173 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 3.6 p90 -151.05 165.25 34.38 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 87.8 mtm-85 -106.44 135.27 48.24 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 99' ' ' SER . 35.8 tp -105.63 118.86 37.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.884 -1.135 . . . . 0.0 108.539 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.852 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.9 mm -67.13 -43.88 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.483 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -100.85 -146.91 20.0 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.406 -0.816 . . . . 0.0 114.374 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.635 ' O ' HD21 ' A' ' 96' ' ' LEU . 5.9 p -73.03 136.77 45.07 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.038 0.447 . . . . 0.0 111.505 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 89.0 p -87.4 -5.98 58.63 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 110.59 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.671 ' HB3' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p -153.46 159.3 42.29 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-N 114.187 -1.369 . . . . 0.0 107.616 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.79 145.44 48.42 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 m -121.09 130.89 53.95 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.91 129.8 34.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.421 1.105 . . . . 0.0 113.257 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.18 164.51 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 112.766 -2.015 . . . . 0.0 109.97 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 35' ' ' GLY . 48.0 mm -98.84 127.31 51.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.0 p -85.44 -12.17 52.59 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.57 0.7 . . . . 0.0 109.699 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 125.81 -78.57 0.37 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.18 -36.78 85.17 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.852 0.384 . . . . 0.0 111.982 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 t -139.62 -171.76 3.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.47 0.652 . . . . 0.0 111.352 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.721 HG12 ' CD1' ' A' ' 106' ' ' ILE . 26.8 m -117.97 131.41 70.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.855 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.2 162.52 36.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 O-C-N 121.672 -0.642 . . . . 0.0 112.655 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -94.22 146.74 23.79 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.177 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' HD12 ' A' ' 105' ' ' ILE . 46.0 p-10 -86.3 -2.03 58.03 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.468 HE21 ' H ' ' A' ' 117' ' ' THR . 21.4 tp60 -60.13 130.88 48.89 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 110.233 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -64.07 -40.89 97.26 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.66 0.743 . . . . 0.0 110.267 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 ' H ' HE21 ' A' ' 115' ' ' GLN . 8.8 t 170.84 141.47 0.09 OUTLIER Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.2 141.12 92.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 CA-C-N 120.619 1.257 . . . . 0.0 111.088 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.852 HG21 ' HB ' ' A' ' 97' ' ' ILE . 7.4 mt -138.99 143.51 31.56 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.11 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.612 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.8 m -140.32 112.11 7.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 119.387 0.994 . . . . 0.0 110.189 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 45.8 t0 -64.32 -44.3 91.97 Favored 'General case' 0 C--N 1.384 2.074 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.69 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 . . . . . 0 C--O 1.26 1.646 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.47 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 120.257 0.075 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 33.3 m -75.58 -19.73 59.07 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.695 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 25.0 m-80 60.34 34.61 20.72 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . 60.1 111.9 0.02 OUTLIER Pre-proline 0 C--O 1.211 -0.971 0 O-C-N 124.351 1.032 . . . . 0.0 111.783 172.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.88 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 25.6 Cg_endo -58.59 -34.09 98.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.036 1.824 . . . . 0.0 114.704 -170.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.88 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 78.8 mm-40 140.09 177.94 0.0 OUTLIER 'General case' 0 CA--C 1.469 -2.145 0 C-N-CA 128.543 2.737 . . . . 0.0 110.355 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -98.33 110.89 23.4 Favored 'General case' 0 N--CA 1.383 -3.788 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.402 167.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.2 110.96 35.23 Favored Pre-proline 0 N--CA 1.424 -1.758 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.345 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -21.77 65.88 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.861 2.374 . . . . 0.0 114.101 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -101.64 8.02 41.88 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.784 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.06 149.08 51.03 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.036 0.446 . . . . 0.0 111.747 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.3 78.32 74.64 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.861 174.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.4 Cg_exo -63.55 147.16 93.18 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 122.271 1.981 . . . . 0.0 110.684 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -95.4 4.34 53.44 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.332 0.587 . . . . 0.0 112.087 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.837 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.33 44.5 mt-30 -119.8 -44.21 2.54 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -171.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 1.8 tt -57.08 -21.44 31.83 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 112.953 -1.931 . . . . 0.0 114.295 -172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -59.42 -44.54 92.84 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -111.02 -2.11 16.04 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.742 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -128.54 66.01 1.4 Allowed 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.469 1.128 . . . . 0.0 109.203 -167.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 96.7 m-85 -65.18 -36.81 85.36 Favored 'General case' 0 C--N 1.257 -3.437 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.127 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.695 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 93.5 mt-10 -133.05 156.57 47.13 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -170.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 97.0 m-85 -147.39 155.13 46.06 Favored Pre-proline 0 C--O 1.201 -1.492 0 O-C-N 123.648 0.593 . . . . 0.0 110.584 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.19 -40.51 85.39 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 121.679 1.586 . . . . 0.0 114.67 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 161.82 150.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 125.093 1.357 . . . . 0.0 110.739 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 28.16 68.6 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 115.541 0.976 . . . . 0.0 115.541 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 96.1 m -110.66 127.73 55.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.6 m-85 -93.53 130.41 39.4 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.238 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' HA ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -105.65 134.99 47.87 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.567 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.837 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.4 t30 -85.62 106.78 17.16 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.824 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' PRO . 3.6 m-85 -106.61 131.97 53.15 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.523 173.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -126.01 144.13 50.83 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -92.34 144.95 24.87 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.346 0.593 . . . . 0.0 112.435 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -67.18 166.42 20.58 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.539 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.24 145.18 96.19 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.583 1.522 . . . . 0.0 110.745 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.62 4.0 73.73 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.284 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.648 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 88.5 m-85 -109.96 130.41 55.53 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.301 1.048 . . . . 0.0 112.303 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 22.6 m -61.86 -40.86 96.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.417 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.13 149.02 49.72 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.592 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HG3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -106.01 -167.38 0.12 Allowed Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' A' ' 39' ' ' ARG . 33.2 Cg_endo -62.01 142.75 93.75 Favored 'Trans proline' 0 C--N 1.366 1.484 0 CA-C-N 123.109 2.146 . . . . 0.0 114.948 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.735 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 86.6 m-85 -133.45 157.02 46.64 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 125.698 1.599 . . . . 0.0 110.229 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 47.2 m -126.16 150.17 48.47 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.344 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.77 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.2 pt -119.36 129.26 75.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.392 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 2.0 mp -120.14 129.64 75.25 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.166 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 76.6 m -65.98 70.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.254 0.55 . . . . 0.0 110.808 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 89.7 mt -100.11 -57.58 2.1 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.019 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -80.05 122.29 26.58 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.152 -171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 50' ' ' VAL . 9.9 m120 54.73 33.24 19.09 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.081 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m 55.25 13.33 0.84 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.384 0.673 . . . . 0.0 111.713 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 60.3 t -97.01 -93.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.226 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 99.6 m95 -147.44 157.05 43.42 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -43.43 98.81 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.195 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.43 100.26 0.36 Allowed Glycine 0 C--O 1.244 0.72 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.701 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -104.36 70.5 0.96 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 122.605 0.362 . . . . 0.0 110.431 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -140.22 152.65 46.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.05 18.65 1.77 Allowed 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 124.066 0.947 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.735 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmm-85 -66.26 -39.68 89.62 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.091 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.1 m -111.53 149.73 30.97 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 79.5 mtp85 -128.07 143.96 51.09 Favored 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 119.334 -0.947 . . . . 0.0 110.499 -172.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 82' ' ' PHE . 15.8 ptp180 -116.13 148.36 40.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.638 0.732 . . . . 0.0 112.155 -176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 62' ' ' SER . 11.0 tmtt? -79.0 138.91 38.25 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.127 -1.397 . . . . 0.0 112.733 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.623 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 45.6 t -70.03 141.83 52.83 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.945 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.7 m -96.24 150.98 19.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.021 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 6.4 ppt_? -134.38 150.71 50.92 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 12.7 t30 -156.53 77.3 4.27 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 29.4 Cg_endo -105.82 8.27 0.22 Allowed 'Trans proline' 0 CA--C 1.592 3.378 0 C-N-CA 122.117 1.878 . . . . 0.0 114.25 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 33.8 Cg_endo -62.2 -30.18 81.51 Favored 'Trans proline' 1 C--N 1.429 4.794 0 CA-C-N 122.103 1.787 . . . . 0.0 111.712 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 56.03 147.32 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 84.8 Cg_endo -68.09 157.59 61.14 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 124.211 3.274 . . . . 0.0 110.269 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 71.5 t -60.79 -44.34 97.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.064 -169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -92.15 9.17 34.69 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.608 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 82.13 20.92 61.83 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 171.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.524 ' C ' ' HG3' ' A' ' 69' ' ' PRO . 78.1 mtm -112.41 99.73 8.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.639 1.72 . . . . 0.0 112.114 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p -128.67 136.54 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.437 0.637 . . . . 0.0 110.723 176.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 62.2 m170 -115.89 154.12 30.32 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -125.47 131.23 72.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 87' ' ' LYS . 97.0 mt -92.08 -50.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.23 -3.35 40.94 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 94.15 16.37 44.37 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.731 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 65.27 85.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 122.027 0.917 . . . . 0.0 112.034 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.5 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.6 tp60 -160.56 176.31 11.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.574 -1.194 . . . . 0.0 107.911 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 14.5 t80 -62.48 128.67 37.09 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.105 0.478 . . . . 0.0 109.89 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.04 -10.54 69.99 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.54 -175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 36.6 t -73.14 143.54 47.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.82 0.343 . . . . 0.0 111.749 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.56 HE21 ' CB ' ' A' ' 101' ' ' SER . 57.1 tt0 -122.47 135.87 54.76 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 172.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.5 pt -128.64 161.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 C-N-CA 122.752 0.421 . . . . 0.0 111.909 -175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.786 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -112.38 140.97 46.66 Favored 'General case' 0 CA--C 1.473 -1.982 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.326 -172.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.88 126.38 53.86 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.917 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 73' ' ' MET . 34.4 t -138.94 139.52 38.0 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.895 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.432 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 37.0 m -101.0 -44.13 5.82 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.14 0.971 . . . . 0.0 112.545 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 94' ' ' TYR . 69.7 m -148.56 161.1 42.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.498 -166.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 46.6 pttt -71.3 -47.74 54.9 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 171.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.459 ' H ' HG22 ' A' ' 91' ' ' THR . . . -98.66 30.88 8.84 Favored Glycine 0 C--N 1.306 -1.127 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.665 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CG ' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -123.76 -179.97 4.58 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -175.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 75.0 mmt-85 -124.86 144.19 50.44 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 100' ' ' SER . 34.8 tp -102.13 120.48 40.52 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 117.719 -1.592 . . . . 0.0 108.647 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.814 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.7 mm -65.59 -44.9 93.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.845 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.28 -138.13 9.95 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 120.943 -0.646 . . . . 0.0 114.198 -176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.9 m -74.15 101.45 3.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.679 ' HA ' HD23 ' A' ' 96' ' ' LEU . 38.6 t -61.57 -42.7 99.22 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.227 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.56 ' CB ' HE21 ' A' ' 85' ' ' GLN . 7.8 t -130.52 116.79 18.66 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.974 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -77.76 146.41 35.88 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 61.8 m -122.58 129.59 52.08 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 1.9 t -90.94 116.55 28.83 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 121.797 0.808 . . . . 0.0 110.688 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.57 162.65 36.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.88 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.755 HD13 HG12 ' A' ' 111' ' ' VAL . 47.3 mm -79.75 124.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.629 0.728 . . . . 0.0 109.185 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.3 p -67.9 -32.72 73.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.627 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.95 -24.93 2.83 Favored Glycine 0 N--CA 1.419 -2.442 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -123.41 -35.11 2.99 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.736 -0.732 . . . . 0.0 111.237 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -143.25 173.41 11.61 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.047 0.539 . . . . 0.0 111.906 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.755 HG12 HD13 ' A' ' 106' ' ' ILE . 28.2 m -98.31 126.76 51.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 CA-C-O 122.087 0.946 . . . . 0.0 110.125 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 47.4 pt -130.53 161.09 41.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.787 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -94.45 147.16 23.52 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -83.28 -0.31 49.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.84 0.352 . . . . 0.0 110.559 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 60.4 tt0 -59.79 131.44 50.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.373 0.606 . . . . 0.0 111.555 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' HB ' ' A' ' 117' ' ' THR . 57.2 mp0 -65.74 -42.79 90.54 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.279 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 2.3 t 159.2 165.46 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . 36.2 Cg_exo -61.41 140.3 87.09 Favored 'Trans proline' 0 C--N 1.371 1.748 0 CA-C-N 121.88 1.707 . . . . 0.0 110.374 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.814 HG21 ' HB ' ' A' ' 97' ' ' ILE . 10.1 mt -142.62 151.95 17.75 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.604 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 81.7 m -150.02 114.95 5.34 Favored 'General case' 0 CA--C 1.575 1.919 0 CA-C-N 119.571 1.078 . . . . 0.0 110.614 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -62.16 -48.06 81.76 Favored 'General case' 0 C--N 1.402 2.87 0 CA-C-N 119.333 0.97 . . . . 0.0 111.231 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.012 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.884 ' N ' HE21 ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.774 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -75.29 -22.21 57.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 118.064 -1.454 . . . . 0.0 110.779 -177.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.1 m-80 57.08 53.56 7.8 Favored 'General case' 0 CA--C 1.469 -2.157 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 74.72 105.93 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.668 0 O-C-N 124.255 0.972 . . . . 0.0 112.325 170.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HA ' ' CD1' ' A' ' 51' ' ' TRP 0.261 18.7 Cg_exo -55.37 -51.55 9.75 Favored 'Trans proline' 0 CA--C 1.491 -1.651 0 C-N-CA 121.318 1.345 . . . . 0.0 113.799 -173.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 40.4 tp10 149.54 164.55 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.399 -2.182 . . . . 0.0 108.884 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.496 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 64.7 t90 -90.22 124.22 34.68 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 8' ' ' LEU . 10.4 tp -107.05 113.17 62.75 Favored Pre-proline 0 N--CA 1.419 -1.994 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.08 -30.76 89.89 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 121.022 1.148 . . . . 0.0 111.64 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 58' ' ' CYS . 21.5 m-85 -65.82 -41.09 92.26 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.194 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -121.4 145.55 47.79 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.088 -164.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 87.37 53.97 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.39 148.99 92.34 Favored 'Trans proline' 0 CA--C 1.504 -1.005 0 C-N-CA 122.902 2.401 . . . . 0.0 109.529 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -91.52 -2.99 56.99 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.302 -167.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.678 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 9.6 mt-30 -116.18 -48.46 2.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.452 0.644 . . . . 0.0 111.285 -168.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -65.24 -15.78 62.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -167.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 t -60.81 -43.11 98.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -100.19 -3.05 32.41 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 18.8 pt-20 -157.75 81.5 0.87 Allowed 'General case' 0 C--O 1.196 -1.736 0 CA-C-O 123.549 1.642 . . . . 0.0 111.531 -173.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 97.7 m-85 -65.38 -37.68 87.73 Favored 'General case' 0 C--N 1.251 -3.693 0 CA-C-N 112.558 -2.11 . . . . 0.0 109.973 175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -88.44 123.88 33.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.025 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 97.4 m-85 -133.97 148.94 70.21 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 92.2 Cg_endo -71.38 159.13 52.52 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.727 3.618 . . . . 0.0 114.102 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 45' ' ' CYS . 43.2 mt -68.09 132.82 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 121.911 0.863 . . . . 0.0 109.465 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 21.79 39.75 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.505 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.687 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 70.0 m -115.36 129.66 56.66 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' CE2' HG12 ' A' ' 44' ' ' ILE . 32.4 m-85 -103.08 132.05 49.63 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.534 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.9 mp -103.03 140.08 37.75 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.678 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.4 t-20 -86.57 103.5 15.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.146 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -113.75 135.66 53.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.215 1.806 . . . . 0.0 113.158 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 80.3 tt0 -121.41 131.66 54.3 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.442 0.464 . . . . 0.0 110.539 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -86.61 149.6 24.81 Favored 'General case' 0 CA--C 1.474 -1.954 0 CA-C-O 121.171 0.51 . . . . 0.0 110.668 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mmt-85 -61.77 131.31 92.91 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 169.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 23.9 Cg_exo -62.16 145.83 96.2 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.369 2.046 . . . . 0.0 112.84 -176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 84.99 19.67 58.93 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.873 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -104.56 139.61 39.19 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.796 0.838 . . . . 0.0 109.516 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 19.5 m -60.18 -42.34 94.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.84 -172.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -72.57 141.4 30.8 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.032 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -92.22 129.52 41.04 Favored Pre-proline 0 C--O 1.255 1.364 0 C-N-CA 122.768 0.427 . . . . 0.0 109.965 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 39' ' ' ARG . 24.0 Cg_exo -61.44 143.35 97.46 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.223 1.948 . . . . 0.0 112.992 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.595 ' H ' ' NH2' ' A' ' 57' ' ' ARG . 52.2 p90 -156.01 158.03 37.16 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.045 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -74.3 147.78 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.403 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.7 pt -103.62 133.51 47.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.693 174.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.606 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.7 mp -125.35 133.22 69.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 117.339 -1.315 . . . . 0.0 107.755 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 5.6 m -55.96 32.36 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.326 0 CA-C-N 120.115 1.325 . . . . 0.0 113.934 -177.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 94.8 mt -63.66 -42.79 98.04 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.43 117.91 32.74 Favored 'General case' 0 CA--C 1.478 -1.821 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 55.5 33.2 20.53 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.153 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 56.82 19.43 4.45 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.093 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 64.7 t -104.26 -87.63 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.189 -2.098 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.3 m95 -151.72 159.38 43.99 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.41 -0.806 . . . . 0.0 111.526 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.4 t -62.93 -44.55 95.76 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.64 83.38 0.05 OUTLIER Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -89.17 -7.04 56.42 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 57.8 tptt -80.93 135.62 35.92 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD1' ' HE3' ' A' ' 55' ' ' LYS . 98.5 m-20 59.89 37.2 21.76 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.44 173.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' NH2' ' H ' ' A' ' 41' ' ' PHE . 57.6 mmm-85 -64.31 -40.97 97.0 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -170.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 10' ' ' PHE . 16.3 m -124.28 148.13 47.62 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.8 mtp85 -130.01 137.32 50.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 117.316 -1.753 . . . . 0.0 111.809 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' NE ' ' HD2' ' A' ' 82' ' ' PHE 0.258 1.5 ptm180 -92.85 155.21 17.77 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 126.927 2.091 . . . . 0.0 108.159 -175.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.337 55.8 mtpt -109.24 153.15 24.24 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 118.879 2.918 . . . . 0.0 118.879 -174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 t -64.17 135.98 56.81 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.9 m -103.5 163.27 12.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.584 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.7 OUTLIER -141.51 151.37 43.22 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 t-20 -130.58 42.8 0.96 Allowed Pre-proline 0 CA--C 1.559 1.31 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.614 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 37.2 Cg_endo -75.9 -14.02 19.4 Favored 'Trans proline' 0 CA--C 1.572 2.379 0 CA-C-N 120.337 1.156 . . . . 0.0 114.695 172.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.5 Cg_endo -60.24 -29.79 89.77 Favored 'Trans proline' 1 C--N 1.425 4.567 0 CA-C-N 121.954 1.733 . . . . 0.0 109.063 174.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.68 ' OD1' ' HA2' ' A' ' 72' ' ' GLY . 0.8 OUTLIER 55.17 152.94 0.06 OUTLIER Pre-proline 0 CA--C 1.568 1.636 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 170.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.595 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 12.3 Cg_exo -65.92 155.25 70.35 Favored 'Trans proline' 0 C--O 1.21 -0.922 0 C-N-CA 124.942 3.762 . . . . 0.0 110.068 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' SG ' ' A' ' 120' ' ' CYS . 70.5 t -60.36 -45.65 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.921 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' CG ' HH22 ' A' ' 122' ' ' ARG . 50.1 t30 -65.05 -39.37 93.21 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.81 174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' A' ' 68' ' ' ASP . . . 105.81 31.98 4.01 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -172.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.501 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 49.6 mtp -122.65 93.75 4.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.641 -0.78 . . . . 0.0 113.016 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 14.4 p -127.65 136.23 61.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.368 0.604 . . . . 0.0 111.145 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 97.4 m-70 -112.49 131.69 55.45 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.804 174.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' VAL . 5.1 m -104.84 112.33 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.796 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.769 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.5 mt -65.07 -44.37 95.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.542 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -100.68 -4.15 28.86 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.91 43.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.286 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.6 mm 64.32 83.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 121.698 0.761 . . . . 0.0 112.474 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.1 tp60 -154.49 171.95 18.57 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.351 -0.84 . . . . 0.0 108.891 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HD2' ' NE ' ' A' ' 60' ' ' ARG . 69.0 t80 -61.34 133.31 55.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 120.991 -1.068 . . . . 0.0 112.466 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.18 5.98 89.41 Favored Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.145 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 90.6 p -80.12 161.34 25.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.239 0.542 . . . . 0.0 111.767 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 54.3 tt0 -133.41 131.74 40.33 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.144 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -128.38 162.98 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.769 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.1 mptm? -109.52 139.75 44.13 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 122.211 1.005 . . . . 0.0 112.479 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.38 89.83 3.18 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.104 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.588 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 27.4 m -114.98 119.01 35.06 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.492 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 55.8 m -77.47 -33.67 54.53 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 123.829 0.706 . . . . 0.0 111.261 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 24.8 m -162.61 170.24 18.86 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.027 -167.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.45 112.83 26.03 Favored 'General case' 0 N--CA 1.388 -3.551 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.36 50.02 0.95 Allowed Glycine 0 C--N 1.266 -3.36 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.23 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 5.8 p90 -149.09 163.14 38.42 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 81.9 mtt85 -104.95 136.07 45.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.702 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 33.5 tp -105.17 119.01 37.98 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 116.042 -2.263 . . . . 0.0 105.883 169.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.617 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.1 mm -66.5 -44.64 90.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.89 -129.86 3.17 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.637 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 t -100.71 119.55 38.77 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.274 1.035 . . . . 0.0 110.507 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.702 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 15.7 m -61.23 -39.2 89.41 Favored 'General case' 0 C--O 1.204 -1.321 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.696 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 23.7 m -127.21 151.32 48.86 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -125.96 147.97 49.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 84' ' ' SER . 74.8 m -120.72 129.28 53.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 26.6 t -85.98 127.49 34.65 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -129.31 162.71 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.629 -176.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 111' ' ' VAL . 34.9 mm -75.33 126.09 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.953 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.541 ' OG ' HG12 ' A' ' 112' ' ' ILE . 50.5 m -91.22 -11.08 39.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.164 0.983 . . . . 0.0 110.133 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 104.0 -60.23 0.46 Allowed Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.896 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -67.51 -38.6 84.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.703 0.764 . . . . 0.0 109.887 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.5 t -153.31 -175.83 5.52 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.739 -171.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 106' ' ' ILE . 13.5 m -113.59 131.65 64.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 172.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.541 HG12 ' OG ' ' A' ' 107' ' ' SER . 48.9 pt -127.7 166.02 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.128 0.49 . . . . 0.0 110.268 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 99.3 m95 -90.97 147.04 23.37 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.591 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 105' ' ' ILE . 48.1 p-10 -85.01 -1.56 56.96 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -69.45 138.44 53.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.385 0.612 . . . . 0.0 112.31 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -64.39 -42.36 96.17 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.268 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 176.81 162.81 0.49 Allowed Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -62.77 142.43 88.95 Favored 'Trans proline' 0 CA--C 1.563 1.936 0 C-N-CA 121.055 1.17 . . . . 0.0 111.667 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.617 HG21 ' HB ' ' A' ' 97' ' ' ILE . 1.7 mp -141.86 149.29 19.94 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.025 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.023 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.576 ' SG ' ' HB ' ' A' ' 70' ' ' VAL . 88.9 m -156.6 112.59 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.18 166.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 46.9 t0 -64.66 -50.81 65.59 Favored 'General case' 0 C--N 1.396 2.628 0 CA-C-N 120.259 1.39 . . . . 0.0 110.722 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.66 HH22 ' CG ' ' A' ' 71' ' ' ASN . 42.5 ttm180 . . . . . 0 C--O 1.264 1.821 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.893 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . 0.26 43.8 mt-30 . . . . . 0 N--CA 1.439 -1.002 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 25.6 m -77.58 -20.7 53.61 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.199 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 52.8 m-80 59.98 35.33 21.56 Favored 'General case' 0 CA--C 1.459 -2.554 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.587 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 3' ' ' ASN . . . 71.52 136.56 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -0.992 0 O-C-N 124.406 1.066 . . . . 0.0 110.294 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.821 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 18.1 Cg_endo -59.33 -73.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.646 0.898 . . . . 0.0 114.337 -175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -174.06 172.3 3.4 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.12 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -87.49 118.71 27.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 ' HB2' ' A' ' 11' ' ' ALA . 12.6 tp -123.71 105.48 32.73 Favored Pre-proline 0 C--N 1.313 -1.0 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 33.6 Cg_endo -63.12 -24.37 73.1 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 123.11 2.54 . . . . 0.0 114.008 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -105.45 7.43 33.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.657 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . -95.41 144.1 26.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.17 0.434 . . . . 0.0 112.17 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.657 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 21.2 mmm180 -129.7 52.27 9.03 Favored Pre-proline 0 CA--C 1.556 1.197 0 O-C-N 123.198 0.311 . . . . 0.0 111.364 174.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 11.4 Cg_exo -66.75 152.18 81.06 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.17 2.58 . . . . 0.0 112.051 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 p -93.78 0.49 56.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.128 -170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.621 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -124.82 -34.99 2.75 Favored 'General case' 0 C--O 1.177 -2.747 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.708 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.98 -40.41 93.33 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.648 1.179 . . . . 0.0 112.417 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -59.46 -34.26 72.31 Favored 'General case' 0 C--N 1.258 -3.406 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.183 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -122.79 2.32 9.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 90.5 mt-10 -144.83 86.45 1.8 Allowed 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -170.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 98.1 m-85 -98.14 -2.92 38.86 Favored 'General case' 0 C--N 1.261 -3.245 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -121.95 129.11 52.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.514 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD1' HG21 ' A' ' 26' ' ' THR . 63.1 m-85 -152.35 152.66 29.64 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.83 163.18 39.13 Favored 'Trans proline' 0 N--CA 1.489 1.252 1 C-N-CA 125.755 4.303 . . . . 0.0 114.399 170.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 4.9 mp -65.45 136.3 26.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.047 0.539 . . . . 0.0 109.903 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 21.86 52.52 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.235 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 22' ' ' PHE . 94.7 m -102.96 129.37 49.68 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -100.23 128.0 46.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.722 -176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.9 mp -110.97 134.6 52.46 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.37 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.539 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.8 t30 -87.38 107.37 18.5 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.346 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -110.35 135.75 50.58 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.566 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -132.41 153.4 50.85 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.126 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 93.9 m -88.17 145.76 25.74 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.951 ' NH2' ' HB2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -83.82 -171.16 0.28 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -62.45 145.84 95.6 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 CA-C-N 120.985 1.388 . . . . 0.0 112.02 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 106' ' ' ILE . . . 94.84 0.45 64.08 Favored Glycine 0 CA--C 1.545 1.939 0 N-CA-C 118.092 1.997 . . . . 0.0 118.092 169.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.951 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 94.5 m-85 -128.12 144.5 51.12 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.341 1.571 . . . . 0.0 114.016 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.739 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 19.0 p -79.91 167.17 20.87 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.466 168.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' HA2' ' NH1' ' A' ' 59' ' ' ARG . . . 148.74 -170.93 29.14 Favored Glycine 0 C--N 1.275 -2.859 0 C-N-CA 119.004 -1.569 . . . . 0.0 113.7 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HD2' ' HE2' ' A' ' 41' ' ' PHE . 17.6 mmt-85 -133.9 98.58 14.43 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.345 -0.427 . . . . 0.0 111.114 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -83.1 113.82 2.16 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 112.763 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HE2' ' HD2' ' A' ' 39' ' ' ARG . 80.6 m-85 -143.64 163.05 34.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.4 m -65.55 144.54 56.92 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.81 129.91 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.811 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 52' ' ' THR . 3.1 mp -120.43 130.77 74.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.536 -174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 73.7 m -60.91 76.66 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 118.294 0.497 . . . . 0.0 111.526 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 52' ' ' THR . 86.0 mt -99.19 -57.49 2.15 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 32.2 ttmt -79.5 121.35 25.1 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 54.57 34.16 20.68 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.497 1.123 . . . . 0.0 110.569 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 m 56.16 19.92 4.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.464 0.65 . . . . 0.0 111.107 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 50.3 t -97.28 -94.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.259 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.821 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.1 m95 -150.86 173.92 13.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.446 0.298 . . . . 0.0 111.357 -177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 44' ' ' ILE . 69.8 p -65.19 -33.22 75.48 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.52 0.513 . . . . 0.0 110.321 -177.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 151.17 -29.68 0.98 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.383 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 43.05 38.08 1.36 Allowed 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.61 135.58 45.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.7 t0 4.96 67.85 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 126.418 2.323 . . . . 0.0 110.648 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -64.96 -38.67 91.73 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.582 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' SER . 57.2 m -117.48 146.12 43.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.739 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 75.0 mtt85 -126.99 136.37 52.15 Favored 'General case' 0 CA--C 1.572 1.794 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.298 -166.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 39.2 ptt180 -90.32 158.63 17.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.419 0.688 . . . . 0.0 112.583 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.275 24.5 mtpt -102.1 156.31 17.64 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 176.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 111' ' ' VAL . 18.4 p -71.68 148.94 45.96 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 112.541 -2.118 . . . . 0.0 110.258 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 111' ' ' VAL . 51.9 m -102.81 172.9 6.57 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.662 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.429 ' NH2' HD13 ' A' ' 112' ' ' ILE . 33.6 ptt-85 -137.65 166.39 24.05 Favored 'General case' 0 C--O 1.181 -2.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.564 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.619 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 4.7 t-20 -135.02 47.62 2.43 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 117.918 -1.513 . . . . 0.0 114.71 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' N ' ' A' ' 65' ' ' ASN . 6.3 Cg_exo -82.15 -5.4 12.03 Favored 'Trans proline' 0 CA--C 1.604 3.98 0 C-N-CA 123.026 2.484 . . . . 0.0 114.917 169.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 61.1 Cg_endo -72.88 -7.2 20.34 Favored 'Trans proline' 0 C--N 1.408 3.699 0 C-N-CA 123.679 2.92 . . . . 0.0 111.068 172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -26.68 147.11 0.03 OUTLIER Pre-proline 0 C--O 1.25 1.082 0 C-N-CA 125.517 1.527 . . . . 0.0 113.897 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 74' ' ' VAL . 83.9 Cg_endo -65.8 152.62 81.06 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.25 2.633 . . . . 0.0 111.561 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.21 -46.61 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.786 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -65.0 -40.62 95.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.452 0.644 . . . . 0.0 109.81 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 109.63 34.81 2.36 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' SER . 64.9 mtt -112.09 92.08 3.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 117.966 0.883 . . . . 0.0 109.718 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -129.13 138.19 55.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 121.33 0.586 . . . . 0.0 110.541 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -113.71 145.22 41.67 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.666 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.6 p -123.08 123.02 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.839 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.74 -44.65 96.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.911 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -97.5 -7.02 32.4 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.666 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 88.06 11.11 67.95 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.449 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' N ' HG21 ' A' ' 76' ' ' VAL . 47.8 mm 85.72 75.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -151.38 -173.36 4.48 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 39.0 t80 -66.49 130.21 42.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.975 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.34 75.86 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.682 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 67.6 m -73.45 150.06 41.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -130.52 139.28 50.5 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.799 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.1 pt -129.31 162.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.67 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mptm? -113.55 143.15 45.02 Favored 'General case' 0 CA--C 1.467 -2.226 0 CA-C-O 120.998 0.428 . . . . 0.0 111.225 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.26 126.45 55.05 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.319 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.85 ' O ' ' HB2' ' A' ' 73' ' ' MET . 48.2 t -137.05 144.15 43.04 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.064 -1.425 . . . . 0.0 108.66 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 62.4 m -111.08 -44.93 3.5 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.797 -0.564 . . . . 0.0 112.442 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 93' ' ' GLY . 17.7 m -153.07 162.37 41.4 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.919 -171.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.6 -45.44 90.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 91' ' ' THR . . . -112.35 70.3 0.22 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.412 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.3 p90 -150.89 167.07 28.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.6 ttp180 -115.92 140.65 49.04 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.865 -0.522 . . . . 0.0 110.933 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 100' ' ' SER . 37.1 tp -96.31 116.31 28.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 117.804 -1.559 . . . . 0.0 107.45 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.7 mm -66.23 -44.41 91.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -97.78 -127.17 5.64 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -86.86 114.59 23.64 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.752 0.787 . . . . 0.0 112.139 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.537 ' HA ' HD23 ' A' ' 96' ' ' LEU . 22.8 t -66.76 -15.73 63.76 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 125.073 1.349 . . . . 0.0 110.325 172.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.31 158.52 44.25 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.164 0.507 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.2 147.83 44.18 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.787 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.2 m -119.81 129.88 54.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 1.9 t -87.54 120.81 29.22 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.945 0.879 . . . . 0.0 112.489 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 165.51 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.285 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 35' ' ' GLY . 20.2 mm -94.08 123.75 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.318 -172.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.9 p -88.29 -8.06 55.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.643 0.735 . . . . 0.0 110.721 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.661 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 129.59 -91.12 0.31 Allowed Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -70.69 -18.84 62.82 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.9 -0.65 . . . . 0.0 111.319 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -146.19 167.48 23.35 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 106' ' ' ILE . 34.2 m -111.91 131.11 64.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.429 HD13 ' NH2' ' A' ' 64' ' ' ARG . 1.4 tp -131.72 143.33 40.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 104' ' ' CYS . 96.6 m95 -78.77 142.59 36.87 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.704 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.41 -0.73 56.6 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -70.79 160.92 31.84 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.496 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.3 tp10 -65.49 -45.08 84.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 162.65 162.87 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -174.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -61.17 137.02 68.47 Favored 'Trans proline' 0 C--N 1.37 1.698 0 CA-C-N 120.559 1.235 . . . . 0.0 110.891 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.565 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 89.2 mt -135.06 133.91 53.27 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.152 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.3 m -141.69 115.23 8.99 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.202 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 95' ' ' ARG . 13.5 t70 -61.84 -48.1 82.07 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.12 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.242 0.697 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.734 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.409 0.147 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 49' ' ' SER . 33.7 m -80.96 -24.02 38.38 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.52 0.676 . . . . 0.0 110.407 173.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.1 t30 59.16 35.87 23.77 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.833 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 56.27 128.93 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.987 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.68 154.17 68.37 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 C-N-CA 121.948 1.766 . . . . 0.0 110.629 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.45 149.38 50.11 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.209 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -70.94 122.76 20.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.577 0.704 . . . . 0.0 111.626 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.02 107.52 54.19 Favored Pre-proline 0 N--CA 1.434 -1.241 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.383 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.95 -22.49 62.77 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.094 1.862 . . . . 0.0 112.057 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.252 18.8 m-30 -63.58 -41.97 98.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.083 -177.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -115.03 149.48 37.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.56 -1.655 . . . . 0.0 114.625 -163.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.67 77.95 75.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.182 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 12.1 Cg_exo -66.06 148.99 86.15 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.746 2.297 . . . . 0.0 112.471 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -93.73 4.72 53.5 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.979 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.813 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 46.3 mt-30 -119.25 -46.01 2.52 Favored 'General case' 0 C--O 1.196 -1.733 0 CA-C-O 122.388 1.09 . . . . 0.0 108.66 -172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 16' ' ' LEU . 5.8 tt -55.81 -29.99 60.66 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.911 -1.949 . . . . 0.0 114.392 -173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.3 t -60.13 -44.88 94.59 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.876 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -115.8 4.66 13.99 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.8 mt-10 -131.49 62.0 1.63 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.67 1.224 . . . . 0.0 108.365 -171.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 92.2 m-85 -64.53 -33.91 77.01 Favored 'General case' 0 C--N 1.259 -3.33 0 CA-C-N 113.689 -1.596 . . . . 0.0 111.239 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.26 134.11 53.09 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' CG ' HG21 ' A' ' 26' ' ' THR . 81.1 m-85 -144.77 165.12 24.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.33 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.28 174.66 12.11 Favored 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.358 3.372 . . . . 0.0 112.043 170.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.52 134.36 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 122.198 0.999 . . . . 0.0 112.459 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.64 55.1 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.933 -1.485 . . . . 0.0 113.549 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.528 HG21 ' CG ' ' A' ' 22' ' ' PHE . 38.9 m -89.66 128.37 36.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' CE2' HG12 ' A' ' 44' ' ' ILE . 25.1 m-85 -105.27 123.89 48.61 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.137 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.7 ' HA ' HE22 ' A' ' 15' ' ' GLN 0.266 50.1 mt -83.82 142.02 30.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 176.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.813 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 49.7 t-20 -94.07 101.77 13.81 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.5 m-85 -107.98 132.36 53.6 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.674 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.6 tt0 -122.76 128.03 49.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.283 174.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.806 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 72.0 m -98.01 143.13 28.9 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.508 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -72.94 170.73 12.44 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.013 -177.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.72 148.23 93.52 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.64 2.226 . . . . 0.0 111.894 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.06 1.49 58.35 Favored Glycine 0 CA--C 1.501 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.901 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 96.5 m-85 -107.46 129.81 54.9 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.614 0.721 . . . . 0.0 111.618 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -63.18 -44.1 96.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.513 -1.221 . . . . 0.0 112.777 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.17 150.88 23.12 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.202 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 5.6 mmt180 -113.47 131.75 22.83 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.806 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 16.3 Cg_exo -63.77 147.54 92.37 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.147 2.564 . . . . 0.0 114.068 -174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 79.1 t80 -128.66 154.22 46.5 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 167.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 m -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-O 121.41 0.624 . . . . 0.0 111.572 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.5 pt -95.8 129.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.581 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 52' ' ' THR . 2.0 mp -114.99 127.93 72.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.453 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' SG ' ' CH2' ' A' ' 51' ' ' TRP . 68.4 m -66.06 81.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 52' ' ' THR . 92.3 mt -95.28 -66.8 0.89 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.562 ' C ' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.4 111.12 18.15 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -171.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.1 m120 52.76 32.23 11.82 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -176.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.4 p 50.45 12.85 0.1 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.528 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 84.8 t -63.24 -45.53 98.11 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.764 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.083 -174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 93.8 m95 148.91 -171.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 129.436 3.094 . . . . 0.0 108.459 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 44' ' ' ILE . 50.6 p -97.42 -0.03 46.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.398 0.618 . . . . 0.0 110.793 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.56 -45.13 1.17 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.648 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.44 40.2 14.39 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 22.0 ptmt -131.28 151.15 51.77 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.364 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 2.7 p30 49.67 26.6 1.87 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.736 1.214 . . . . 0.0 111.722 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 41' ' ' PHE . 30.6 mmm180 -65.21 -41.55 94.37 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.782 -174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 81.8 m -127.49 147.88 50.31 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.773 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.57 133.39 48.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.241 -174.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.54 ' CD ' HE21 ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.73 -174.61 5.33 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 46.2 mtpt -107.19 152.39 24.15 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.6 t -67.38 138.99 57.14 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.097 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 46.5 m -89.74 149.67 22.63 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 120.895 0.378 . . . . 0.0 110.915 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -136.98 141.73 42.57 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 11.4 t-20 -128.15 72.17 79.47 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 120.485 0.183 . . . . 0.0 110.899 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.5 Cg_endo -73.57 -26.91 13.48 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 N-CA-C 114.316 0.852 . . . . 0.0 114.316 172.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 24.5 Cg_endo -57.12 -41.12 77.71 Favored 'Trans proline' 0 C--N 1.405 3.54 0 CA-C-N 121.288 1.496 . . . . 0.0 113.812 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 44.55 157.28 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 122.399 1.095 . . . . 0.0 113.16 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.635 ' HG3' HG23 ' A' ' 74' ' ' VAL . 91.3 Cg_endo -77.91 158.57 31.06 Favored 'Trans proline' 0 N--CA 1.4 -4.0 0 C-N-CA 121.949 1.766 . . . . 0.0 109.943 167.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.0 t -62.79 -43.76 99.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.935 ' ND2' ' HA ' ' A' ' 90' ' ' CYS . 24.6 p30 -62.58 -38.49 90.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.916 176.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.35 32.86 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.087 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' SER . 97.2 mtp -95.8 20.96 9.1 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.2 t -71.86 132.48 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -117.35 142.55 46.97 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.258 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.5 p -120.81 118.06 55.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 118.348 -1.341 . . . . 0.0 110.99 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -64.85 -44.66 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.847 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -110.05 8.88 24.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.744 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.19 18.81 60.11 Favored Glycine 0 N--CA 1.481 1.686 0 N-CA-C 115.544 0.978 . . . . 0.0 115.544 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 68.59 78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 122.169 0.985 . . . . 0.0 112.279 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.751 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 18.6 tt0 -149.72 169.66 20.52 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.083 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.751 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 10.6 t80 -62.83 128.87 37.93 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.87 -13.53 66.98 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.6 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLN . 40.9 t -73.63 146.58 44.5 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -121.41 136.31 54.97 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.433 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG22 HG23 ' A' ' 76' ' ' VAL . 48.2 pt -127.34 160.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.498 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HD3' ' CB ' ' A' ' 101' ' ' SER . 75.3 mmtt -108.89 150.31 27.87 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.38 98.94 6.16 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.362 -1.744 . . . . 0.0 111.285 174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' MET . 35.9 t -115.36 122.04 44.65 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.917 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.935 ' HA ' ' ND2' ' A' ' 71' ' ' ASN . 49.6 m -82.13 -37.51 26.13 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.403 0.621 . . . . 0.0 112.528 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 93' ' ' GLY . 15.4 m -162.91 165.24 25.37 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.821 -169.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.323 87.7 tttt -63.23 -48.21 79.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.555 0.693 . . . . 0.0 112.841 173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.632 ' H ' HG22 ' A' ' 91' ' ' THR . . . -121.06 73.11 0.35 Allowed Glycine 0 CA--C 1.485 -1.802 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.407 -173.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.591 ' CE2' ' SG ' ' A' ' 90' ' ' CYS . 1.9 p90 -149.2 166.32 29.22 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 94.9 mtt-85 -105.3 136.18 45.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.749 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.96 121.35 44.6 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 117.37 -1.732 . . . . 0.0 106.807 167.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.2 mm -65.01 -44.59 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 -171.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.09 -126.1 5.4 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.949 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.8 p -78.27 99.61 6.36 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.2 p -66.41 -26.39 67.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.857 0.863 . . . . 0.0 111.092 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 87' ' ' LYS . 38.1 t -138.38 135.36 35.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -100.01 148.1 24.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.9 m -123.89 130.77 53.13 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.378 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -83.06 124.83 30.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.031 0.919 . . . . 0.0 112.767 177.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.76 162.95 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.082 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.725 HD13 HG12 ' A' ' 111' ' ' VAL . 47.1 mm -82.02 121.72 35.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.946 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' HG23 ' A' ' 112' ' ' ILE . 2.5 m -63.95 -38.9 92.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.617 1.199 . . . . 0.0 110.418 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.1 -70.25 0.31 Allowed Glycine 0 N--CA 1.413 -2.871 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.908 -172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -98.41 -2.26 39.54 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 117.046 0.423 . . . . 0.0 111.587 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 61' ' ' LYS . 15.0 t -151.56 174.19 13.72 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.688 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.725 HG12 HD13 ' A' ' 106' ' ' ILE . 24.9 m -110.6 130.24 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.905 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.465 HG23 ' OG ' ' A' ' 107' ' ' SER . 50.9 pt -129.79 165.27 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.529 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -91.07 146.19 24.06 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.61 -36.85 84.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.246 0.618 . . . . 0.0 110.507 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -34.66 120.89 0.5 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.4 tp10 -66.81 -41.78 86.98 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.33 -1.304 . . . . 0.0 110.187 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 10.6 t 167.81 151.77 0.1 Allowed Pre-proline 0 N--CA 1.479 0.975 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.43 139.63 65.8 Favored 'Trans proline' 0 CA--C 1.553 1.475 0 CA-C-N 120.669 1.275 . . . . 0.0 111.601 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.749 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.3 mp -133.37 131.15 57.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 93.7 m -126.6 110.3 13.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.215 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.7 t70 -63.56 -46.12 87.37 Favored 'General case' 0 C--N 1.388 2.245 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 89.5 mtm180 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 124.424 1.089 . . . . 0.0 113.422 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 57.5 m -75.75 -16.54 60.12 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.486 1.114 . . . . 0.0 108.885 176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 33.4 t30 60.99 40.17 15.62 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.254 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 52.28 116.46 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.37 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 22.1 Cg_endo -61.41 -59.19 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 120.788 0.992 . . . . 0.0 113.457 -173.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.9 pt-20 157.43 167.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.862 1.665 . . . . 0.0 108.778 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -87.8 116.0 25.64 Favored 'General case' 0 N--CA 1.423 -1.778 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.654 171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 tp -87.98 105.54 9.43 Favored Pre-proline 0 N--CA 1.425 -1.715 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.95 -25.34 77.82 Favored 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 122.52 2.147 . . . . 0.0 112.915 -169.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.82 -38.54 86.66 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -114.92 151.52 33.89 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.809 -1.541 . . . . 0.0 113.402 -165.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -126.4 96.56 35.93 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.082 174.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.96 153.99 67.44 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -5.53 28.49 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.95 -50.05 3.17 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.205 1.479 . . . . 0.0 110.74 -173.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -61.14 -16.93 49.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.016 -172.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t -57.96 -42.46 85.03 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.26 -8.22 18.43 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 120.971 0.415 . . . . 0.0 110.079 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 19.7 pt-20 -145.1 82.86 1.67 Allowed 'General case' 0 C--O 1.2 -1.544 0 CA-C-O 123.03 1.395 . . . . 0.0 112.583 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.697 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.4 m-85 -66.65 -37.64 85.23 Favored 'General case' 1 C--N 1.235 -4.397 0 CA-C-N 112.508 -2.133 . . . . 0.0 113.392 172.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 72.5 mt-10 -110.85 125.03 53.18 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -171.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 16.8 m-85 -130.13 172.83 6.58 Favored Pre-proline 0 C--O 1.202 -1.419 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.105 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 94.4 Cg_endo -77.13 171.65 17.48 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.935 3.09 . . . . 0.0 113.045 168.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.19 135.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 124.267 1.027 . . . . 0.0 112.708 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.57 28.4 16.69 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.854 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 90.3 m -108.18 126.57 52.94 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 44' ' ' ILE . 49.0 m-85 -99.99 132.16 45.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.589 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -111.81 142.87 43.64 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.3 t-20 -90.3 108.06 19.53 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.383 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.57 135.4 52.21 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.303 1.041 . . . . 0.0 112.739 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 79.0 mm-40 -116.45 130.75 56.93 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.807 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.6 m -86.13 147.6 26.08 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.574 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -53.83 148.33 20.42 Favored Pre-proline 0 CA--C 1.509 -0.628 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.87 144.01 99.48 Favored 'Trans proline' 0 N--CA 1.439 -1.72 0 N-CA-C 110.444 -0.637 . . . . 0.0 110.444 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 96.79 -8.97 66.03 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.823 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.13 139.86 34.13 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.198 0.999 . . . . 0.0 113.187 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 t -62.12 -43.28 99.19 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.057 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.04 142.63 40.01 Favored Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.083 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' HG3' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -92.61 -179.82 1.15 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 39' ' ' ARG . 24.8 Cg_exo -61.38 143.92 98.04 Favored 'Trans proline' 0 C--N 1.374 1.912 0 CA-C-N 121.715 1.648 . . . . 0.0 111.574 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -131.6 149.14 52.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.83 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 33.7 m -114.43 121.44 43.57 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.407 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 54' ' ' ALA . 45.7 pt -89.69 130.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 123.645 0.591 . . . . 0.0 109.612 177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.9 mp -119.31 127.61 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 11.0 t -62.0 97.53 0.09 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.48 -72.25 0.64 Allowed 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.912 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -74.21 127.89 34.12 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.43 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 50' ' ' VAL . 99.0 m-20 55.23 34.01 21.83 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 124.563 1.165 . . . . 0.0 111.016 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m 56.01 20.03 4.05 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.136 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 48' ' ' ASN . 50.6 t -103.81 -92.68 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.139 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -156.5 173.74 16.47 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.275 0.56 . . . . 0.0 111.793 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.37 -31.75 73.08 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.19 -20.23 9.78 Favored Glycine 0 N--CA 1.478 1.464 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 47.51 39.3 9.25 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.9 130.37 35.24 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 51.43 33.34 10.01 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.402 0.681 . . . . 0.0 110.689 168.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 -63.86 -39.8 95.05 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.5 m -105.31 138.34 41.67 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -129.19 146.09 51.19 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 118.879 -1.128 . . . . 0.0 112.624 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG3' HE21 ' A' ' 81' ' ' GLN . 34.7 ptt180 -114.28 139.59 49.3 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 121.264 0.554 . . . . 0.0 110.746 -173.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' ' N ' ' A' ' 62' ' ' SER . 8.3 tmtt? -80.78 143.74 32.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.523 1.129 . . . . 0.0 113.104 -175.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.756 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 42.8 t -64.63 141.56 58.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.879 0.847 . . . . 0.0 110.148 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.465 ' O ' HG22 ' A' ' 80' ' ' ILE . 83.3 m -95.34 172.18 8.25 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.651 -175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 148.94 43.58 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.816 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -156.83 58.06 1.51 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.883 171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 36.9 Cg_endo -68.43 -30.76 29.06 Favored 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 121.72 1.614 . . . . 0.0 114.971 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -61.56 -30.18 85.68 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 121.77 1.647 . . . . 0.0 113.156 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 58.47 168.42 0.07 OUTLIER Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 121.538 0.685 . . . . 0.0 111.675 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.752 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.9 Cg_exo -69.78 155.59 65.46 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.935 2.423 . . . . 0.0 109.096 171.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.69 -44.12 96.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.498 HD22 ' HA ' ' A' ' 90' ' ' CYS . 64.5 t30 -62.75 -39.59 94.62 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.309 173.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 91.77 14.91 55.96 Favored Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.549 ' HB3' ' O ' ' A' ' 89' ' ' SER . 54.7 ttm -100.57 84.71 2.8 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.411 0.624 . . . . 0.0 112.025 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.752 HG23 ' CG ' ' A' ' 69' ' ' PRO . 39.9 t -116.33 128.15 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 122.369 1.08 . . . . 0.0 110.068 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 92.3 m-70 -68.74 -36.56 78.54 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.872 -1.513 . . . . 0.0 114.163 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG22 ' A' ' 86' ' ' ILE . 3.6 p 44.13 83.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 125.017 1.327 . . . . 0.0 113.927 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.91 HD11 ' HE2' ' A' ' 87' ' ' LYS . 70.8 mt -62.88 -47.64 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.6 mmtt -97.22 -8.97 28.65 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -172.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.53 8.06 68.45 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 119.776 -1.202 . . . . 0.0 113.606 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 63' ' ' CYS . 47.0 mm 93.65 78.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 123.105 0.562 . . . . 0.0 111.929 170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 60' ' ' ARG . 65.3 tp60 -150.4 165.29 33.58 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.56 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 105' ' ' ILE . 80.7 t80 -63.64 130.05 42.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.653 0.661 . . . . 0.0 110.188 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.97 -7.14 76.71 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.573 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 43.1 t -72.14 144.37 48.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.511 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.6 tt0 -123.2 138.25 54.69 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 76' ' ' VAL . 47.0 pt -128.14 160.4 38.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.91 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.7 mptp? -109.01 142.33 39.84 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.109 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -111.46 95.39 5.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.711 172.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.549 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.4 t -122.09 137.52 54.79 Favored 'General case' 0 CA--C 1.462 -2.427 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.619 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 24.0 m -104.43 -131.68 0.29 Allowed 'General case' 0 C--N 1.265 -3.069 0 CA-C-O 122.696 1.236 . . . . 0.0 109.255 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 13.9 m -61.49 136.71 58.12 Favored 'General case' 1 C--N 1.239 -4.232 0 C-N-CA 126.84 2.056 . . . . 0.0 113.646 -175.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -63.63 132.1 50.06 Favored 'General case' 0 N--CA 1.38 -3.946 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.7 61.47 Favored Glycine 0 C--N 1.261 -3.604 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.628 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.2 OUTLIER -115.89 -178.11 3.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -133.28 147.79 51.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 119' ' ' ILE . 29.9 tp -102.95 123.86 47.36 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.9 -44.47 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 121.273 0.558 . . . . 0.0 111.182 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -87.19 -165.48 41.37 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 114.889 -1.05 . . . . 0.0 114.97 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' ' OE1' ' A' ' 115' ' ' GLN . 9.6 t -65.72 133.86 51.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.564 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -81.84 -5.49 58.26 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.41 0.684 . . . . 0.0 112.211 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.0 p -152.12 159.38 43.65 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -129.14 142.31 50.92 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 64.4 m -118.95 129.21 55.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.626 ' HB2' ' CE3' ' A' ' 113' ' ' TRP . 11.4 t -88.51 122.87 32.45 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.051 -176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -128.66 163.45 33.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.496 -176.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.862 HD13 HG12 ' A' ' 111' ' ' VAL . 31.1 mm -81.64 124.61 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.0 p -69.11 -33.88 74.19 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.446 1.117 . . . . 0.0 110.699 172.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 152.69 -80.32 0.19 Allowed Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.704 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.07 -40.36 96.09 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 122.966 0.507 . . . . 0.0 111.39 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -143.86 173.6 11.56 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.02 0.928 . . . . 0.0 111.489 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 106' ' ' ILE . 26.9 m -108.69 130.26 61.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 CA-C-O 122.013 0.911 . . . . 0.0 112.43 -174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.2 pt -132.11 164.75 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.634 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.626 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 97.4 m95 -91.41 146.29 23.93 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -81.36 -2.21 48.39 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.719 ' OE1' ' HB3' ' A' ' 99' ' ' SER . 64.6 tp60 -61.32 128.15 34.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.7 mt-10 -66.1 -40.66 90.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.109 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER 163.62 136.4 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.44 134.06 49.44 Favored 'Trans proline' 0 C--N 1.356 0.944 0 CA-C-N 119.094 0.712 . . . . 0.0 111.24 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.841 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.6 mt -125.64 115.2 42.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.29 107.41 18.3 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 117.709 -1.597 . . . . 0.0 109.094 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -64.65 -42.53 95.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.488 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 67.8 mtt-85 . . . . . 0 C--O 1.268 2.037 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.902 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 -22.83 61.49 Favored 'General case' 0 C--O 1.212 -0.914 0 C-N-CA 122.781 0.433 . . . . 0.0 111.455 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 9.0 p30 57.31 41.74 26.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.316 0.646 . . . . 0.0 112.725 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 89.93 120.07 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 124.636 1.175 . . . . 0.0 113.934 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.913 ' HA ' ' NE1' ' A' ' 51' ' ' TRP . 17.0 Cg_exo -62.56 -56.86 0.54 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.255 1.303 . . . . 0.0 112.761 -176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 17.0 pt-20 156.62 172.48 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.174 -1.83 . . . . 0.0 108.301 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -105.56 131.57 52.79 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.443 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 10' ' ' PHE . 13.8 tp -118.64 107.05 43.24 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.372 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -62.01 -27.7 79.75 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.097 1.865 . . . . 0.0 112.783 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 8' ' ' LEU . 2.3 m-30 -66.32 -40.94 90.27 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.771 1.272 . . . . 0.0 110.06 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.41 153.66 31.68 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.183 -1.826 . . . . 0.0 114.624 -161.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -119.25 84.22 27.42 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.097 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 16.0 Cg_exo -63.02 145.12 94.04 Favored 'Trans proline' 0 C--O 1.218 -0.484 0 C-N-CA 122.087 1.858 . . . . 0.0 110.021 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -97.15 -0.01 47.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.017 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -117.56 -14.5 10.26 Favored 'General case' 0 C--O 1.188 -2.182 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -175.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 0.89 47.25 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -174.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 t -61.96 -49.06 77.61 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -121.71 2.59 10.08 Favored 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.151 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 55.2 mp0 -95.36 -71.95 0.65 Allowed 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.335 -172.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 86.7 m-85 65.69 -16.21 0.11 Allowed 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.676 0.791 . . . . 0.0 112.181 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' GLU . 78.5 mt-10 -114.08 128.23 56.29 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.313 0.578 . . . . 0.0 111.905 -173.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 1' ' ' GLN . 91.8 m-85 -148.86 164.91 19.31 Favored Pre-proline 0 C--N 1.345 0.39 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.962 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.95 151.05 73.68 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 123.844 3.029 . . . . 0.0 112.39 173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.14 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 39.59 6.02 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.457 -1.83 . . . . 0.0 110.642 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.7 t -125.0 152.03 44.77 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -109.01 130.84 55.49 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 22' ' ' PHE . 10.1 mp -112.83 144.59 42.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.892 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 58.1 t30 -91.75 103.87 16.39 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.215 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 13' ' ' PRO . 11.2 m-85 -106.51 130.01 54.36 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.624 170.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -122.96 127.33 48.72 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.121 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.1 163.34 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.133 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 33' ' ' ARG . 34.6 ttt85 -77.72 145.86 71.64 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.51 151.73 84.42 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.82 1.68 . . . . 0.0 110.823 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.58 -6.39 57.39 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.94 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CB ' ' HB3' ' A' ' 58' ' ' CYS . 51.2 m-85 -87.75 144.25 26.72 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 33.6 m -60.0 -42.06 93.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.434 0.694 . . . . 0.0 112.263 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.63 171.21 45.07 Favored Glycine 0 C--O 1.229 -0.214 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.023 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 41' ' ' PHE . 76.2 mmt-85 -107.24 162.73 18.76 Favored Pre-proline 0 CA--C 1.49 -1.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.17 139.96 86.58 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 110.372 -0.665 . . . . 0.0 110.372 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 69.3 m-85 -148.3 154.76 40.44 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.207 0.527 . . . . 0.0 111.594 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -74.56 153.17 39.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.756 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.1 pt -122.5 144.94 30.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.908 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' HG23 ' A' ' 52' ' ' THR . 2.1 mt -129.24 132.71 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.509 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 2.9 m -64.71 46.99 0.02 OUTLIER 'General case' 1 N--CA 1.54 4.057 0 CA-C-N 120.385 1.448 . . . . 0.0 113.584 -176.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 52' ' ' THR . 90.1 mt -63.69 -42.79 97.95 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -168.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 30.9 ttmt -126.3 119.89 28.54 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 m120 54.69 33.77 20.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.106 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 m 50.52 24.58 1.66 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.872 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' TRP . 97.8 t -93.63 -12.97 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.314 1.054 . . . . 0.0 108.212 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.913 ' NE1' ' HA ' ' A' ' 5' ' ' PRO . 64.3 m95 77.99 -177.75 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.392 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.782 HG23 ' H ' ' A' ' 44' ' ' ILE . 68.6 p -66.32 -32.49 73.92 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.456 0.646 . . . . 0.0 109.835 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 123.33 83.39 0.61 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.263 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.784 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -73.31 -12.17 60.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.156 0.503 . . . . 0.0 110.122 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.34 134.88 54.5 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 30.61 17.59 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 113.238 -1.801 . . . . 0.0 111.91 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 54' ' ' ALA . 50.5 mmm-85 -65.36 -40.2 93.27 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.494 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 71.6 m -120.41 143.18 48.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.996 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 97.6 mtt180 -130.08 138.92 50.97 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.742 -167.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG3' ' NE2' ' A' ' 81' ' ' GLN . 18.1 ptp180 -85.91 145.27 27.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.313 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.2 mmmt -79.29 149.92 31.66 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.6 t -71.94 137.75 47.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.865 -1.97 . . . . 0.0 112.193 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.411 ' SG ' ' C ' ' A' ' 81' ' ' GLN . 93.8 m -95.85 151.64 19.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.202 1.001 . . . . 0.0 110.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -127.01 139.53 52.96 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.656 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 t30 -113.75 44.26 0.3 Allowed Pre-proline 0 CA--C 1.563 1.477 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 11.5 Cg_endo -57.72 -19.87 40.18 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.718 1.612 . . . . 0.0 115.12 170.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.656 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 26.3 Cg_endo -68.14 11.06 0.28 Allowed 'Trans proline' 0 C--N 1.403 3.395 0 C-N-CA 122.132 1.888 . . . . 0.0 112.036 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 66' ' ' PRO . 10.5 m-20 -39.33 153.18 0.18 Allowed Pre-proline 0 C--N 1.365 1.259 0 C-N-CA 124.329 1.052 . . . . 0.0 111.327 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.721 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.4 Cg_exo -68.41 153.53 73.82 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 124.76 3.64 . . . . 0.0 114.139 -171.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.12 -46.31 96.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.064 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -82.48 -12.36 57.87 Favored 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 87.42 28.81 23.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.882 1.513 . . . . 0.0 116.882 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.77 ' HB2' ' O ' ' A' ' 89' ' ' SER . 67.0 mtt -109.74 95.37 5.56 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 118.709 1.255 . . . . 0.0 111.931 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.721 HG23 ' CG ' ' A' ' 69' ' ' PRO . 41.1 t -118.58 132.65 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.27 1.028 . . . . 0.0 111.291 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 53.2 m170 -106.91 141.42 38.16 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 p -122.01 130.24 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.964 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.456 HD11 ' HE2' ' A' ' 87' ' ' LYS . 93.1 mt -88.51 -82.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.408 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -64.58 -42.31 95.71 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.83 89.11 0.92 Allowed Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.456 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 86' ' ' ILE . 45.7 mm -13.18 85.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 126.654 1.982 . . . . 0.0 113.804 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.824 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 57.0 tt0 -163.72 -173.99 3.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 170.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.824 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 54.7 t80 -60.84 130.19 45.25 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.669 0.747 . . . . 0.0 111.219 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.12 -8.64 69.98 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.874 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -75.21 150.1 38.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -134.02 132.27 39.88 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 75' ' ' HIS . 0.2 OUTLIER -127.85 162.15 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.586 -179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' CD ' ' HB3' ' A' ' 101' ' ' SER . 75.0 mmtt -109.95 149.87 29.3 Favored 'General case' 0 CA--C 1.45 -2.88 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.192 -173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CE1' ' OE1' ' A' ' 115' ' ' GLN . 95.8 m-85 -115.39 130.15 56.8 Favored 'General case' 0 N--CA 1.388 -3.535 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.058 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.77 ' O ' ' HB2' ' A' ' 73' ' ' MET . 28.3 p -148.87 153.42 38.03 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.39 176.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.504 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 47.6 m -107.14 -39.68 5.64 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.006 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.8 m -163.09 162.76 25.89 Favored 'General case' 0 C--O 1.184 -2.347 0 CA-C-N 114.222 -1.354 . . . . 0.0 107.391 -171.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.278 39.6 ttpt -67.35 -48.01 68.75 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 164.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.16 60.75 1.6 Allowed Glycine 0 C--N 1.287 -2.143 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.137 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.638 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 2.3 p90 -149.37 167.95 24.72 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -113.52 135.6 53.72 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.0 tp -100.46 122.68 43.58 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.4 mm -65.44 -44.46 94.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.581 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.24 -141.63 10.48 Favored Glycine 0 CA--C 1.498 -1.008 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.773 -173.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 m -66.79 122.25 17.26 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.685 0.755 . . . . 0.0 111.569 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.596 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.7 p -86.85 -5.41 59.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.119 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HB3' ' CD ' ' A' ' 87' ' ' LYS . 31.2 p -153.07 159.54 42.83 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -136.14 147.03 47.55 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.34 128.54 52.37 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 18.0 t -90.65 121.6 32.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.28 0.562 . . . . 0.0 111.047 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.57 163.45 34.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.794 -175.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.793 HD13 HG12 ' A' ' 111' ' ' VAL . 47.4 mm -78.96 124.61 37.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.3 p -90.85 -7.34 52.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.107 0.956 . . . . 0.0 108.703 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 124.41 -83.83 0.36 Allowed Glycine 0 CA--C 1.498 -0.984 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.42 -39.64 95.03 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.133 0.492 . . . . 0.0 111.84 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -141.83 174.63 10.4 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.465 -169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.793 HG12 HD13 ' A' ' 106' ' ' ILE . 14.6 m -106.86 128.58 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 48.1 pt -129.51 162.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.371 -178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.449 ' CE3' ' HB2' ' A' ' 104' ' ' CYS . 98.1 m95 -95.07 148.26 22.54 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -80.96 -2.68 48.79 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 55.4 tt0 -70.97 135.08 47.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.2 mm-40 -65.88 -44.94 83.86 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.1 t 169.63 152.17 0.15 Allowed Pre-proline 0 N--CA 1.471 0.61 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 19.7 Cg_exo -64.01 142.72 82.51 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.202 1.935 . . . . 0.0 112.77 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' A' ' 97' ' ' ILE . 3.8 mp -142.6 154.58 17.93 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 119' ' ' ILE . 86.5 m -143.69 114.21 7.54 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.93 -0.481 . . . . 0.0 110.664 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -64.73 -40.47 95.39 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 118.838 0.745 . . . . 0.0 110.357 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 125.654 1.582 . . . . 0.0 113.407 176.607 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.7 m -75.96 -21.2 57.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.326 0.65 . . . . 0.0 109.881 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.73 42.19 17.24 Favored 'General case' 0 CA--C 1.562 1.41 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 64.82 110.55 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -57.69 -39.78 84.95 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.166 1.911 . . . . 0.0 114.395 -176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 124.29 -164.39 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 127.656 2.382 . . . . 0.0 107.412 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.553 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 69.1 t90 -111.73 128.85 56.21 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.419 0.628 . . . . 0.0 112.355 175.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.08 114.64 61.15 Favored Pre-proline 0 C--O 1.22 -0.454 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 1.5 Cg_endo -61.23 -29.1 85.93 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 121.526 1.484 . . . . 0.0 113.369 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -64.69 -41.86 95.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.588 1.185 . . . . 0.0 108.595 -175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -108.86 150.32 27.84 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 112.824 -1.989 . . . . 0.0 114.418 -164.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -132.08 82.7 58.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.027 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 82.8 Cg_endo -65.33 145.8 84.33 Favored 'Trans proline' 0 C--N 1.363 1.316 0 C-N-CA 123.452 2.768 . . . . 0.0 113.672 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -87.06 -22.46 25.43 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.184 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.761 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -100.98 -32.47 10.62 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.784 0.802 . . . . 0.0 110.525 -169.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 13' ' ' PRO . 2.9 tt -61.6 -24.5 66.73 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 125.907 1.683 . . . . 0.0 113.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -59.28 -42.2 90.69 Favored 'General case' 0 C--N 1.285 -2.229 0 O-C-N 123.649 0.593 . . . . 0.0 109.848 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -119.19 -3.55 10.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.1 mt-10 -130.77 88.55 2.63 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 122.126 0.965 . . . . 0.0 108.743 -170.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.782 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 76.6 m-85 -94.93 -2.62 50.19 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.095 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -112.14 119.61 39.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.656 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 26' ' ' THR . 45.4 m-85 -143.87 150.12 48.68 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.21 164.28 35.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 1 C-N-CA 125.445 4.097 . . . . 0.0 112.902 174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.2 mp -67.61 133.12 32.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.074 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.15 59.5 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.515 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 22' ' ' PHE . 27.0 m -69.31 135.8 50.93 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.56 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.562 ' CE2' HG12 ' A' ' 44' ' ' ILE . 27.1 m-85 -103.9 130.94 51.54 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.745 ' HA ' ' NE2' ' A' ' 15' ' ' GLN . 42.0 mt -99.76 126.86 45.9 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.761 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.9 t30 -79.07 103.91 9.34 Favored 'General case' 0 N--CA 1.396 -3.165 0 CA-C-N 113.719 -1.582 . . . . 0.0 108.023 -172.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 3.3 m-85 -103.84 132.17 50.36 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.72 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.0 tt0 -116.49 125.97 52.7 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.716 -1.584 . . . . 0.0 109.31 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -83.13 124.41 30.46 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.489 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 4.3 ptm180 -55.52 158.48 5.84 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.43 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 41.7 Cg_endo -61.45 144.53 98.16 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 120.876 1.051 . . . . 0.0 111.712 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.27 -1.13 64.34 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.367 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 80.0 m-85 -112.5 137.61 50.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.248 1.023 . . . . 0.0 113.388 175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 8.7 t -103.94 -159.73 0.73 Allowed 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.1 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -3.61 61.47 Favored Glycine 0 CA--C 1.491 -1.425 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.946 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 59.26 118.55 0.02 OUTLIER Pre-proline 0 C--N 1.315 -0.915 0 C-N-CA 124.271 1.029 . . . . 0.0 111.472 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -72.43 113.86 3.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 120.962 1.108 . . . . 0.0 112.25 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' H ' HH21 ' A' ' 57' ' ' ARG . 74.8 m-85 -129.07 146.15 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.726 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 11.5 m -72.97 147.18 45.44 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.622 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.0 pt -85.37 131.02 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 27' ' ' TYR . 1.8 mp -120.02 130.11 74.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -50.47 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 92.1 mt -126.53 -67.0 0.88 Allowed 'General case' 0 C--N 1.342 0.248 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 16.2 tptm -70.03 124.03 23.04 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 50' ' ' VAL . 12.9 t-20 54.58 34.83 22.17 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.9 0.88 . . . . 0.0 108.675 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.85 18.92 0.56 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.579 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 60.9 t -99.57 -78.5 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 CA-C-O 121.197 0.522 . . . . 0.0 110.892 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -150.19 171.64 16.6 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 122.932 0.493 . . . . 0.0 110.125 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 t -76.6 -3.26 36.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.072 0.463 . . . . 0.0 110.608 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.95 -17.34 52.76 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 47.47 25.0 0.55 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.39 136.02 35.69 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 55.12 30.94 15.3 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.712 173.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 HH21 ' H ' ' A' ' 41' ' ' PHE . 15.0 mmm180 -65.48 -41.15 93.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -173.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' SER . 79.5 m -125.85 145.84 50.07 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.515 -173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 85.0 mtp180 -128.46 135.08 48.97 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.208 -177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.63 ' HG3' HE21 ' A' ' 81' ' ' GLN . 32.9 ptt180 -99.09 153.92 18.51 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 122.971 0.508 . . . . 0.0 111.019 174.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 111' ' ' VAL 0.325 29.0 mmmt -89.45 151.66 21.88 Favored 'General case' 0 CA--C 1.47 -2.126 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 p -74.29 149.98 40.42 Favored 'General case' 0 N--CA 1.403 -2.819 0 CA-C-N 112.303 -2.226 . . . . 0.0 112.157 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 113' ' ' TRP . 0.5 OUTLIER -103.21 175.68 5.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.671 177.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 113' ' ' TRP . 8.5 ptm180 -126.64 138.96 53.5 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -174.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.544 ' H ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -149.56 30.77 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 176.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 83.7 Cg_exo -50.52 -41.93 50.89 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.858 1.705 . . . . 0.0 114.679 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 37.4 Cg_endo -60.91 -29.85 88.87 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 122.386 2.057 . . . . 0.0 115.079 -175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 p30 44.75 160.45 0.01 OUTLIER Pre-proline 0 CA--C 1.586 2.338 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.98 ' HG3' HG23 ' A' ' 74' ' ' VAL . 11.9 Cg_exo -68.25 152.35 75.96 Favored 'Trans proline' 0 CA--C 1.495 -1.448 0 C-N-CA 123.139 2.559 . . . . 0.0 112.585 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 71' ' ' ASN . 7.1 p -61.1 -46.53 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.915 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' N ' HG13 ' A' ' 70' ' ' VAL . 52.1 t-20 -65.49 -40.11 92.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 122.287 1.042 . . . . 0.0 109.62 171.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 96.47 33.96 5.99 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.816 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB2' ' O ' ' A' ' 89' ' ' SER . 96.9 mtp -100.51 20.99 13.94 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -173.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.98 HG23 ' HG3' ' A' ' 69' ' ' PRO . 42.9 t -69.53 131.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.092 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -111.48 121.97 46.61 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 86' ' ' ILE . 13.8 t -102.07 110.19 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.942 -175.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.73 -44.06 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -112.66 7.08 18.58 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 -174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 76' ' ' VAL . . . 85.07 14.87 68.33 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.924 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 49.4 mm 78.19 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.563 0.697 . . . . 0.0 111.098 176.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.63 HE21 ' HG3' ' A' ' 60' ' ' ARG . 66.0 tp60 -148.02 168.13 23.12 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.658 ' CE1' HG12 ' A' ' 106' ' ' ILE . 31.4 t80 -60.62 130.17 45.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.601 0.715 . . . . 0.0 111.776 173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.09 -11.25 72.37 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.716 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 37.8 t -73.18 144.62 46.76 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.034 0.445 . . . . 0.0 110.488 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -126.94 135.9 51.54 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 76' ' ' VAL . 46.2 pt -128.36 161.09 37.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.481 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 4.9 mptt -109.6 141.56 41.94 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.832 0.348 . . . . 0.0 111.257 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.441 ' CD1' ' HG3' ' A' ' 118' ' ' PRO . 39.7 m-85 -120.72 46.21 2.06 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 123.94 0.896 . . . . 0.0 113.339 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.575 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 17.2 p -75.26 146.83 40.77 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.909 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 61.2 m -97.38 -29.96 13.21 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.924 0.89 . . . . 0.0 110.22 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 93' ' ' GLY . 1.9 m -175.09 164.48 3.33 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 123.699 0.625 . . . . 0.0 110.462 -167.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -62.28 -46.14 90.13 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' H ' HG22 ' A' ' 91' ' ' THR . . . -119.93 83.55 0.36 Allowed Glycine 0 N--CA 1.435 -1.428 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.369 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 90' ' ' CYS . 4.4 p90 -150.2 163.86 37.15 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 121' ' ' ASP . 70.8 mtt180 -103.77 135.03 46.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.886 HD12 ' O ' ' A' ' 119' ' ' ILE . 32.6 tp -102.5 121.33 42.15 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 171.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.2 mm -65.72 -44.45 93.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.144 0.973 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.727 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -86.28 -170.64 47.15 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.116 -1.402 . . . . 0.0 114.445 -177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.585 ' OG ' ' HA ' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -61.13 114.51 3.17 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.345 -0.928 . . . . 0.0 111.068 -178.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.585 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 7.1 t -62.85 -43.19 99.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 123.895 0.878 . . . . 0.0 112.795 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 7.7 t -131.95 109.6 10.17 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.545 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -69.97 142.64 52.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.865 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.5 m -124.06 129.96 51.76 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 15.5 t -80.46 122.04 26.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 161.83 32.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.381 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.736 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -90.07 125.37 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.083 0.468 . . . . 0.0 111.214 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 53.8 m -88.35 -7.66 56.33 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.445 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 105.35 -72.52 0.23 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.312 -176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -64.96 -40.01 94.35 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.516 0.674 . . . . 0.0 112.023 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -146.71 171.94 14.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.774 -171.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.736 HG12 HD13 ' A' ' 106' ' ' ILE . 10.8 m -115.47 131.98 66.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.324 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.1 pt -128.22 164.66 29.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 63' ' ' CYS . 98.5 m95 -95.19 148.71 22.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -81.31 -2.26 48.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.349 0.595 . . . . 0.0 110.01 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 64.9 tp60 -68.04 118.62 11.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.871 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 117' ' ' THR . 49.1 tp10 -70.78 -45.22 65.12 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.449 0.642 . . . . 0.0 112.097 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 12.7 t 161.99 138.47 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 88' ' ' TYR . 29.2 Cg_exo -61.99 136.43 61.08 Favored 'Trans proline' 0 C--N 1.355 0.913 0 CA-C-N 119.727 0.938 . . . . 0.0 110.48 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.886 ' O ' HD12 ' A' ' 96' ' ' LEU . 7.0 mt -130.86 124.33 56.14 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.395 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.8 m -113.68 103.02 10.81 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 116.556 -2.058 . . . . 0.0 112.277 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . 33.1 t70 -65.31 -42.76 92.69 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 C--O 1.256 1.397 0 O-C-N 124.377 1.048 . . . . 0.0 113.005 -172.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 51' ' ' TRP . 19.3 m -73.56 -27.96 61.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.462 0.649 . . . . 0.0 111.154 -171.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 3' ' ' ASN . 10.1 m120 57.95 34.33 24.18 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.555 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 65.82 116.37 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 123.71 0.632 . . . . 0.0 112.37 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 26.2 Cg_endo -65.45 -58.9 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 121.014 1.142 . . . . 0.0 114.066 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 19.5 pt-20 156.18 -169.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.275 1.43 . . . . 0.0 109.211 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 9' ' ' PRO . 66.7 t90 -104.54 126.21 51.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.597 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.24 115.81 61.51 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 7' ' ' TRP . 11.5 Cg_exo -58.01 -31.35 92.7 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.077 1.851 . . . . 0.0 111.283 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -65.76 -39.65 91.27 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.713 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.31 144.11 48.0 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.838 -1.528 . . . . 0.0 114.806 -163.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -123.59 78.28 55.45 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.946 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.41 148.76 92.78 Favored 'Trans proline' 0 CA--C 1.505 -0.968 0 C-N-CA 123.489 2.793 . . . . 0.0 112.307 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -91.93 -4.93 54.05 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.973 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 5.4 mt-30 -116.4 -44.17 2.89 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.585 1.183 . . . . 0.0 108.819 -169.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 5.0 tt -61.27 -39.66 91.2 Favored 'General case' 0 CA--C 1.486 -1.507 0 CA-C-N 112.716 -2.038 . . . . 0.0 115.203 -167.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -50.44 -42.6 54.36 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.113 -175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -98.75 -3.22 36.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.565 0.62 . . . . 0.0 111.229 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 16.0 pt-20 -151.84 82.53 1.28 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 123.797 1.761 . . . . 0.0 112.609 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 88.9 m-85 -64.41 -38.6 91.61 Favored 'General case' 0 C--N 1.263 -3.179 0 CA-C-N 111.12 -2.764 . . . . 0.0 112.093 172.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.3 141.24 36.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' O ' ' SG ' ' A' ' 2' ' ' CYS . 61.2 m-85 -144.97 167.02 15.71 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.258 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 22' ' ' PHE . 96.4 Cg_endo -75.19 164.33 33.21 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 124.669 3.579 . . . . 0.0 114.209 172.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 49' ' ' SER . 97.5 mt -64.69 135.71 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-O 121.879 0.847 . . . . 0.0 111.105 175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.72 20.9 57.31 Favored Glycine 0 N--CA 1.436 -1.34 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.668 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 89.6 m -103.96 128.61 51.5 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.692 ' CD2' HG12 ' A' ' 44' ' ' ILE . 70.7 m-85 -101.9 127.74 48.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.371 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' HE22 ' A' ' 15' ' ' GLN . 11.3 mp -97.86 141.18 31.17 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.631 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.694 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 57.0 t30 -90.51 105.47 17.84 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.929 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.586 ' CE1' HD11 ' A' ' 43' ' ' ILE . 4.0 m-85 -107.92 134.92 50.15 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 125.473 1.509 . . . . 0.0 112.233 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 57.8 mp0 -118.28 126.63 52.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.668 0.605 . . . . 0.0 110.084 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.87 146.24 24.04 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.583 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -66.73 163.4 42.94 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.62 145.38 97.67 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.853 1.702 . . . . 0.0 111.279 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 108' ' ' GLY . . . 100.11 -10.91 60.29 Favored Glycine 0 N--CA 1.435 -1.388 0 C-N-CA 120.53 -0.843 . . . . 0.0 114.263 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 58' ' ' CYS . 80.0 m-85 -84.45 136.47 33.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.006 176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 46.6 m -61.51 -42.34 98.66 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.887 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.84 172.59 42.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.048 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -115.54 127.84 26.46 Favored Pre-proline 0 C--O 1.247 0.925 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.149 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.75 143.77 87.3 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.437 2.091 . . . . 0.0 112.682 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 57' ' ' ARG . 55.9 m-85 -139.28 160.85 38.84 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' A' ' 27' ' ' TYR . 20.0 p -66.77 156.65 34.91 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.775 0.321 . . . . 0.0 111.85 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.77 ' HB ' ' CE3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -99.94 -5.8 9.21 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.115 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -173.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.785 HD12 HG21 ' A' ' 52' ' ' THR . 0.3 OUTLIER 17.15 123.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 127.729 2.412 . . . . 0.0 114.513 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 60.6 m -72.84 69.23 0.93 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.424 0.63 . . . . 0.0 111.338 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 52' ' ' THR . 68.2 mt -91.88 -52.53 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.167 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 15.2 tptm -80.63 116.18 20.52 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.296 -172.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 50' ' ' VAL . 59.9 m-20 55.36 35.11 24.29 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.632 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 24' ' ' ILE . 77.6 p 54.11 20.08 2.37 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 124.213 0.945 . . . . 0.0 112.13 -176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 48' ' ' ASN . 44.9 t -99.03 -88.17 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.75 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.77 ' CE3' ' HB ' ' A' ' 43' ' ' ILE . 98.8 m95 -152.51 163.12 40.2 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.685 0.394 . . . . 0.0 111.234 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.785 HG21 HD12 ' A' ' 44' ' ' ILE . 82.3 p -66.67 -35.24 79.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.889 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.3 79.01 1.08 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.703 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.488 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -105.07 65.83 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 122.421 -0.458 . . . . 0.0 112.02 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -112.53 157.57 20.98 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 51.65 24.53 2.4 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.037 1.335 . . . . 0.0 111.65 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' NH2' ' CD2' ' A' ' 41' ' ' PHE . 56.7 mmm-85 -65.14 -40.91 95.08 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.84 -174.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 76.4 m -112.26 143.54 43.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 77.5 mtp85 -128.9 139.06 52.3 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 116.797 -1.961 . . . . 0.0 114.912 -164.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 56.1 ttp180 -74.64 138.63 43.03 Favored 'General case' 0 CA--C 1.571 1.775 0 C-N-CA 130.064 3.346 . . . . 0.0 115.957 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 38.8 mtpt -94.2 156.18 16.68 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.4 m -68.68 135.87 52.04 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 113.474 -1.693 . . . . 0.0 113.088 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.11 146.8 24.04 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 125.812 1.645 . . . . 0.0 110.667 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -142.87 148.5 37.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 9.3 t-20 -119.95 70.67 14.78 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.8 Cg_endo -83.69 -9.59 9.93 Favored 'Trans proline' 0 CA--C 1.59 3.285 0 C-N-CA 121.072 1.181 . . . . 0.0 114.983 168.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 33.3 Cg_exo -53.02 -40.7 75.66 Favored 'Trans proline' 1 C--N 1.419 4.242 0 C-N-CA 121.73 1.62 . . . . 0.0 110.959 177.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.2 p30 45.01 143.22 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 126.422 1.889 . . . . 0.0 115.939 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 22.3 Cg_exo -62.72 145.23 94.94 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.984 1.789 . . . . 0.0 108.731 174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.28 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.351 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.669 ' OD1' ' HB3' ' A' ' 90' ' ' CYS . 7.2 m120 -63.88 -40.34 96.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 116.59 9.44 11.31 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.3 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.436 ' C ' ' HG2' ' A' ' 69' ' ' PRO . 63.4 ttp -112.62 113.11 25.09 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 2.7 p -132.91 139.33 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.635 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.678 ' O ' ' HB ' ' A' ' 86' ' ' ILE . 90.2 m-70 -117.46 150.28 39.18 Favored 'General case' 0 C--O 1.199 -1.569 0 C-N-CA 123.244 0.617 . . . . 0.0 111.383 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 86' ' ' ILE . 59.7 t -113.71 129.58 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.484 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.742 HD11 ' HE3' ' A' ' 87' ' ' LYS . 87.5 mt -94.31 -64.15 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.744 0.783 . . . . 0.0 112.244 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 75.6 mmtt -86.54 -13.03 47.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.371 -171.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 84' ' ' SER . . . 98.0 128.53 6.08 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -172.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.7 mm -59.12 83.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.399 1.095 . . . . 0.0 110.598 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 84' ' ' SER . 70.2 tp60 -160.2 169.12 23.91 Favored 'General case' 0 C--O 1.194 -1.835 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 176.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 31.7 t80 -59.32 132.95 55.55 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.212 -0.93 . . . . 0.0 112.957 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.43 9.94 62.59 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.351 -171.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.704 ' HA ' ' HB2' ' A' ' 78' ' ' LYS . 24.9 p -77.18 160.66 28.8 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.2 tt0 -151.45 127.33 10.31 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -129.25 163.26 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.721 -178.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.742 ' HE3' HD11 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -103.75 142.55 34.16 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -178.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -110.27 47.86 0.94 Allowed 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.059 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 106.69 4.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.131 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.669 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 36.8 m -75.59 -36.25 60.36 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.708 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 93' ' ' GLY . 50.3 m -160.29 151.35 19.11 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.179 -172.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -64.2 -45.83 86.6 Favored 'General case' 0 CA--C 1.564 1.517 0 O-C-N 120.578 -1.326 . . . . 0.0 114.122 171.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.557 ' H ' HG22 ' A' ' 91' ' ' THR . . . -95.47 22.59 38.05 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.475 ' CD1' ' O ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -119.28 177.0 5.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -177.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -130.0 143.09 50.61 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.566 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -101.96 120.77 40.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.435 0.636 . . . . 0.0 109.492 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.0 mm -65.43 -44.69 94.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.391 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.646 ' N ' HD12 ' A' ' 119' ' ' ILE . . . -84.5 -130.77 2.09 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.836 -0.697 . . . . 0.0 114.007 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 4.5 t -99.54 107.72 19.97 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.057 -177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 m -61.06 -41.66 97.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.897 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 19.1 p -118.0 106.39 12.87 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.385 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 85' ' ' GLN . . . -74.4 147.46 42.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.165 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.6 m -121.11 127.31 51.5 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 113' ' ' TRP . 29.3 t -91.18 119.65 31.46 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.59 0.709 . . . . 0.0 112.413 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.67 162.83 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.407 -1.27 . . . . 0.0 109.953 -176.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 111' ' ' VAL . 24.6 mm -83.82 122.0 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -67.8 -36.33 80.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.784 0.802 . . . . 0.0 111.735 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA2' ' CA ' ' A' ' 35' ' ' GLY . . . 144.96 -43.5 0.95 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.529 -174.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -114.46 -11.33 12.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.273 0.559 . . . . 0.0 111.45 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.2 t -153.95 174.72 14.26 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.719 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.796 HG12 HD13 ' A' ' 106' ' ' ILE . 19.3 m -116.33 131.25 69.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' CYS . 49.0 pt -129.24 159.87 40.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.342 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.599 ' CD2' ' HB2' ' A' ' 104' ' ' CYS . 95.2 m95 -88.39 143.44 27.0 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -88.24 1.18 55.06 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -171.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 118' ' ' PRO . 61.2 tt0 -66.39 135.21 54.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.248 0.546 . . . . 0.0 112.036 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -65.79 -41.77 91.54 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.573 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 ' H ' ' HG2' ' A' ' 115' ' ' GLN . 8.8 t 170.73 132.28 0.06 OUTLIER Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.163 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.548 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 30.6 Cg_exo -62.15 140.01 81.41 Favored 'Trans proline' 0 C--N 1.349 0.585 0 N-CA-C 109.958 -0.824 . . . . 0.0 109.958 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.743 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.4 mt -129.32 129.54 67.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.115 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.2 m -115.81 97.42 6.1 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 118.532 -1.267 . . . . 0.0 108.831 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -62.17 -49.06 77.33 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.406 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 . . . . . 0 C--O 1.258 1.527 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.657 -179.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 . . . . . 0 N--CA 1.428 -1.54 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 49' ' ' SER . 11.9 m -76.18 -19.29 58.57 Favored 'General case' 0 C--O 1.195 -1.811 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.8 OUTLIER 60.73 36.13 19.47 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.204 1.802 . . . . 0.0 112.633 -174.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 70.14 124.1 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 124.778 1.231 . . . . 0.0 112.269 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.699 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 24.8 Cg_exo -56.45 -49.47 14.86 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.501 1.468 . . . . 0.0 111.114 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.6 pt-20 140.42 -168.35 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.273 2.229 . . . . 0.0 107.467 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.8 t90 -105.94 126.24 51.94 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 11' ' ' ALA . 12.6 tp -106.98 113.39 62.62 Favored Pre-proline 0 N--CA 1.421 -1.887 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.87 -21.32 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.222 1.948 . . . . 0.0 114.026 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.35 9.6 39.7 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 8' ' ' LEU . . . -142.7 149.03 38.29 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.44 82.56 64.95 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 91.1 Cg_endo -69.97 154.22 67.13 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.538 2.158 . . . . 0.0 112.873 176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.2 p -100.91 -0.5 36.64 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.732 -166.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.857 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 23.2 mt-30 -122.45 -32.85 3.55 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.921 0.867 . . . . 0.0 110.64 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.578 HD12 ' HG2' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -61.35 -40.77 95.48 Favored 'General case' 0 CA--C 1.479 -1.752 0 CA-C-N 114.242 -1.344 . . . . 0.0 113.554 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.1 t -51.27 -37.76 49.05 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 123.791 0.682 . . . . 0.0 110.071 -178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.21 -25.29 17.14 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.798 0.809 . . . . 0.0 110.714 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 5.7 pt-20 -145.65 86.06 1.73 Allowed 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 122.914 1.34 . . . . 0.0 112.243 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 93.9 m-85 -62.85 -39.34 94.09 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 112.464 -2.153 . . . . 0.0 110.85 176.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 73.2 mt-10 -106.64 126.32 52.12 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.14 -173.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.673 ' CD1' HG21 ' A' ' 26' ' ' THR . 96.8 m-85 -130.75 156.25 80.16 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.177 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.06 162.05 43.66 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 124.241 3.294 . . . . 0.0 111.234 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 24' ' ' ILE . 5.1 mp -68.07 132.07 32.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.41 21.38 10.72 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 119.462 -1.351 . . . . 0.0 114.357 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 22' ' ' PHE . 91.3 m -110.75 130.05 55.68 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.35 0.595 . . . . 0.0 109.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.74 133.69 44.83 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.875 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HA ' HE22 ' A' ' 15' ' ' GLN . 63.1 mt -107.79 144.9 34.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.819 0.818 . . . . 0.0 112.794 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.857 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 63.1 t30 -93.99 94.31 8.37 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.362 -173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 13' ' ' PRO . 17.6 m-85 -106.0 133.23 51.04 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.144 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.9 tt0 -124.57 143.22 50.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.812 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.4 m -87.77 147.9 24.96 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.004 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.684 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 24.3 ptt85 -84.79 173.96 6.45 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.12 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 90.6 Cg_endo -70.95 153.4 63.49 Favored 'Trans proline' 0 C--N 1.364 1.361 0 CA-C-N 120.77 1.311 . . . . 0.0 115.335 -171.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' CG2' ' A' ' 106' ' ' ILE . . . 83.82 13.97 73.89 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.945 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 91.2 m-85 -107.47 130.36 54.85 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 59' ' ' ARG . 37.8 t -62.71 -43.43 98.83 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.887 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.32 150.5 43.8 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.202 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -104.57 141.89 23.49 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.72 149.19 66.82 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.107 2.538 . . . . 0.0 115.184 -171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -132.84 154.37 50.39 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.897 175.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 63.8 m -72.58 153.87 41.06 Favored 'General case' 0 C--N 1.287 -2.117 0 O-C-N 121.826 -0.546 . . . . 0.0 110.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 54' ' ' ALA . 46.2 pt -118.22 143.98 27.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 121.7 0.762 . . . . 0.0 112.474 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.626 ' H ' HG23 ' A' ' 52' ' ' THR . 2.2 mp -136.0 141.4 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.417 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -69.07 47.63 0.07 Allowed 'General case' 0 N--CA 1.515 2.775 0 CA-C-N 120.512 1.505 . . . . 0.0 112.104 -178.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.797 HD12 HG22 ' A' ' 52' ' ' THR . 93.1 mt -63.35 -42.47 98.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.586 0.707 . . . . 0.0 112.449 -173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 31.2 ttmt -101.65 120.8 40.9 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 m120 55.06 34.3 22.21 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 124.367 1.042 . . . . 0.0 110.626 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.725 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.4 m 52.88 23.35 2.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 124.154 0.909 . . . . 0.0 110.826 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 88.8 t -101.4 -83.09 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.545 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.433 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.699 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.7 m95 -156.09 170.83 21.28 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 121.126 0.489 . . . . 0.0 112.254 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.797 HG22 HD12 ' A' ' 46' ' ' LEU . 76.9 p -66.4 -32.2 73.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.694 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.32 -26.74 2.43 Favored Glycine 0 N--CA 1.465 0.606 0 CA-C-N 114.286 -1.324 . . . . 0.0 112.347 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . 48.12 33.32 3.5 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 56' ' ' ASP . 87.5 tttt -96.77 148.15 23.2 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 5.8 p-10 51.93 33.51 11.8 Favored 'General case' 0 CA--C 1.483 -1.623 0 C-N-CA 124.873 1.269 . . . . 0.0 111.871 176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.496 HH22 ' HB2' ' A' ' 30' ' ' TYR . 56.2 mmm-85 -64.01 -42.33 97.19 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 8.0 m -135.94 149.01 48.76 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 82.3 mtp180 -131.54 141.54 49.74 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.206 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -99.74 141.34 32.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.392 0.677 . . . . 0.0 110.654 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.811 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.5 tmtt? -85.43 146.23 27.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.886 0.874 . . . . 0.0 112.805 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.811 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 17.9 p -73.08 147.35 45.06 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.605 0.717 . . . . 0.0 111.482 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.89 166.88 13.68 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.833 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.28 141.04 47.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -126.19 -0.27 0.05 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 174.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -38.59 -31.26 0.22 Allowed 'Trans proline' 0 C--N 1.406 3.572 0 C-N-CA 122.976 2.451 . . . . 0.0 116.559 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.542 ' HD2' ' C ' ' A' ' 65' ' ' ASN . 1.5 Cg_endo -59.8 -29.54 89.82 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 120.643 1.265 . . . . 0.0 112.029 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 46.06 162.54 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 124.963 1.305 . . . . 0.0 114.404 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.602 ' CG ' ' HB ' ' A' ' 74' ' ' VAL . 17.4 Cg_exo -65.06 148.2 89.25 Favored 'Trans proline' 0 N--CA 1.437 -1.817 0 C-N-CA 122.064 1.843 . . . . 0.0 108.405 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 p -62.54 -33.36 59.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.493 0.663 . . . . 0.0 111.717 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 p30 -90.12 -1.52 57.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.055 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.22 16.16 80.85 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.377 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.609 ' HB3' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -99.27 84.3 2.99 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 121.591 0.71 . . . . 0.0 112.186 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 13.7 p -140.08 139.9 36.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.431 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 43.5 m170 -114.21 144.94 42.38 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -121.66 128.58 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.847 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.5 mt -85.67 -52.07 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -96.27 -6.72 37.29 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -173.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 89.78 28.74 17.78 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.773 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm 65.7 84.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 65.5 tp60 -151.81 162.77 40.49 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.026 177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' CE1' HG12 ' A' ' 106' ' ' ILE . 16.3 t80 -59.43 128.87 39.22 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.647 0.737 . . . . 0.0 110.682 175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.35 -7.0 75.46 Favored Glycine 0 C--O 1.202 -1.895 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.436 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 97.8 p -79.16 164.11 24.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.106 -0.644 . . . . 0.0 111.424 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 47.4 tt0 -132.05 145.37 51.38 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.141 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' VAL . 43.0 pt -129.62 161.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 124.217 1.007 . . . . 0.0 109.289 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.847 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.6 mptp? -115.71 137.72 51.8 Favored 'General case' 0 C--O 1.196 -1.744 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 69' ' ' PRO . 39.5 m-85 -108.53 19.3 19.93 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 126.289 1.836 . . . . 0.0 115.081 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 73' ' ' MET . 44.8 t -62.1 132.85 54.2 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.087 0.946 . . . . 0.0 111.029 -169.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 61.5 m -88.61 -125.62 0.05 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 113.551 -1.658 . . . . 0.0 108.826 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.586 HG21 ' HD2' ' A' ' 122' ' ' ARG . 20.7 m -72.72 158.05 36.33 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 126.485 1.914 . . . . 0.0 111.965 -176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -62.73 -46.07 89.8 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.901 -1.124 . . . . 0.0 113.67 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.543 ' H ' HG22 ' A' ' 91' ' ' THR . . . -111.25 88.02 0.49 Allowed Glycine 0 CA--C 1.493 -1.306 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.187 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.789 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.8 OUTLIER -167.9 -168.13 0.94 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 40.0 ptt180 -143.61 150.28 38.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 167.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.621 HD13 ' HA ' ' A' ' 100' ' ' SER . 7.7 tt -107.0 121.47 44.52 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.57 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.3 mm -65.19 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--O 1.253 1.282 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -90.6 -125.81 3.17 Favored Glycine 0 C--O 1.211 -1.323 0 O-C-N 123.477 0.486 . . . . 0.0 113.079 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.5 m -94.14 123.63 37.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.969 0.414 . . . . 0.0 111.825 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.621 ' HA ' HD13 ' A' ' 96' ' ' LEU . 7.2 m -83.83 -5.6 59.24 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 123.722 0.809 . . . . 0.0 110.251 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 p -153.9 161.13 42.25 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -141.15 149.48 41.55 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.608 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 66.3 m -122.92 130.04 52.34 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.572 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.8 t -73.25 115.45 12.61 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.577 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.24 162.59 29.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.051 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.712 HD13 HG12 ' A' ' 111' ' ' VAL . 49.5 mm -81.51 125.86 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.935 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 112' ' ' ILE . 82.6 p -88.68 -13.41 39.8 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.581 0.705 . . . . 0.0 110.168 174.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 122.86 -73.41 0.39 Allowed Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.225 -178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.32 -40.08 95.19 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 121.388 0.613 . . . . 0.0 111.513 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -145.15 -171.99 3.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.377 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 106' ' ' ILE . 28.0 m -113.91 128.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 2.5 pp -131.18 163.31 37.37 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.449 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -89.25 146.62 24.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.152 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.608 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 6.4 m-20 -62.84 -36.12 82.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.124 0.57 . . . . 0.0 110.573 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.632 HE21 ' HA ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -34.24 124.93 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.803 1.241 . . . . 0.0 113.487 178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 117' ' ' THR . 96.7 mt-10 -66.12 -41.59 90.35 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.373 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.632 ' HA ' HE21 ' A' ' 115' ' ' GLN . 1.2 t 163.72 164.27 0.06 OUTLIER Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -176.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 26.6 Cg_endo -63.87 113.99 2.4 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 120.701 0.934 . . . . 0.0 112.448 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.614 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 62.3 mt -125.41 128.26 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.337 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.81 108.19 5.54 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 65.6 t0 -63.91 -48.89 74.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.586 ' HD2' HG21 ' A' ' 91' ' ' THR . 61.5 ttt85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.214 -0.782 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.6 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 35.8 m -72.89 -21.32 60.93 Favored 'General case' 0 C--N 1.379 1.873 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 169.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 2.8 t-20 63.8 41.18 7.05 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.27 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 72.51 137.96 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 125.154 1.381 . . . . 0.0 114.031 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.689 ' HB3' ' CD1' ' A' ' 51' ' ' TRP . 37.8 Cg_endo -78.04 -99.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.303 1.335 . . . . 0.0 114.392 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -159.14 161.6 36.32 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.004 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -83.53 119.59 24.89 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 33.3 tp -117.42 108.52 43.35 Favored Pre-proline 0 N--CA 1.427 -1.586 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 32.8 Cg_endo -63.54 -23.94 70.4 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 122.535 2.157 . . . . 0.0 112.676 -176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.26 16.3 m-30 -64.24 -42.19 96.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.401 1.096 . . . . 0.0 110.021 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -120.83 155.55 33.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.179 -1.828 . . . . 0.0 114.515 -160.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -138.25 90.67 13.33 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.297 175.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 8.2 Cg_exo -70.11 151.65 67.18 Favored 'Trans proline' 0 CA--C 1.486 -1.885 0 C-N-CA 123.458 2.772 . . . . 0.0 111.834 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 p -90.67 -5.69 55.47 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.141 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -120.23 -39.71 2.77 Favored 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.713 -172.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 3.9 tt -61.75 -40.65 95.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t -47.98 -40.78 23.48 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.6 -6.95 13.89 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.11 0.481 . . . . 0.0 110.041 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 mm-40 -133.34 72.74 1.49 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.773 1.273 . . . . 0.0 107.668 -172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 85.2 m-85 -64.79 -36.4 84.2 Favored 'General case' 1 C--N 1.243 -4.045 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.262 175.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 3' ' ' ASN . 98.3 mt-10 -99.56 118.69 36.67 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.672 0.749 . . . . 0.0 112.467 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 26' ' ' THR . 14.1 m-85 -128.37 155.65 78.15 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.338 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.9 153.39 78.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 124.07 3.18 . . . . 0.0 112.673 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.706 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 mp -66.81 131.79 32.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.69 24.76 44.7 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.82 -174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.604 HG21 ' HD2' ' A' ' 22' ' ' PHE . 60.0 m -115.76 132.52 56.61 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 29.9 m-85 -101.06 131.55 46.91 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.094 -171.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 22' ' ' PHE . 50.1 mt -99.86 139.28 35.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 176.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 25.6 t-20 -84.32 107.54 16.66 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.847 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.462 ' OH ' HD13 ' A' ' 16' ' ' LEU . 6.3 m-85 -110.7 138.36 47.19 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.0 mt-10 -123.02 133.89 54.33 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.796 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.811 ' SG ' ' HG3' ' A' ' 40' ' ' PRO . 34.7 m -98.23 164.35 12.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.184 0.594 . . . . 0.0 110.597 176.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.546 ' HG3' HH12 ' A' ' 12' ' ' ARG . 4.9 ttm105 -73.5 166.7 41.63 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.536 ' C ' HG21 ' A' ' 106' ' ' ILE . 12.9 Cg_exo -68.2 153.26 75.03 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.561 2.174 . . . . 0.0 111.473 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.9 20.44 53.53 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.847 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 40.9 m-85 -105.74 137.92 42.8 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-O 121.902 0.858 . . . . 0.0 113.104 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.751 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 77.8 p -61.44 -42.21 98.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.057 0.932 . . . . 0.0 111.888 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -95.36 174.16 32.02 Favored Glycine 0 N--CA 1.414 -2.788 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.934 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 72.8 mmt-85 -133.63 130.75 20.96 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.811 ' HG3' ' SG ' ' A' ' 32' ' ' CYS . 21.0 Cg_exo -62.36 144.22 94.78 Favored 'Trans proline' 0 CA--C 1.485 -1.969 0 C-N-CA 121.648 1.565 . . . . 0.0 112.679 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -134.68 156.81 48.11 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' TYR . 66.1 m -61.0 141.64 57.2 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.865 0.841 . . . . 0.0 112.824 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' CE3' ' A' ' 51' ' ' TRP . 48.0 pt -96.3 136.86 25.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.837 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 52' ' ' THR . 1.2 mp -130.46 142.44 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.262 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -63.56 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.99 0 CA-C-N 120.435 1.47 . . . . 0.0 112.761 -175.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 52' ' ' THR . 93.8 mt -63.84 -42.19 97.65 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -169.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 18.9 tptm -95.56 108.35 20.59 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -166.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 55.49 38.51 30.35 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.224 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m 59.07 27.4 16.34 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.088 0.946 . . . . 0.0 109.542 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 47' ' ' LYS . 55.9 t -128.67 161.68 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 49.6 m95 -66.64 154.27 40.98 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 122.397 1.094 . . . . 0.0 112.352 -172.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.629 HG22 HD12 ' A' ' 46' ' ' LEU . 76.6 p -63.85 -32.41 73.91 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.002 -166.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.672 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 151.13 75.34 0.01 OUTLIER Glycine 0 CA--C 1.485 -1.843 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.92 -13.62 60.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.38 0.61 . . . . 0.0 110.369 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.27 141.01 38.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 52.66 28.49 6.26 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 125.884 1.674 . . . . 0.0 113.478 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.672 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 14.9 mmm180 -65.76 -41.13 92.45 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.949 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 94.3 m -120.9 134.95 55.3 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.408 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.751 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 83.8 mtp180 -130.58 135.69 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -96.44 162.26 13.56 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.676 -176.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 60' ' ' ARG . 88.6 tttt -90.1 155.17 19.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.311 0.644 . . . . 0.0 112.216 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 45.6 t -73.48 140.41 46.42 Favored 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -90.36 158.67 17.0 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.04 0.936 . . . . 0.0 110.599 175.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -140.74 155.52 46.42 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -140.99 76.83 21.6 Favored Pre-proline 0 C--O 1.209 -1.071 0 C-N-CA 118.058 -1.457 . . . . 0.0 113.703 177.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.712 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 25.0 Cg_exo -67.06 -20.24 50.62 Favored 'Trans proline' 0 CA--C 1.586 3.082 0 C-N-CA 122.712 2.275 . . . . 0.0 114.506 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.1 Cg_endo -60.81 -23.51 76.79 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.14 1.893 . . . . 0.0 111.726 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 4.0 t70 -2.82 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.24 0 C-N-CA 125.469 1.508 . . . . 0.0 113.685 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 68' ' ' ASP . 19.7 Cg_exo -61.0 147.21 96.41 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.17 1.913 . . . . 0.0 111.975 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.05 -24.92 34.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.096 -175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -93.37 6.29 48.62 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.225 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 38.14 92.61 Favored Glycine 0 C--N 1.354 1.529 0 C-N-CA 120.015 -1.088 . . . . 0.0 111.669 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.595 ' HB3' ' O ' ' A' ' 89' ' ' SER . 39.4 mtt -104.85 18.03 23.07 Favored 'General case' 0 C--O 1.206 -1.193 0 N-CA-C 116.347 1.981 . . . . 0.0 116.347 -169.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 7.6 p -92.44 128.32 44.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.097 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -104.72 127.91 52.65 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.042 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.659 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -108.23 110.19 31.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.735 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD11 ' HE2' ' A' ' 87' ' ' LYS . 80.4 mt -65.17 -47.34 87.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.014 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 84' ' ' SER . 75.8 mmtt -100.73 -1.65 34.51 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 118.522 2.786 . . . . 0.0 118.522 -168.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 91.95 16.94 49.65 Favored Glycine 0 CA--C 1.549 2.201 0 C-N-CA 120.114 -1.041 . . . . 0.0 114.626 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 76' ' ' VAL . 48.5 mm 64.47 87.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.769 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 33.4 tt0 -168.36 -167.94 0.86 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.769 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 16.1 t80 -66.98 128.86 37.95 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.149 0.5 . . . . 0.0 111.079 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.31 -9.27 77.86 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.362 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.491 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 61.6 m -74.32 147.5 42.2 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.283 0.563 . . . . 0.0 110.878 177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 57.9 tt0 -124.03 132.9 53.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 76' ' ' VAL . 45.7 pt -127.64 161.53 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.082 -175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.697 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.2 mptp? -114.52 139.85 49.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.565 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -103.5 16.35 26.68 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 126.704 2.001 . . . . 0.0 112.162 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 73' ' ' MET . 39.8 t -63.14 141.01 58.93 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.615 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 3.3 m -96.09 -93.89 0.2 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 93' ' ' GLY . 2.2 m -97.56 161.41 13.79 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 124.871 1.269 . . . . 0.0 110.455 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.29 -48.29 78.75 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.152 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 91' ' ' THR . . . -100.91 67.57 0.48 Allowed Glycine 0 N--CA 1.474 1.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.136 -173.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -151.94 175.22 12.72 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.5 mtt-85 -122.02 144.83 48.66 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.695 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 22.1 tp -107.09 123.68 48.58 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 43.9 mm -64.78 -44.41 96.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.351 0.596 . . . . 0.0 112.163 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.474 ' N ' HD13 ' A' ' 119' ' ' ILE . . . -102.87 -145.01 14.81 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.285 -0.959 . . . . 0.0 113.809 -177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 6.1 m -66.74 108.13 2.4 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.695 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 18.0 m -61.05 -39.16 88.77 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 125.286 1.434 . . . . 0.0 110.57 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 50.6 m -129.64 151.11 50.6 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -121.26 143.31 49.23 Favored 'General case' 0 N--CA 1.411 -2.392 0 O-C-N 123.862 0.726 . . . . 0.0 109.207 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 58.2 m -122.29 129.89 52.62 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.967 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 48.3 t -86.27 122.4 30.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.609 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.18 163.54 34.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 C-N-CA 124.489 1.116 . . . . 0.0 109.935 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.762 HD13 HG12 ' A' ' 111' ' ' VAL . 51.3 mm -85.51 121.48 37.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 118.974 -1.091 . . . . 0.0 109.301 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.0 t -62.76 -43.31 99.14 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.841 1.305 . . . . 0.0 109.002 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 149.55 -75.01 0.26 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -66.94 -35.39 79.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -142.11 -177.32 5.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 106' ' ' ILE . 27.7 m -113.9 129.8 69.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.694 0.759 . . . . 0.0 109.157 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.0 pt -129.68 163.01 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.108 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -95.88 148.17 22.89 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -81.03 -1.4 43.82 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.602 ' OE1' ' HB2' ' A' ' 99' ' ' SER . 64.3 tp60 -62.51 123.68 18.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.876 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.518 ' O ' ' HB ' ' A' ' 117' ' ' THR . 51.8 tp10 -68.07 -44.22 76.83 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 121.671 0.748 . . . . 0.0 111.51 175.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t 167.44 154.47 0.12 Allowed Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.89 115.07 1.71 Allowed 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 122.042 1.828 . . . . 0.0 112.822 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.673 ' O ' HD12 ' A' ' 96' ' ' LEU . 2.1 mp -117.76 119.6 62.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.26 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.5 m -103.79 116.46 32.35 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 64.9 t0 -62.69 -49.5 74.87 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.667 0.746 . . . . 0.0 110.914 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 . . . . . 0 C--O 1.256 1.441 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.501 179.194 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 47.6 mt-30 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' SG ' ' CZ2' ' A' ' 51' ' ' TRP . 50.9 m -71.25 -19.63 62.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.442 173.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.51 24.92 0.58 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.829 0.823 . . . . 0.0 110.442 -173.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 20' ' ' PHE . . . 70.85 143.95 0.1 OUTLIER Pre-proline 0 C--N 1.37 1.48 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 4' ' ' ALA . 1.1 Cg_endo -75.97 -66.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 108.523 -1.376 . . . . 0.0 108.523 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 151.25 -176.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.985 1.714 . . . . 0.0 110.345 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.3 t90 -75.66 120.19 20.73 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 57' ' ' ARG . 14.4 tp -112.91 118.44 44.62 Favored Pre-proline 0 N--CA 1.414 -2.243 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.393 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.33 -30.3 87.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.017 1.811 . . . . 0.0 113.321 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' HD2' ' HG ' ' A' ' 8' ' ' LEU . 94.0 m-85 -66.43 -40.35 89.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.96 147.16 46.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -159.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.59 78.95 62.82 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -64.53 149.31 90.15 Favored 'Trans proline' 0 CA--C 1.503 -1.027 0 C-N-CA 123.714 2.943 . . . . 0.0 111.641 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -86.17 -14.03 45.26 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.73 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -111.95 -26.31 8.97 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -170.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.79 -41.85 99.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -56.0 -38.41 70.45 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 114.315 -1.312 . . . . 0.0 111.697 -170.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -112.06 12.28 20.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLU . 80.7 mm-40 -131.62 -75.72 0.52 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.979 0.419 . . . . 0.0 112.025 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 82.4 m-85 70.13 -30.61 0.2 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.397 1.079 . . . . 0.0 111.345 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' GLU . 99.4 mt-10 -110.6 116.98 32.29 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.142 0.496 . . . . 0.0 111.12 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 28' ' ' LEU . 78.5 m-85 -136.03 147.35 60.41 Favored Pre-proline 0 C--O 1.215 -0.762 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.138 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HG2' ' OG1' ' A' ' 26' ' ' THR . 85.8 Cg_endo -68.5 157.56 61.3 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 C-N-CA 123.997 3.131 . . . . 0.0 113.809 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.726 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 1.9 mp -68.78 133.4 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.4 37.25 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.264 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.643 ' OG1' ' HG2' ' A' ' 23' ' ' PRO . 86.6 m -117.38 127.75 54.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.303 1.049 . . . . 0.0 111.648 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -85.77 135.73 33.62 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.639 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 22' ' ' PHE . 11.1 mp -115.52 146.6 41.55 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 8.3 t-20 -91.31 105.82 18.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.398 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 m-85 -111.96 141.18 45.94 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 125.162 1.385 . . . . 0.0 113.549 175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -114.18 174.02 6.15 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.1 m -125.15 153.13 43.51 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.446 ' HG3' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -76.4 161.28 75.29 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HG3' ' A' ' 33' ' ' ARG . 85.6 Cg_endo -67.73 152.79 77.33 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.463 2.109 . . . . 0.0 113.615 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.83 65.97 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.231 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.773 ' CG ' ' HB3' ' A' ' 58' ' ' CYS . 25.4 m-85 -108.22 134.61 50.81 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.5 m -61.5 -41.7 97.69 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.491 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.55 162.56 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.19 -0.914 . . . . 0.0 114.473 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 mmt-85 -115.85 152.06 47.07 Favored Pre-proline 0 C--O 1.239 0.503 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.708 ' HA ' ' NH2' ' A' ' 57' ' ' ARG . 23.6 Cg_exo -62.09 142.58 92.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.796 1.664 . . . . 0.0 113.09 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -141.54 152.7 44.33 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.399 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.5 m -72.64 151.4 42.3 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.882 0.372 . . . . 0.0 111.278 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 HG13 ' CE3' ' A' ' 51' ' ' TRP . 47.8 pt -120.12 145.34 26.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 109.989 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 HG21 ' A' ' 52' ' ' THR . 1.4 mp -136.34 144.44 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.341 -171.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.815 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 1.5 m -68.05 36.81 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-N 120.151 1.341 . . . . 0.0 111.938 -173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.787 HD12 HG22 ' A' ' 52' ' ' THR . 79.7 mt -64.48 -41.97 96.16 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -110.37 123.79 50.51 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.934 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.6 m120 56.12 33.34 21.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.154 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 m 55.92 22.37 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.384 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.9 t -104.97 -102.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.531 ' CZ2' ' SG ' ' A' ' 2' ' ' CYS . 94.4 m95 -149.27 158.03 43.84 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.777 0.717 . . . . 0.0 111.896 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.787 HG22 HD12 ' A' ' 46' ' ' LEU . 51.3 p -64.09 -42.06 97.07 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -176.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.75 58.73 0.15 Allowed Glycine 0 CA--C 1.49 -1.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.659 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -72.8 -13.89 61.4 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.981 0.896 . . . . 0.0 108.764 175.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.09 137.33 33.61 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.952 -1.477 . . . . 0.0 114.59 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 60.47 36.67 20.1 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.197 0.999 . . . . 0.0 110.531 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.708 ' NH2' ' HA ' ' A' ' 40' ' ' PRO . 18.1 mmm180 -61.09 -43.24 99.19 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.979 -1.464 . . . . 0.0 113.646 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.773 ' HB3' ' CG ' ' A' ' 36' ' ' TYR . 1.8 m -140.69 154.51 46.4 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.94 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 99.2 mtt180 -128.87 138.57 52.1 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.601 -168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' HB3' ' A' ' 82' ' ' PHE . 31.5 ptt-85 -99.61 166.72 11.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.385 1.074 . . . . 0.0 112.096 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.776 ' CD ' ' H ' ' A' ' 62' ' ' SER . 6.1 tmtt? -95.58 -177.18 3.98 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.886 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.776 ' H ' ' CD ' ' A' ' 61' ' ' LYS . 56.4 m -126.61 151.55 47.85 Favored 'General case' 0 N--CA 1.414 -2.233 0 C-N-CA 123.967 0.907 . . . . 0.0 109.68 -171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 55.8 m -99.63 162.56 12.94 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.317 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -141.19 154.35 45.78 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -136.64 23.27 0.08 OUTLIER Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.4 Cg_endo -50.47 -28.84 22.56 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 121.498 1.466 . . . . 0.0 115.242 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 1.7 Cg_endo -60.23 -30.21 90.69 Favored 'Trans proline' 0 C--N 1.405 3.514 0 CA-C-N 121.212 1.468 . . . . 0.0 110.746 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' OD2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER 49.44 163.36 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 173.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 72' ' ' GLY . 23.3 Cg_exo -62.38 145.83 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.062 1.842 . . . . 0.0 109.382 172.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.89 -45.47 98.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.71 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 90' ' ' CYS . 99.3 m-20 -65.09 -39.7 93.56 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.022 174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' HA2' ' OD2' ' A' ' 68' ' ' ASP . . . 108.43 41.49 1.48 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 120.812 -0.708 . . . . 0.0 114.127 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' SER . 66.9 mtt -131.98 90.89 2.88 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 14.8 p -128.31 136.74 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.126 0.489 . . . . 0.0 110.771 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -110.36 133.68 53.03 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.663 ' HA ' HG22 ' A' ' 86' ' ' ILE . 27.0 m -105.21 106.22 20.1 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 121.14 0.495 . . . . 0.0 110.712 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.34 -44.98 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 122.223 1.011 . . . . 0.0 112.306 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 75.7 mmtt -99.95 -8.37 24.03 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.492 -1.231 . . . . 0.0 114.32 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . 89.29 9.88 66.62 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.463 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 79' ' ' GLY . 47.8 mm 90.52 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 82' ' ' PHE . 66.2 tp60 -150.66 168.6 23.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 122.215 -0.303 . . . . 0.0 111.067 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HD2' ' A' ' 60' ' ' ARG . 25.0 t80 -63.4 129.62 41.01 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.868 -0.52 . . . . 0.0 110.018 174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.63 -4.1 79.08 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.3 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 94.0 p -80.14 161.87 25.04 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -131.16 139.19 49.73 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.935 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 76' ' ' VAL . 42.8 pt -128.98 160.54 39.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.001 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -111.73 142.43 44.09 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.196 -178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HE2' ' HB3' ' A' ' 102' ' ' ALA . 72.5 m-85 -116.53 82.09 1.73 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.576 1.173 . . . . 0.0 113.006 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 73' ' ' MET . 19.7 p -81.34 157.15 25.16 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.645 ' HB3' HD22 ' A' ' 71' ' ' ASN . 76.7 m -117.97 -48.75 2.54 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 69.6 m -148.14 168.7 21.76 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.148 -171.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -103.3 100.78 10.68 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.36 51.68 0.66 Allowed Glycine 0 C--N 1.254 -3.985 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.577 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.8 p90 -150.26 170.83 18.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 17.7 ptp180 -129.21 138.87 51.96 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.973 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 34.6 tp -99.55 120.07 39.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 119' ' ' ILE . 91.6 mt -65.32 -43.52 94.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 112.984 -1.917 . . . . 0.0 113.732 -172.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.785 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -106.98 -118.47 4.36 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.149 -176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 t -96.47 121.25 38.08 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.21 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 78.9 p -78.42 -14.26 59.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.448 1.099 . . . . 0.0 111.193 175.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.1 m -134.65 151.03 50.74 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.364 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB3' ' HE2' ' A' ' 88' ' ' TYR . . . -127.87 147.36 50.45 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 80.9 m -121.72 130.33 53.36 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.007 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 122.45 24.18 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.123 0.963 . . . . 0.0 112.877 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -128.68 164.34 31.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 113.241 -1.8 . . . . 0.0 109.575 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.832 HD13 HG12 ' A' ' 111' ' ' VAL . 49.7 mm -82.02 119.27 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.412 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.637 ' OG ' HG12 ' A' ' 112' ' ' ILE . 15.0 m -67.78 -39.84 84.05 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.298 1.047 . . . . 0.0 111.505 174.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.82 -75.43 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.341 -1.754 . . . . 0.0 108.771 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -94.7 -3.0 50.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.387 0.613 . . . . 0.0 110.209 176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 171.05 17.8 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.276 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 106' ' ' ILE . 35.4 m -115.88 129.8 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.349 178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.637 HG12 ' OG ' ' A' ' 107' ' ' SER . 46.8 pt -133.7 168.42 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 122.033 -0.417 . . . . 0.0 111.312 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.52 144.85 27.68 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.356 1.063 . . . . 0.0 109.913 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 105' ' ' ILE . 8.4 p-10 -87.8 0.59 55.58 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -169.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -59.48 138.97 57.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.397 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.36 -40.68 96.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.51 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -175.6 152.2 1.32 Allowed Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.52 135.67 58.5 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 120.712 1.29 . . . . 0.0 109.372 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.785 HD13 ' HA3' ' A' ' 98' ' ' GLY . 7.1 mt -135.35 133.83 52.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.981 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 99.7 m -152.3 111.94 3.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 119.183 0.901 . . . . 0.0 111.707 166.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 11.8 t70 -63.05 -48.81 77.09 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.862 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 122' ' ' ARG . 25.7 ttm-85 . . . . . 0 C--O 1.256 1.403 0 O-C-N 124.335 1.022 . . . . 0.0 113.492 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 49' ' ' SER . 1.3 m -60.29 -15.93 29.7 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 114.887 1.439 . . . . 0.0 114.887 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.807 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 60.4 32.4 20.6 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.983 0.897 . . . . 0.0 111.41 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.804 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.87 127.76 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.65 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.922 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 19.1 Cg_endo -55.86 -46.68 29.65 Favored 'Trans proline' 0 C--N 1.325 -0.703 0 C-N-CA 121.559 1.506 . . . . 0.0 113.782 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 22.4 pt-20 153.89 171.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 125.064 1.477 . . . . 0.0 108.514 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -82.19 118.85 23.4 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.464 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 14.9 tp -120.29 110.01 36.37 Favored Pre-proline 0 N--CA 1.426 -1.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.16 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 8' ' ' LEU . 36.2 Cg_endo -64.53 -22.77 64.91 Favored 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 122.858 2.372 . . . . 0.0 111.802 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 19.5 m-30 -63.2 -42.34 99.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 122.739 1.257 . . . . 0.0 110.095 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -116.07 148.1 40.59 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.248 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.3 79.51 65.76 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.185 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 87.9 Cg_endo -68.97 154.7 70.35 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.914 1.743 . . . . 0.0 112.502 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.7 p -96.74 -1.42 46.46 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.843 -168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.498 HE22 ' CB ' ' A' ' 28' ' ' LEU . 1.3 mt-30 -118.14 -35.97 3.7 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-O 122.259 1.028 . . . . 0.0 110.779 -170.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' GLU . 4.4 tt -62.16 -40.78 97.14 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -170.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.4 t -38.15 -45.72 0.97 Allowed 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -96.76 -24.92 15.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.881 0.848 . . . . 0.0 109.015 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 10.3 pt-20 -136.39 83.85 2.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.479 1.609 . . . . 0.0 112.138 -171.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.804 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 91.3 m-85 -65.09 -37.06 86.3 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 111.796 -2.456 . . . . 0.0 111.29 174.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.807 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 89.8 mt-10 -112.4 141.26 46.35 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.577 -169.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD1' HD11 ' A' ' 28' ' ' LEU . 50.2 m-85 -137.67 162.85 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.809 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.01 161.08 44.4 Favored 'Trans proline' 0 CA--C 1.556 1.593 0 C-N-CA 124.438 3.425 . . . . 0.0 113.173 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.4 mt -68.24 134.94 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 CA-C-O 121.413 0.625 . . . . 0.0 110.057 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 20.27 47.36 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.747 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.5 m -119.24 128.94 54.66 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 14.3 m-85 -103.43 127.24 50.84 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.375 0.607 . . . . 0.0 110.382 -173.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 22' ' ' PHE . 11.2 mp -89.66 143.89 26.44 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 20.7 t-20 -88.67 107.0 18.7 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.417 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.01 139.61 50.09 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 125.369 1.467 . . . . 0.0 112.773 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.4 tt0 -129.19 143.84 51.0 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.598 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 88.5 m -93.95 140.9 29.14 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -61.56 163.14 12.6 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.77 145.85 97.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.386 1.391 . . . . 0.0 111.745 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 94.19 3.17 63.63 Favored Glycine 0 N--CA 1.427 -1.962 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.957 -177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 78.4 m-85 -107.66 128.68 54.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.231 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 t -63.62 -42.21 98.21 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.644 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.4 145.27 48.74 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 120.658 -0.782 . . . . 0.0 115.025 -166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -82.65 110.7 23.86 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.19 141.3 82.05 Favored 'Trans proline' 0 N--CA 1.441 -1.611 0 C-N-CA 120.692 0.928 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 78.5 m-85 -145.02 157.87 43.99 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 9.6 m -70.58 148.44 48.15 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 54' ' ' ALA . 47.1 pt -103.98 129.22 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.078 0.466 . . . . 0.0 109.83 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 52' ' ' THR . 2.1 mp -120.44 129.34 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.232 -176.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.73 ' O ' HG12 ' A' ' 24' ' ' ILE . 94.6 m -57.81 44.53 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.766 HD12 HG22 ' A' ' 52' ' ' THR . 94.2 mt -63.39 -42.8 98.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 29.7 ttmt -104.22 113.44 26.99 Favored 'General case' 0 CA--C 1.454 -2.712 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 54.13 33.88 18.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.138 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 1.9 m 50.38 27.34 2.7 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.384 -172.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.591 ' O ' ' CD1' ' A' ' 51' ' ' TRP . 77.7 t -91.62 -54.85 6.83 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.073 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.473 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.591 ' CD1' ' O ' ' A' ' 50' ' ' VAL . 85.7 m95 153.58 167.99 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 C-N-CA 129.272 3.029 . . . . 0.0 110.171 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.766 HG22 HD12 ' A' ' 46' ' ' LEU . 70.3 p -67.66 -34.65 77.37 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.351 177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.01 65.79 0.08 OUTLIER Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.231 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.45 26.05 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -111.66 155.93 22.64 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.133 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 t0 55.15 18.25 2.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.475 1.131 . . . . 0.0 109.378 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' NH2' ' HB2' ' A' ' 41' ' ' PHE . 56.2 mmm-85 -65.88 -39.56 90.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.976 -176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 10' ' ' PHE . 77.6 m -116.91 140.36 49.55 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -130.32 137.72 50.08 Favored 'General case' 0 N--CA 1.427 -1.618 0 C-N-CA 119.198 -1.001 . . . . 0.0 112.683 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 52.4 ptt85 -81.32 166.35 20.57 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 126.008 1.723 . . . . 0.0 110.049 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HB3' HG13 ' A' ' 111' ' ' VAL . 59.8 tptt -92.33 139.84 30.2 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.287 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 t -70.15 140.48 52.61 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.31 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 51.8 m -89.31 153.02 21.21 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.905 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -132.3 150.65 52.11 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' N ' ' HD3' ' A' ' 66' ' ' PRO . 5.6 t-20 -126.11 60.78 37.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 9.4 Cg_endo -96.98 12.69 1.0 Allowed 'Trans proline' 1 CA--C 1.612 4.407 0 C-N-CA 122.01 1.807 . . . . 0.0 114.145 165.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HG2' ' OH ' ' A' ' 88' ' ' TYR . 90.9 Cg_endo -86.38 9.65 3.94 Favored 'Trans proline' 1 C--N 1.418 4.198 0 C-N-CA 123.232 2.622 . . . . 0.0 111.836 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -35.92 152.41 0.08 OUTLIER Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.711 1.604 . . . . 0.0 113.64 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' HG23 ' A' ' 74' ' ' VAL . 56.9 Cg_endo -72.28 -179.67 4.21 Favored 'Trans proline' 0 CA--C 1.496 -1.413 0 C-N-CA 123.758 2.972 . . . . 0.0 111.606 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.19 -45.54 98.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.132 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.725 HD21 ' HG3' ' A' ' 73' ' ' MET . 0.8 OUTLIER -92.28 -2.9 56.15 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 116.762 -1.975 . . . . 0.0 110.23 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.13 26.21 64.66 Favored Glycine 0 CA--C 1.563 3.062 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.725 ' HG3' HD21 ' A' ' 71' ' ' ASN . 65.1 mtt -64.78 -38.59 91.5 Favored 'General case' 0 N--CA 1.512 2.632 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 69.3 t 2.28 106.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -169.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 78.1 m-70 -87.92 118.41 27.44 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.3 p -104.66 103.76 15.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.878 0.847 . . . . 0.0 110.817 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.6 mt -63.61 -48.06 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.85 -8.49 24.03 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 97.46 3.8 58.45 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 115.496 0.958 . . . . 0.0 115.496 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.546 HG12 HG21 ' A' ' 76' ' ' VAL . 48.9 mm 89.6 80.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.816 ' HG2' ' N ' ' A' ' 82' ' ' PHE . 51.7 tt0 -149.97 169.27 21.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.009 0.433 . . . . 0.0 111.902 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.816 ' N ' ' HG2' ' A' ' 81' ' ' GLN . 9.8 t80 -59.39 126.98 29.82 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 167.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.4 -11.28 72.58 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.24 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.8 m -74.79 149.64 39.63 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.664 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.33 135.97 53.75 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.769 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.9 pt -128.04 161.55 36.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.924 -176.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 75' ' ' HIS . 1.7 mptt -109.18 142.44 39.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.231 0.539 . . . . 0.0 110.383 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.527 ' OH ' ' HG2' ' A' ' 67' ' ' PRO . 19.4 m-85 -107.36 42.41 1.33 Allowed 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 124.667 1.187 . . . . 0.0 113.018 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 5.8 m -65.45 129.51 39.99 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.591 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' A' ' 94' ' ' TYR . 53.8 m -81.93 -34.88 29.64 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.408 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 13.5 m -147.87 154.52 40.52 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.955 -1.929 . . . . 0.0 109.944 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.0 tptt -62.59 -45.66 91.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 118.252 0.478 . . . . 0.0 111.949 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 91' ' ' THR . . . -110.93 72.14 0.21 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.161 -1.018 . . . . 0.0 113.239 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -151.34 171.37 17.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -178.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 121' ' ' ASP . 9.3 ptm180 -127.88 149.12 50.44 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.051 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.922 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 8.7 tt -107.72 125.01 50.86 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.723 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.1 mm -64.28 -45.5 95.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -95.27 -123.69 4.14 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.135 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB3' ' HG3' ' A' ' 115' ' ' GLN . 38.4 t -75.63 89.35 2.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.076 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.507 ' N ' HD22 ' A' ' 96' ' ' LEU . 16.7 m -61.17 -37.9 84.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.729 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.6 p -132.47 146.17 51.73 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.653 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.67 147.22 37.23 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.5 m -121.97 130.48 53.35 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -81.01 125.16 29.82 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.292 0.568 . . . . 0.0 112.397 178.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -129.81 162.2 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.566 -178.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.739 HD13 HG12 ' A' ' 111' ' ' VAL . 46.9 mm -83.21 126.68 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.048 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.674 ' HB3' HD12 ' A' ' 112' ' ' ILE . 95.7 p -88.91 -14.29 37.1 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.889 0.852 . . . . 0.0 109.286 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 124.01 -74.07 0.4 Allowed Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.59 -40.25 95.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.415 0.626 . . . . 0.0 112.302 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 61' ' ' LYS . 15.4 t -142.89 -176.76 5.02 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.54 -169.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 82' ' ' PHE . 16.5 m -114.82 131.08 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.676 0.79 . . . . 0.0 109.452 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 107' ' ' SER . 0.2 OUTLIER -128.89 162.41 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 O-C-N 122.207 -0.308 . . . . 0.0 110.697 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.93 144.26 25.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.7 3.52 50.52 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -171.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.589 ' HG3' ' HB3' ' A' ' 99' ' ' SER . 58.2 tt0 -55.67 126.96 27.71 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 117' ' ' THR . 97.1 mt-10 -66.26 -42.4 88.56 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.29 0.567 . . . . 0.0 110.608 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 13.9 t 168.4 142.28 0.06 OUTLIER Pre-proline 0 C--O 1.247 0.974 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.67 138.44 75.01 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 CA-C-N 119.125 0.723 . . . . 0.0 111.541 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.922 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.5 mt -132.33 130.6 60.4 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 C-N-CA 123.339 0.656 . . . . 0.0 109.424 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.56 98.66 6.14 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 117.5 -1.68 . . . . 0.0 111.734 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 64.6 t0 -63.48 -43.36 97.51 Favored 'General case' 0 C--N 1.378 1.817 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 52.7 mmm-85 . . . . . 0 C--O 1.266 1.925 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.471 0.653 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 14.9 m -73.27 -19.76 60.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.562 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.82 38.08 24.73 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 58.62 122.44 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.953 0.901 . . . . 0.0 112.263 176.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HG2' HD11 ' A' ' 16' ' ' LEU . 24.3 Cg_endo -68.44 -60.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 120.107 0.538 . . . . 0.0 110.921 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 14.0 pt-20 158.59 168.6 0.01 OUTLIER 'General case' 0 C--O 1.244 0.815 0 C-N-CA 125.602 1.561 . . . . 0.0 107.466 173.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -82.0 117.96 22.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 10' ' ' PHE . 5.4 tt -93.81 113.45 60.49 Favored Pre-proline 0 N--CA 1.41 -2.475 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.77 -26.63 75.07 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.576 1.517 . . . . 0.0 113.417 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.734 ' O ' ' HG3' ' A' ' 33' ' ' ARG 0.274 7.8 m-30 -63.68 -42.76 97.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.72 138.74 37.98 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.734 -166.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 107.2 41.09 Favored Pre-proline 0 C--N 1.311 -1.065 0 O-C-N 121.22 -0.925 . . . . 0.0 112.563 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 13.9 Cg_exo -63.59 145.82 92.02 Favored 'Trans proline' 0 CA--C 1.487 -1.837 0 C-N-CA 123.644 2.896 . . . . 0.0 111.744 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 15' ' ' GLN . 44.5 p -69.0 -31.41 70.22 Favored 'General case' 0 C--N 1.258 -3.409 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.349 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.585 HE22 ' CA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -98.16 -34.53 10.71 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.475 -166.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 5' ' ' PRO . 7.4 tt -61.87 -41.57 98.0 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 124.704 1.201 . . . . 0.0 114.097 -170.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.3 t -58.73 -44.16 90.38 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.474 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -99.34 -1.63 38.38 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -113.62 -71.75 0.74 Allowed 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 120.753 0.311 . . . . 0.0 110.251 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 73.8 m-85 76.72 -36.52 0.26 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.318 1.847 . . . . 0.0 114.413 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -109.04 127.84 54.46 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.657 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 28' ' ' LEU . 86.3 m-85 -141.87 157.49 64.33 Favored Pre-proline 0 CA--C 1.557 1.224 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.42 162.13 40.89 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 124.479 3.453 . . . . 0.0 113.226 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 45' ' ' CYS . 2.9 mp -70.4 133.18 32.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.89 0 CA-C-O 121.702 0.763 . . . . 0.0 111.31 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.15 -5.24 59.13 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 114.134 -1.393 . . . . 0.0 112.647 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 21.6 m -69.23 134.98 49.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 110.659 176.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 44' ' ' ILE . 45.9 m-85 -105.41 131.35 52.95 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 42' ' ' SER . 10.6 mp -109.39 137.95 46.48 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.551 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 46.8 t30 -88.88 107.59 19.08 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.847 -171.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.688 ' CD1' ' HG3' ' A' ' 13' ' ' PRO . 3.8 m-85 -104.81 137.47 42.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-N 113.866 -1.516 . . . . 0.0 111.948 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -120.73 130.68 54.15 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.179 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 36' ' ' TYR . 96.9 m -86.71 146.59 26.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 118.422 0.556 . . . . 0.0 110.013 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.734 ' HG3' ' O ' ' A' ' 10' ' ' PHE . 11.6 mtp180 -57.77 158.62 11.72 Favored Pre-proline 0 C--O 1.246 0.918 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.89 143.63 99.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 CA-C-N 118.714 0.577 . . . . 0.0 111.094 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.592 ' CA ' HG21 ' A' ' 106' ' ' ILE . . . 92.99 -7.59 76.51 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 33' ' ' ARG . 84.5 m-85 -82.48 138.35 34.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 117.957 0.878 . . . . 0.0 113.364 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -85.91 -7.88 58.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.015 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 57' ' ' ARG . . . -77.81 171.51 55.15 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.495 -0.86 . . . . 0.0 114.015 -176.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -92.26 122.52 64.6 Favored Pre-proline 0 CA--C 1.485 -1.52 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -31.49 93.7 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.44 0.76 . . . . 0.0 110.321 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' HB3' ' NH2' ' A' ' 57' ' ' ARG . 39.9 t80 23.0 -153.53 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.214 0 C-N-CA 127.269 2.227 . . . . 0.0 114.14 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 58.5 m -133.38 152.21 51.9 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 47.6 pt -99.85 129.88 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 170.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.649 ' H ' ' CG2' ' A' ' 52' ' ' THR . 1.9 mp -118.57 128.58 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 51' ' ' TRP . 72.0 m -60.21 97.88 0.05 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.199 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 44' ' ' ILE . 88.9 mt -125.89 -55.87 1.48 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.618 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 116.85 14.66 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.501 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 m120 55.47 32.94 19.96 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m 54.93 16.91 1.62 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.234 -174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 99.3 t -91.91 -78.07 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.285 0 C-N-CA 122.246 0.218 . . . . 0.0 110.924 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 98.2 m95 -153.38 -163.72 1.74 Allowed 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 122.605 0.362 . . . . 0.0 110.157 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.649 ' CG2' ' H ' ' A' ' 44' ' ' ILE . 3.0 p -93.09 -5.57 50.03 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.11 -12.5 60.46 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 44.87 36.52 1.91 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.508 0.723 . . . . 0.0 112.713 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 60.2 pttt -74.36 139.53 44.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.335 -175.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t0 44.73 37.91 2.52 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.468 0.707 . . . . 0.0 111.61 164.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.564 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 25.5 mmm180 -64.31 -39.57 94.18 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.744 -170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.24 147.94 43.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -125.53 142.88 51.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.119 -1.032 . . . . 0.0 112.617 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 82' ' ' PHE . 2.2 ptm180 -125.4 144.69 50.39 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 126.699 2.0 . . . . 0.0 107.829 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 62' ' ' SER . 88.5 tttt -111.94 156.6 21.83 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-O 121.209 0.528 . . . . 0.0 111.184 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' GLN . 6.2 m -69.31 140.98 54.39 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.623 ' SG ' ' CE2' ' A' ' 113' ' ' TRP 0.384 0.9 OUTLIER -101.99 -169.85 1.74 Allowed 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 117.852 -1.539 . . . . 0.0 110.996 178.244 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -143.02 153.6 43.14 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.722 -172.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.98 52.83 10.25 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 24.8 Cg_endo -66.96 -31.13 38.39 Favored 'Trans proline' 0 CA--C 1.587 3.161 0 C-N-CA 121.938 1.759 . . . . 0.0 115.483 176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 21.8 Cg_endo -57.74 -35.68 98.7 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 121.811 1.674 . . . . 0.0 114.561 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 2.7 p30 37.59 143.48 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.803 ' CG ' HG23 ' A' ' 74' ' ' VAL . 7.5 Cg_exo -71.21 156.57 59.04 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.295 3.33 . . . . 0.0 112.354 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.97 -45.29 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.06 12.85 36.18 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.41 31.2 28.33 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.895 -1.621 . . . . 0.0 111.298 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.952 ' SD ' ' HA ' ' A' ' 90' ' ' CYS . 55.9 mtt -64.09 -38.27 90.46 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.724 1.609 . . . . 0.0 113.068 -171.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' CG ' ' A' ' 69' ' ' PRO . 52.3 t -67.37 132.57 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 122.238 1.018 . . . . 0.0 113.691 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -113.87 123.5 49.93 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.248 171.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 86' ' ' ILE . 4.7 p -98.31 108.6 22.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.089 0.947 . . . . 0.0 110.836 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.641 HD11 ' HE3' ' A' ' 87' ' ' LYS . 96.7 mt -64.58 -45.4 95.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.369 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.41 -50.58 3.11 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.07 26.12 0.16 Allowed Glycine 0 CA--C 1.534 1.261 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.257 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 63' ' ' CYS . 40.5 mm 61.14 92.44 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 117.512 0.656 . . . . 0.0 110.545 177.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 66.4 tp60 -173.15 165.34 4.9 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 60.3 t80 -63.8 130.42 44.1 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 118.92 -1.112 . . . . 0.0 108.995 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.79 16.57 65.35 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.292 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.0 t -110.51 137.14 48.6 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.952 -0.734 . . . . 0.0 110.146 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 55.2 tt0 -120.46 134.96 55.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.667 1.187 . . . . 0.0 110.349 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.52 HD12 ' CZ3' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -127.65 163.54 30.89 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HE3' HD11 ' A' ' 77' ' ' ILE . 2.7 mptm? -103.59 145.29 30.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.151 0.977 . . . . 0.0 112.936 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -117.37 61.19 0.75 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.877 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' A' ' 73' ' ' MET . 19.7 p -74.71 156.91 36.13 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.952 ' HA ' ' SD ' ' A' ' 73' ' ' MET . 97.0 m -114.26 -119.66 0.31 Allowed 'General case' 0 C--N 1.272 -2.782 0 CA-C-O 122.584 1.183 . . . . 0.0 110.349 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 14.1 m -81.4 162.19 23.45 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 126.705 2.002 . . . . 0.0 109.014 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -63.83 -48.57 76.26 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 91' ' ' THR . . . -97.74 64.55 0.88 Allowed Glycine 0 CA--C 1.471 -2.677 0 C-N-CA 120.135 -1.031 . . . . 0.0 111.126 -172.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.773 ' CE2' ' HB2' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -150.44 169.71 20.82 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.433 0.635 . . . . 0.0 109.312 -171.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 95.6 mtt-85 -125.72 147.88 49.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 171.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 15.6 tp -100.44 118.32 36.42 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.924 -1.911 . . . . 0.0 106.435 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.0 mm -65.82 -44.79 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.869 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HD13 ' A' ' 119' ' ' ILE . . . -102.04 -141.9 12.09 Favored Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.819 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' OE1' ' A' ' 115' ' ' GLN . 5.3 m -71.84 115.32 10.91 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.694 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.7 t -62.57 -42.39 99.52 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.588 1.155 . . . . 0.0 112.053 174.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -130.2 151.71 50.42 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -126.36 147.49 49.74 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.119 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 60.7 m -124.48 132.72 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 123.685 0.615 . . . . 0.0 111.281 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 79.6 m -70.17 122.08 18.78 Favored 'General case' 0 CA--C 1.559 1.297 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.459 HD12 ' CG ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -129.14 162.69 36.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.665 HD13 HG12 ' A' ' 111' ' ' VAL . 32.1 mm -82.22 123.03 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 118.46 -1.296 . . . . 0.0 109.878 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.1 t -63.45 -42.62 98.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.477 1.132 . . . . 0.0 108.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 154.4 -70.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.213 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -94.01 -2.9 52.34 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 122.765 -0.256 . . . . 0.0 110.771 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -152.11 172.39 16.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.045 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.665 HG12 HD13 ' A' ' 106' ' ' ILE . 20.0 m -116.14 130.92 70.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.5 pt -129.54 166.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.753 -174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CE2' ' SG ' ' A' ' 63' ' ' CYS . 98.9 m95 -93.41 147.29 23.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.285 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 33.4 m-20 -66.63 -16.75 64.42 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.678 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.627 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 65.0 tp60 -61.34 126.58 27.87 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.444 0.64 . . . . 0.0 110.367 -177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.7 tt0 -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.577 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t 161.88 140.84 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.95 139.66 80.62 Favored 'Trans proline' 0 C--O 1.241 0.664 0 CA-C-N 119.88 0.993 . . . . 0.0 110.583 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.632 ' O ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -131.08 126.85 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 86.4 m -114.66 126.74 55.22 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.588 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 42.3 t0 -63.45 -39.62 94.96 Favored 'General case' 0 CA--C 1.478 -1.822 0 CA-C-O 122.086 0.946 . . . . 0.0 109.628 -177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 . . . . . 0 C--O 1.261 1.69 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.509 175.421 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.943 0.402 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 22' ' ' PHE . 22.1 m -76.16 -20.98 57.06 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 59.13 39.69 22.73 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.448 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.705 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . . . 63.43 127.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 C-N-CA 124.126 0.971 . . . . 0.0 112.779 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 9.4 Cg_endo -58.41 -58.8 0.63 Allowed 'Trans proline' 0 CA--C 1.501 -1.154 0 C-N-CA 121.38 1.387 . . . . 0.0 114.398 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 7' ' ' TRP . 44.3 tp10 160.77 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.708 1.203 . . . . 0.0 107.835 -171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.484 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 81.3 t90 -90.27 124.6 35.02 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 172.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 10' ' ' PHE . 4.6 tt -118.1 107.08 44.25 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-O 121.373 0.606 . . . . 0.0 112.218 -172.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.97 -21.75 49.32 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.652 2.901 . . . . 0.0 115.263 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.38 7.53 45.92 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.41 -0.806 . . . . 0.0 112.352 -178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.596 ' C ' ' HD3' ' A' ' 13' ' ' PRO . . . -131.04 149.08 52.78 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.019 0.437 . . . . 0.0 111.619 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -120.87 63.45 11.21 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HD3' ' C ' ' A' ' 11' ' ' ALA . 15.6 Cg_exo -62.58 146.64 95.4 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 123.341 2.694 . . . . 0.0 112.232 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -93.3 -8.01 43.28 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.523 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.78 ' O ' ' HB2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -120.05 -32.41 4.2 Favored 'General case' 0 C--O 1.179 -2.656 0 CA-C-O 121.952 0.882 . . . . 0.0 111.986 -172.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 51.5 tp -61.79 -39.51 91.94 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.84 -174.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -51.53 -42.29 61.66 Favored 'General case' 0 C--N 1.263 -3.158 0 O-C-N 124.681 1.238 . . . . 0.0 111.413 -167.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.23 8.45 6.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.264 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.78 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 91.3 mt-10 -133.45 71.59 1.47 Allowed 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.705 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 57.8 m-85 -65.28 -37.44 87.18 Favored 'General case' 1 C--N 1.237 -4.294 0 CA-C-N 112.755 -2.021 . . . . 0.0 111.977 -174.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.44 139.27 51.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 28' ' ' LEU . 82.1 m-85 -148.61 160.04 37.02 Favored Pre-proline 0 C--O 1.209 -1.028 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.042 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.09 160.98 46.04 Favored 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.313 3.342 . . . . 0.0 113.184 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 45' ' ' CYS . 96.3 mt -65.72 136.13 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 121.582 0.706 . . . . 0.0 109.686 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.67 12.44 59.42 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.193 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 92.2 m -104.57 129.39 52.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -101.15 130.84 47.29 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 22' ' ' PHE . 10.9 mp -102.45 136.58 42.02 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.183 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -90.4 104.36 16.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.352 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -108.18 131.89 54.19 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.266 -1.333 . . . . 0.0 111.331 174.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -120.91 128.22 52.57 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 80.6 m -88.86 149.55 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . 25.2 mmm180 -54.09 146.31 30.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.6 146.24 97.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.853 1.702 . . . . 0.0 111.668 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.686 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 85.55 17.52 61.94 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.288 -0.958 . . . . 0.0 114.426 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 33' ' ' ARG . 58.0 m-85 -104.48 132.52 50.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.078 0.942 . . . . 0.0 112.061 174.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 m -61.34 -42.22 98.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.473 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.02 142.31 31.61 Favored Glycine 0 N--CA 1.436 -1.315 0 C-N-CA 119.719 -1.229 . . . . 0.0 112.333 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.43 126.14 67.67 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -62.89 142.1 87.06 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.926 1.75 . . . . 0.0 111.634 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.35 150.25 52.19 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.565 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -70.84 144.87 50.61 Favored 'General case' 0 N--CA 1.407 -2.597 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.098 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 pt -98.77 128.44 50.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.3 mp -120.15 129.11 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -59.63 29.71 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.496 1.119 . . . . 0.0 113.794 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 96.1 mt -64.18 -41.98 96.88 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 125.642 1.577 . . . . 0.0 112.757 -174.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.606 ' HB3' ' O ' ' A' ' 51' ' ' TRP . 13.7 tppt? -91.71 108.6 20.02 Favored 'General case' 0 CA--C 1.481 -1.709 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.932 -170.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 54.96 35.08 23.74 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.4 1.062 . . . . 0.0 110.584 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.97 28.97 16.98 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.786 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 40.0 t -116.44 -97.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.606 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 97.8 m95 -149.74 156.74 42.36 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.217 0.462 . . . . 0.0 110.076 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.423 ' HB ' HD12 ' A' ' 46' ' ' LEU . 10.1 t -62.01 -43.16 99.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.591 ' O ' ' HD3' ' A' ' 57' ' ' ARG . . . 176.12 96.35 0.1 Allowed Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.014 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.53 52.26 0.72 Allowed 'General case' 0 C--N 1.312 -1.036 0 O-C-N 122.861 -0.2 . . . . 0.0 111.46 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 56' ' ' ASP . 65.1 pttt -111.6 -142.67 0.39 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.582 -0.074 . . . . 0.0 110.869 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 34.0 t70 -65.28 60.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.835 1.254 . . . . 0.0 109.917 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 52.4 mmm-85 -66.34 -39.73 89.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.112 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 36' ' ' TYR . 84.8 m -115.65 145.89 42.31 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.634 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -130.97 141.84 50.29 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.011 -163.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 81' ' ' GLN . 1.5 ptm180 -101.6 147.69 26.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 124.427 1.091 . . . . 0.0 109.224 176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.303 54.0 mtpt -95.2 153.42 17.67 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 -175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.3 t -66.73 137.36 56.61 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.99 -2.368 . . . . 0.0 108.73 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.637 ' HA ' HG23 ' A' ' 111' ' ' VAL . 99.3 m -89.46 156.76 18.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.373 0.669 . . . . 0.0 110.547 -174.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.61 150.7 46.56 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.463 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -148.82 43.22 0.29 Allowed Pre-proline 0 C--N 1.281 -2.404 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.083 173.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 9.8 Cg_endo -54.17 -22.5 25.95 Favored 'Trans proline' 0 C--N 1.4 3.255 0 C-N-CA 123.003 2.469 . . . . 0.0 113.505 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 66' ' ' PRO 0.292 34.6 Cg_exo -51.34 -40.72 61.41 Favored 'Trans proline' 0 C--N 1.391 2.794 0 CA-C-N 119.841 0.979 . . . . 0.0 109.596 174.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.607 ' OD1' ' HD2' ' A' ' 69' ' ' PRO . 19.7 t70 54.15 150.31 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 O-C-N 124.79 1.306 . . . . 0.0 113.55 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 47.3 Cg_endo -63.96 153.35 76.38 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 122.52 2.147 . . . . 0.0 109.194 173.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.07 -45.18 99.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 119.125 -0.464 . . . . 0.0 111.541 -169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -64.02 -40.25 95.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.576 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.77 36.11 2.1 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.53 ' N ' ' HG2' ' A' ' 69' ' ' PRO . 95.1 mtp -122.53 87.02 2.68 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.934 -0.633 . . . . 0.0 112.212 -174.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.68 138.79 52.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -114.71 144.07 44.04 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.7 p -122.12 122.82 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 C-N-CA 118.005 -1.478 . . . . 0.0 110.964 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.452 HD11 ' HE2' ' A' ' 87' ' ' LYS . 96.4 mt -65.54 -44.11 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 114.537 -1.211 . . . . 0.0 113.741 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.7 mmtt -108.48 7.27 26.81 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.596 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 84.02 18.23 63.52 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 119.272 -1.442 . . . . 0.0 113.377 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 76' ' ' VAL . 49.2 mm 64.97 79.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.235 1.017 . . . . 0.0 113.096 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 9.0 mm100 -145.46 166.49 25.5 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.873 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -61.01 129.82 43.29 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.182 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.58 77.79 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.355 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 21.4 m -74.95 150.27 39.12 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 177.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.69 136.14 52.87 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.941 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 76' ' ' VAL . 44.3 pt -128.78 164.51 30.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.93 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HE2' HD11 ' A' ' 77' ' ' ILE . 5.8 mptp? -109.02 140.54 42.41 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.325 0.391 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 96' ' ' LEU . 27.9 m-85 -113.95 84.06 1.97 Allowed 'General case' 0 CA--C 1.469 -2.17 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -80.03 158.35 26.52 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.296 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.65 ' HB3' ' CE2' ' A' ' 94' ' ' TYR . 4.9 t -125.14 -33.69 2.84 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.966 0.888 . . . . 0.0 110.772 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 47.1 m -145.65 151.2 37.68 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -63.08 -45.26 92.98 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.171 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 91' ' ' THR . . . -113.49 76.05 0.24 Allowed Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.683 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.685 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.8 OUTLIER -150.93 165.54 33.37 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 121' ' ' ASP . 78.7 mmt-85 -102.87 135.81 43.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 100' ' ' SER . 40.4 tp -97.35 117.41 31.51 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.273 172.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.5 mm -66.7 -44.31 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.971 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.556 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -92.18 -126.87 3.98 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.59 ' HB2' ' HG3' ' A' ' 115' ' ' GLN . 58.1 m -92.17 120.16 32.5 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.714 0.768 . . . . 0.0 111.419 -175.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 96' ' ' LEU . 5.0 m -81.88 -4.61 56.94 Favored 'General case' 0 CA--C 1.505 -0.756 0 C-N-CA 126.263 1.825 . . . . 0.0 109.68 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 28.0 p -150.52 157.19 42.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.604 176.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 113' ' ' TRP . . . -135.8 148.46 48.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.597 1.186 . . . . 0.0 108.333 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.0 m -120.27 130.02 54.3 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 111' ' ' VAL . 34.6 t -87.07 123.37 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.405 1.098 . . . . 0.0 113.046 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.87 161.74 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.38 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.775 HD13 HG12 ' A' ' 111' ' ' VAL . 32.8 mm -80.95 122.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.337 0 C-N-CA 119.464 -0.895 . . . . 0.0 111.288 -172.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.6 m -64.87 -40.65 95.47 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.952 1.358 . . . . 0.0 109.742 167.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 138.82 -71.84 0.44 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 113.443 -1.708 . . . . 0.0 108.945 -173.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.81 -34.47 77.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.348 0.594 . . . . 0.0 110.097 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 177.73 8.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.036 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG12 HD13 ' A' ' 106' ' ' ILE . 9.7 m -111.45 130.5 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.9 pt -128.39 164.25 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.478 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.495 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 35.2 m95 -97.36 146.32 25.29 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.596 0.759 . . . . 0.0 110.604 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -85.13 0.61 51.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.59 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 56.3 tt0 -61.41 139.52 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -64.93 -41.34 95.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.731 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 5.1 t 165.97 146.36 0.05 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.445 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.0 Cg_exo -62.11 143.66 94.98 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.544 2.163 . . . . 0.0 111.774 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.738 HG21 ' HB ' ' A' ' 97' ' ' ILE . 69.6 mt -140.45 148.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 32.5 m -138.3 112.13 8.37 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 121.603 -0.686 . . . . 0.0 110.803 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 95' ' ' ARG . 25.5 t70 -63.45 -43.48 97.26 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.733 0.697 . . . . 0.0 111.549 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 . . . . . 0 C--O 1.255 1.359 0 O-C-N 125.148 1.53 . . . . 0.0 113.428 -178.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 23' ' ' PRO . 48.1 mt-30 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 53.8 m -72.37 -20.15 61.5 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.231 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 28.1 t30 59.86 39.31 20.62 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.583 0.706 . . . . 0.0 110.333 -178.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.54 122.87 0.02 OUTLIER Pre-proline 0 C--N 1.357 0.892 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.655 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' A' ' 51' ' ' TRP . 31.8 Cg_exo -54.22 -44.39 49.83 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.077 1.851 . . . . 0.0 111.902 -171.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 138.73 -174.79 0.0 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.668 2.387 . . . . 0.0 108.743 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -103.18 130.54 50.4 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.393 0.616 . . . . 0.0 109.864 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD22 ' NH2' ' A' ' 57' ' ' ARG . 51.6 tp -112.44 120.44 41.31 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.963 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.527 ' HD2' HD12 ' A' ' 8' ' ' LEU . 34.8 Cg_exo -53.87 -38.42 85.78 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 C-N-CA 122.333 2.022 . . . . 0.0 111.76 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 1.9 m-30 -62.74 -43.6 98.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.483 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . -125.41 146.0 49.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.305 -1.77 . . . . 0.0 114.43 -163.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.62 90.07 51.42 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.596 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.541 ' HG2' ' HB3' ' A' ' 16' ' ' LEU . 88.0 Cg_endo -67.76 150.55 79.04 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.598 2.199 . . . . 0.0 112.645 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -99.16 -4.72 31.5 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.304 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 29' ' ' ASN 0.256 24.8 mt-30 -98.59 -37.59 9.48 Favored 'General case' 0 C--O 1.187 -2.237 0 CA-C-O 122.922 1.344 . . . . 0.0 107.766 -175.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' HB3' ' HG2' ' A' ' 13' ' ' PRO . 8.0 tt -61.98 -40.46 95.68 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 113.056 -1.883 . . . . 0.0 113.892 -172.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.7 t -59.81 -44.03 94.19 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 123.823 0.702 . . . . 0.0 111.309 -169.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -115.41 5.36 14.54 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 92.9 mt-10 -115.57 -55.01 2.48 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.573 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 65.97 -38.08 0.28 Allowed 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 126.632 1.973 . . . . 0.0 114.503 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' A' ' 3' ' ' ASN . 68.6 mm-40 -112.3 133.02 54.65 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' HB3' HG21 ' A' ' 26' ' ' THR . 97.3 m-85 -129.97 145.27 56.47 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.741 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 52.7 Cg_exo -55.22 -32.84 82.29 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 125.153 3.902 . . . . 0.0 114.888 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 1.7 mp 111.47 147.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 125.197 1.399 . . . . 0.0 108.719 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.82 31.29 62.5 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.533 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.599 HG21 ' HB3' ' A' ' 22' ' ' PHE . 15.1 t -120.89 146.12 46.94 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.336 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -105.65 128.77 53.84 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.535 -178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' CB ' HE22 ' A' ' 15' ' ' GLN . 11.1 mp -100.49 137.91 38.26 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.697 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 54.3 t-20 -86.98 106.99 18.2 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.336 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 5.1 m-85 -111.46 138.81 47.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.08 -0.964 . . . . 0.0 113.14 174.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 82.7 tt0 -115.37 129.71 56.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.345 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.6 m -88.49 140.71 29.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.551 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -119.22 -50.59 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -166.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.727 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 11.4 Cg_endo -68.11 18.75 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.756 1.637 . . . . 0.0 115.054 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.47 50.03 Favored Glycine 0 C--O 1.212 -1.273 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.973 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.727 ' CE2' ' HG2' ' A' ' 34' ' ' PRO . 75.1 m-85 -66.33 141.32 58.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.803 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -61.74 -43.13 99.45 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.856 -172.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.25 150.58 51.73 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.155 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -84.65 120.76 74.42 Favored Pre-proline 0 N--CA 1.416 -2.146 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 175.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.25 145.35 98.75 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.443 1.428 . . . . 0.0 112.625 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.26 145.12 48.19 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.136 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 7.2 m -71.59 148.59 46.47 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.874 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.2 pt -108.86 133.19 54.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.416 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' THR . 1.7 mp -118.01 127.35 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.723 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.23 76.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.927 0.394 . . . . 0.0 110.238 179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 93.2 mt -94.87 -51.55 4.64 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -109.77 115.88 30.65 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.4 0.619 . . . . 0.0 111.114 -173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' HB2' HG23 ' A' ' 50' ' ' VAL . 25.9 m120 54.58 33.04 18.25 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 113.525 -1.67 . . . . 0.0 109.972 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 2' ' ' CYS . 48.0 t 51.77 10.49 0.11 Allowed 'General case' 0 CA--C 1.573 1.841 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.436 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 48' ' ' ASN . 73.9 t -64.61 -44.24 96.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 122.791 0.437 . . . . 0.0 110.153 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 98.0 m95 121.51 152.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 128.312 2.645 . . . . 0.0 109.19 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 44' ' ' ILE . 1.2 t -61.37 -47.17 87.09 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -174.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.5 102.3 0.16 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.02 0.58 54.97 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-O 121.932 0.873 . . . . 0.0 110.758 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HE2' ' OD2' ' A' ' 56' ' ' ASP . 87.2 tttt -80.51 139.22 36.48 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' OD2' ' HE2' ' A' ' 55' ' ' LYS . 99.6 m-20 58.78 29.42 18.69 Favored 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 126.025 1.73 . . . . 0.0 111.707 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' NH2' HD22 ' A' ' 8' ' ' LEU . 86.8 mtm180 -66.99 -39.81 87.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.71 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 3.1 m -126.98 146.3 50.38 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.032 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -125.31 138.74 54.08 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 118.585 -1.246 . . . . 0.0 113.847 -164.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' HB3' ' A' ' 82' ' ' PHE 0.25 39.0 ttm180 -96.17 147.9 23.27 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 127.971 2.508 . . . . 0.0 112.41 -178.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.828 ' HD3' ' N ' ' A' ' 62' ' ' SER . 10.4 tmtt? -112.67 144.19 42.6 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.828 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.3 t -69.66 140.6 53.65 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.565 ' H ' ' HA ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -82.94 160.63 22.02 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.047 0.939 . . . . 0.0 113.097 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -142.77 146.53 34.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.285 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.64 82.14 12.8 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 122.249 1.023 . . . . 0.0 111.361 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.569 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 30.1 Cg_endo -79.72 -22.5 7.69 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 173.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 66' ' ' PRO . 35.1 Cg_endo -60.88 -30.47 90.12 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 121.95 1.732 . . . . 0.0 112.354 177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 40.3 m-20 50.43 170.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.045 0.938 . . . . 0.0 112.58 -178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 1.1 ' HG3' HG23 ' A' ' 74' ' ' VAL . 6.6 Cg_exo -69.89 154.54 67.12 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.203 1.935 . . . . 0.0 110.613 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.76 -45.7 98.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.552 ' ND2' ' SD ' ' A' ' 73' ' ' MET . 31.6 p-10 -107.84 14.15 25.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 69' ' ' PRO . . . 77.07 29.29 57.12 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.552 ' SD ' ' ND2' ' A' ' 71' ' ' ASN . 25.8 mtp -93.57 10.23 33.47 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 117.693 0.747 . . . . 0.0 112.891 -172.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.1 HG23 ' HG3' ' A' ' 69' ' ' PRO . 48.4 t -68.06 133.12 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.78 144.31 43.19 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.628 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 79' ' ' GLY . 2.4 p -123.41 128.64 74.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.507 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.441 HD11 ' HE3' ' A' ' 87' ' ' LYS . 83.9 mt -85.93 -52.39 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 75.8 mmtt -98.4 -2.13 39.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 92.09 20.08 37.31 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.185 -1.007 . . . . 0.0 114.203 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm 66.29 88.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.829 ' HG2' ' H ' ' A' ' 82' ' ' PHE . 44.1 tt0 -166.11 -169.97 1.6 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 168.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.829 ' H ' ' HG2' ' A' ' 81' ' ' GLN . 41.5 t80 -63.66 130.91 46.22 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.659 0.743 . . . . 0.0 110.563 173.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.86 -11.35 68.03 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.013 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 68.7 m -74.55 146.13 42.86 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.568 0.699 . . . . 0.0 112.644 177.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.36 135.23 48.45 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 101' ' ' SER . 45.1 pt -127.54 159.58 37.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.289 -176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -108.25 140.55 41.33 Favored 'General case' 0 CA--C 1.475 -1.938 0 CA-C-O 121.312 0.577 . . . . 0.0 112.425 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -114.43 128.46 56.35 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.98 172.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 12.1 t -139.24 140.3 37.67 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.627 170.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 53.5 m -98.54 -37.29 9.61 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 94' ' ' TYR . 99.7 m -154.69 162.62 41.05 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.637 -169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -62.85 -46.57 87.28 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 170.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 91' ' ' THR . . . -123.21 82.91 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.736 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.65 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 1.7 p90 -152.29 166.56 31.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.564 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 95.2 mtt-85 -103.99 138.59 40.32 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD2' ' HA ' ' A' ' 100' ' ' SER . 38.2 tp -99.81 114.78 28.18 Favored 'General case' 0 C--N 1.268 -2.949 0 C-N-CA 116.853 -1.939 . . . . 0.0 108.125 166.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HB ' HG21 ' A' ' 119' ' ' ILE . 44.8 mm -65.77 -44.36 93.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.662 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.667 ' HA3' HD12 ' A' ' 119' ' ' ILE . . . -87.15 -137.7 5.27 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 119.812 -1.185 . . . . 0.0 114.373 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 m -101.57 116.37 32.6 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.366 0.603 . . . . 0.0 111.173 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.538 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 38.3 t -62.37 -43.8 97.97 Favored 'General case' 0 C--O 1.2 -1.55 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.668 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 13.7 m -114.51 111.59 21.63 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 117.897 -1.521 . . . . 0.0 109.988 -177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.95 143.67 45.59 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.066 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.618 ' HB ' ' OD2' ' A' ' 114' ' ' ASP . 86.6 m -123.04 130.78 53.23 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.86 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 82' ' ' PHE . 38.1 t -82.46 125.69 31.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.257 0.551 . . . . 0.0 112.036 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -128.99 162.91 35.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.684 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.621 HD13 HG12 ' A' ' 111' ' ' VAL . 19.7 mm -96.57 121.73 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 118.083 -1.447 . . . . 0.0 107.462 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.9 p -66.76 -33.62 76.02 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.77 0.795 . . . . 0.0 109.903 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 106' ' ' ILE . . . 164.74 -75.68 0.16 Allowed Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.982 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -102.81 -0.55 31.24 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.624 0.726 . . . . 0.0 110.675 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -148.14 166.14 28.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.573 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.621 HG12 HD13 ' A' ' 106' ' ' ILE . 29.2 m -119.02 131.8 70.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.789 0.804 . . . . 0.0 111.962 -175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.3 pt -129.03 162.8 35.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -88.41 147.53 24.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.779 0.323 . . . . 0.0 110.162 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.618 ' OD2' ' HB ' ' A' ' 103' ' ' THR . 8.0 m-20 -62.91 -35.4 79.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.862 0.865 . . . . 0.0 112.446 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -57.31 138.56 54.67 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 121.934 0.873 . . . . 0.0 112.821 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' THR . 80.0 mm-40 -63.38 -42.55 98.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.553 -1.658 . . . . 0.0 112.178 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 11.7 t 170.7 153.87 0.2 Allowed Pre-proline 0 C--O 1.245 0.862 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -175.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.433 ' C ' HG13 ' A' ' 119' ' ' ILE . 25.5 Cg_exo -62.16 140.84 85.89 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.115 1.077 . . . . 0.0 109.799 176.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.667 HD12 ' HA3' ' A' ' 98' ' ' GLY . 87.8 mt -142.76 150.68 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.8 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.57 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 119' ' ' ILE . 81.8 m -150.82 110.36 4.01 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 118.905 0.775 . . . . 0.0 109.861 170.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.564 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 29.1 t70 -63.37 -42.79 98.88 Favored 'General case' 0 C--N 1.379 1.881 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 56.1 ttm-85 . . . . . 0 C--O 1.243 0.711 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.651 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 C--O 1.227 -0.118 0 CA-C-O 120.567 0.222 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 49' ' ' SER . 21.0 m -73.78 -20.98 60.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.06 38.8 23.9 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 113.802 -1.545 . . . . 0.0 110.569 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.03 122.92 0.02 OUTLIER Pre-proline 0 C--O 1.214 -0.801 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.25 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 11.8 Cg_endo -53.6 -65.7 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.397 2.065 . . . . 0.0 113.587 -172.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 16.3 pt-20 154.5 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.31 1.044 . . . . 0.0 109.721 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -105.43 129.41 53.74 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.026 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 12.2 tp -125.58 115.28 25.06 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.43 -177.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.98 -22.45 62.63 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.429 2.753 . . . . 0.0 113.733 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.551 ' HB3' ' NE ' ' A' ' 33' ' ' ARG . 1.1 p90 -99.09 10.42 41.5 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.19 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . . . -146.69 150.03 34.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -135.89 89.14 21.49 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 123.55 0.74 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 91.5 Cg_endo -70.43 150.1 63.61 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 123.464 2.776 . . . . 0.0 114.439 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -110.37 -10.69 14.58 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.23 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.893 ' HB2' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.7 -19.52 12.84 Favored 'General case' 0 C--O 1.188 -2.14 0 CA-C-O 122.318 1.056 . . . . 0.0 112.563 -168.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 20' ' ' PHE . 49.3 tp -62.54 -40.15 95.87 Favored 'General case' 0 C--N 1.247 -3.869 0 C-N-CA 128.958 2.903 . . . . 0.0 115.187 173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 t -48.9 -39.91 27.83 Favored 'General case' 0 C--N 1.271 -2.83 0 C-N-CA 125.543 1.537 . . . . 0.0 114.633 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -124.11 -6.22 7.8 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.598 0.714 . . . . 0.0 109.361 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -98.47 -63.77 1.1 Allowed 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.93 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 16' ' ' LEU . 79.8 m-85 66.75 -34.06 0.21 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.479 1.511 . . . . 0.0 113.702 174.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.55 125.71 54.1 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 121.159 -0.216 . . . . 0.0 111.005 -172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 28' ' ' LEU . 12.5 m-85 -134.73 148.54 67.63 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.25 164.84 32.15 Favored 'Trans proline' 0 CA--C 1.547 1.149 1 C-N-CA 125.678 4.252 . . . . 0.0 113.185 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 96.6 mt -70.51 133.55 31.64 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 CA-C-O 122.133 0.968 . . . . 0.0 111.42 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.92 20.69 49.3 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.279 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.4 m -118.09 130.31 56.06 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.599 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HB2' ' A' ' 42' ' ' SER . 25.7 m-85 -96.03 131.86 41.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.301 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 15' ' ' GLN . 97.0 mt -106.93 134.86 49.44 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.444 0.64 . . . . 0.0 112.562 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.64 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 98.4 m-20 -66.87 78.46 0.12 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.777 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 13' ' ' PRO . 3.2 m-85 -82.5 138.29 34.37 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-O 121.348 0.594 . . . . 0.0 111.4 166.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 50.9 tp10 -130.62 145.56 51.93 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.584 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -83.06 147.88 27.87 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.551 ' NE ' ' HB3' ' A' ' 10' ' ' PHE . 13.9 ptt180 -54.47 153.86 9.58 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.27 144.15 98.53 Favored 'Trans proline' 0 CA--C 1.555 1.555 0 C-N-CA 122.548 2.166 . . . . 0.0 114.156 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 106' ' ' ILE . . . 75.93 34.48 47.64 Favored Glycine 0 C--N 1.359 1.833 0 N-CA-C 115.676 1.031 . . . . 0.0 115.676 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 19.9 m-85 -110.64 136.94 48.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.1 m -60.41 -40.78 92.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.686 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.1 145.04 42.34 Favored Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.643 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -87.14 130.39 48.19 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.32 142.24 95.34 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.746 1.631 . . . . 0.0 112.469 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -137.9 147.96 44.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.632 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 63.7 m -71.71 147.0 47.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.849 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 54' ' ' ALA . 47.1 pt -90.33 131.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.65 0.262 . . . . 0.0 110.889 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HG ' ' A' ' 46' ' ' LEU . 1.8 mp -116.38 127.52 73.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.106 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -65.86 81.52 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.504 ' HG ' ' HB ' ' A' ' 44' ' ' ILE . 86.8 mt -100.58 -52.33 3.37 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 47' ' ' LYS 0.306 35.2 ttmt -63.87 -96.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 118.164 2.653 . . . . 0.0 118.164 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' LYS . 98.5 m-20 -99.6 33.44 2.5 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 9.0 m 61.58 28.51 17.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 123.942 0.776 . . . . 0.0 110.439 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.474 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 40.4 t -97.78 -99.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.191 -1.997 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.443 ' CD1' ' HA ' ' A' ' 5' ' ' PRO . 99.6 m95 -154.28 164.72 38.13 Favored 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 121.932 -0.48 . . . . 0.0 110.904 176.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -64.8 -35.03 79.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -60.16 0.57 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.328 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' C ' ' HG2' ' A' ' 57' ' ' ARG . . . 45.34 40.88 5.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.735 0.414 . . . . 0.0 111.526 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -109.18 157.32 18.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.442 ' H ' ' HZ ' ' A' ' 10' ' ' PHE . 99.3 m-20 54.28 15.84 1.07 Allowed 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.331 1.052 . . . . 0.0 110.216 -176.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' HG2' ' C ' ' A' ' 54' ' ' ALA . 28.1 mmm180 -66.69 -39.97 88.32 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.208 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 10' ' ' PHE . 25.0 m -95.88 140.97 29.89 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 80.4 mtp85 -127.04 135.58 51.0 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.106 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HD2' HE21 ' A' ' 81' ' ' GLN . 22.4 ptt-85 -97.59 168.4 10.38 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.333 1.453 . . . . 0.0 108.518 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 62' ' ' SER . 49.8 tttp -112.97 155.1 25.37 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.11 0.481 . . . . 0.0 110.643 176.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . 47.4 t -69.51 142.3 53.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 173.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.13 159.07 17.69 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.493 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -134.38 146.05 49.52 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -145.64 85.96 7.56 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HD2' ' HD3' ' A' ' 67' ' ' PRO . 76.7 Cg_endo -103.04 10.13 0.36 Allowed 'Trans proline' 0 CA--C 1.591 3.34 0 N-CA-C 116.242 1.593 . . . . 0.0 116.242 170.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HD3' ' HD2' ' A' ' 66' ' ' PRO . 40.2 Cg_exo -55.09 -41.76 75.61 Favored 'Trans proline' 1 C--N 1.417 4.14 0 CA-C-N 121.781 1.672 . . . . 0.0 110.372 -178.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 p30 41.78 131.49 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 112.807 -1.997 . . . . 0.0 115.441 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HG2' ' CA ' ' A' ' 72' ' ' GLY . 90.9 Cg_endo -70.88 153.89 63.58 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.114 2.543 . . . . 0.0 109.522 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.92 -46.38 96.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.483 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 73' ' ' MET . 28.7 t-20 -64.4 -40.44 95.78 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 121.505 0.669 . . . . 0.0 110.107 175.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 69' ' ' PRO . . . 105.53 28.95 5.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.968 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.701 ' HB2' ' O ' ' A' ' 89' ' ' SER . 65.7 mtt -104.19 89.03 3.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.429 0.633 . . . . 0.0 111.432 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 69' ' ' PRO . 47.0 t -120.73 131.86 71.75 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.689 169.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -115.39 140.44 49.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 79' ' ' GLY . 3.1 p -120.3 116.86 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.806 -177.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.663 HD11 ' HE2' ' A' ' 87' ' ' LYS . 69.9 mt -64.21 -44.84 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HB2' ' OG ' ' A' ' 84' ' ' SER . 42.8 mmtm -116.06 12.96 15.75 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -172.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.606 ' H ' HG22 ' A' ' 76' ' ' VAL . . . 85.12 20.97 56.47 Favored Glycine 0 CA--C 1.569 3.461 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 76' ' ' VAL . 47.8 mm 65.64 76.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-O 121.928 0.87 . . . . 0.0 109.869 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.571 HE21 ' HD2' ' A' ' 60' ' ' ARG . 18.4 tm0? -149.42 166.65 28.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.163 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' HG12 ' A' ' 106' ' ' ILE . 21.8 t80 -62.92 127.28 30.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 121.932 0.872 . . . . 0.0 111.434 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.59 -5.21 73.59 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.215 -175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.637 ' OG ' ' HB2' ' A' ' 78' ' ' LYS . 19.8 m -75.04 150.19 38.98 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.471 0.309 . . . . 0.0 111.592 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' HD12 ' A' ' 77' ' ' ILE . 58.5 tt0 -129.34 142.47 50.81 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 HG23 ' A' ' 76' ' ' VAL . 43.4 pt -128.2 160.52 38.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.909 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.663 ' HE2' HD11 ' A' ' 77' ' ' ILE . 4.6 mptp? -112.53 141.53 46.18 Favored 'General case' 0 CA--C 1.466 -2.28 0 CA-C-O 121.683 0.754 . . . . 0.0 111.252 -176.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -113.15 127.67 56.26 Favored 'General case' 0 N--CA 1.38 -3.944 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.466 170.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.701 ' O ' ' HB2' ' A' ' 73' ' ' MET . 29.6 p -140.8 152.78 45.46 Favored 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.154 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.55 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 57.4 m -115.58 -45.13 2.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.064 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 93' ' ' GLY . 19.5 m -158.56 166.93 30.95 Favored 'General case' 0 C--O 1.202 -1.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.829 -170.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.694 ' HG3' ' N ' ' A' ' 93' ' ' GLY . 20.0 ptpt -65.29 -47.78 75.44 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 121.81 0.814 . . . . 0.0 111.95 168.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 91' ' ' THR . . . -108.14 61.22 0.31 Allowed Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.644 -172.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.566 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 2.2 p90 -147.81 168.35 22.39 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HB2' ' CB ' ' A' ' 121' ' ' ASP . 96.9 mtt180 -122.72 143.65 49.66 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 119' ' ' ILE . 7.7 tt -103.6 116.94 33.28 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 115.834 -2.346 . . . . 0.0 106.89 174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.576 ' HB ' HG21 ' A' ' 119' ' ' ILE . 43.8 mm -66.1 -44.42 91.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.388 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 119' ' ' ILE . . . -96.61 -127.82 5.62 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 119.86 -1.162 . . . . 0.0 114.625 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.545 ' OG ' ' HG3' ' A' ' 115' ' ' GLN . 15.9 p -79.59 118.39 21.39 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 95.8 p -82.71 -6.98 59.67 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.329 1.052 . . . . 0.0 109.33 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' SER . 29.8 p -154.13 160.69 42.04 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . . . -130.52 144.93 51.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 89.4 m -122.71 130.83 53.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -79.2 128.26 33.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.73 159.77 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.103 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.758 HD13 HG12 ' A' ' 111' ' ' VAL . 49.2 mm -86.52 128.81 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.797 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 112' ' ' ILE . 80.0 p -104.17 -6.07 21.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.785 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 35' ' ' GLY . . . 133.94 -93.82 0.26 Allowed Glycine 0 C--O 1.207 -1.562 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.379 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -88.89 -2.09 58.42 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.881 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -148.05 162.46 39.33 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.758 HG12 HD13 ' A' ' 106' ' ' ILE . 29.0 m -118.21 132.06 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 120.806 0.336 . . . . 0.0 111.679 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -128.35 164.34 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.162 0.506 . . . . 0.0 112.235 -176.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -93.35 149.17 21.43 Favored 'General case' 0 C--O 1.246 0.914 0 C-N-CA 123.771 0.828 . . . . 0.0 109.701 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -85.23 -0.71 55.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.116 0.484 . . . . 0.0 111.871 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.545 ' HG3' ' OG ' ' A' ' 99' ' ' SER . 31.4 tt0 -65.02 129.69 40.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 117' ' ' THR . 79.1 mm-40 -66.65 -41.62 87.97 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.107 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 116' ' ' GLU . 1.5 t 168.55 158.83 0.16 Allowed Pre-proline 0 N--CA 1.475 0.775 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.93 132.95 44.76 Favored 'Trans proline' 0 C--N 1.38 2.192 0 CA-C-N 119.842 0.979 . . . . 0.0 110.403 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 97' ' ' ILE . 90.5 mt -134.11 130.18 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.274 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 75.5 m -137.76 122.92 19.23 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 95' ' ' ARG . 50.5 t0 -61.45 -47.11 87.21 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.319 -0.863 . . . . 0.0 112.603 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.733 HH21 HG21 ' A' ' 91' ' ' THR . 54.1 ttm-85 . . . . . 0 C--O 1.269 2.103 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.551 . . . . . . . . 1 1 . 1 stop_ save_